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Fetal exposure to excess glucocorticoid is associated with low birth weight and 
increased cardiovascular disease risk in first generation offspring. Such phenotypes 
can be produced experimentally through the administration of the synthetic 
glucocorticoid dexamethasone (Dex) to pregnant rats during the last week of 
gestation. These ‘programmed effects’ can be transmitted to a second generation 
through both maternal and paternal lines. The overall hypothesis for this thesis was 
that the transmission of programmed effects through the male line may result from 
alterations in fetal germ cells, which form sperm in adulthood.  
Epigenetic reprogramming of germ cells is characterised by the genome-wide erasure 
and subsequent re-establishment of 5-methylcytosine (5mC), however this process 
has not previously been described for the rat. Furthermore, the involvement of more 
recently identified cytosine modifications; 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC), has not been characterised 
during germ cell ontogeny. Using immunofluorescence to study DNA modifications 
during late gestation I identified that 5hmC, 5fC and 5caC were present between 
e14.5 and e16.5 but absent thereafter. In contrast, 5mC was absent during this time 
but remethylation was noted from e19.5 onwards. Prenatal Dex exposure was 
associated with the presence of significantly more 5mC-positive germ cells at e19.5 
relative to controls. This difference did not persist at e20.5 suggesting that Dex 
exposure promotes premature global remethylation. The mechanisms for this are 
unclear since there were no differences between groups in the localisation of the 
DNA methyltransferases DNMT3a and 3b, or in markers of normal testis maturation.   
To enable the study of gene-specific changes in DNA methylation in the germline a 
colony of Germ Cell Specific-Enhanced Green Fluorescent Protein (GCS-EGFP) rats 
was established and characterised. GCS-EGFP rats had a transgenerational decrease 
in pup weight with Dex exposure, as in Wistar rats. The expression of both 
established and novel candidate genes was compared between strains. Multiple genes 
across different pathways had altered expression, with some affected in both Wistar 
and GCS-EGFP rats, whilst other differences were strain-specific. Enhanced 
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Reduced Representation Bisulfite Sequencing was performed on liver and fetal germ 
cells from males exposed to Dex in utero to explore effects on DNA methylation.  
These studies confirm that epigenetic reprogramming occurs in the rat and that this 
process may be susceptible to modification by prenatal Dex exposure. GCS-EGFP 
rats also exhibited a Dex programming phenotype, with decreased pup weight and 
altered liver gene expression. The use of this unique strain of rats will permit 
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Chapter 1 Introduction 
Cardiovascular disease has a significant impact on the health and economy of 
society, and is the predominant cause of mortality within Europe [1]. It is therefore 
important to investigate the factors which might predispose an individual to this 
condition. Fetal programming is the concept that a change in the environment in 
utero can alter tissue structure and function, and lead to an increased risk of disease 
[2,3]. Evidence for programming has come from a range of epidemiological studies, 
exploring, for example, the relationships between maternal diet or stress levels in 
pregnancy with offspring birth weight and subsequent cardiovascular disease risk 
[2,4-7]. Such studies will be explored in depth later in this thesis, but 
characteristically indicate that an altered in utero environment correlates with a 
decrease in birth weight, and alteration of metabolic parameters, such as glucose 
intolerance, and increased blood pressure [2,4-7].  Laboratory models have been 
developed to investigate this phenomenon further, in a more controlled environment. 
Models of both undernutrition and over-exposure to glucocorticoids (a class of 
steroid hormones that bind to the Glucocorticoid Receptor (GR), present in almost 
every vertebrate animal cell) during pregnancy have been shown to correlate with 
low birth weight and increased cardiometabolic disease risk in offspring [8-10]. 
Intriguingly, these phenotypes can be transmitted to a subsequent generation without 
further intervention [10,11].  
In our research group, the synthetic glucocorticoid Dexamethasone (Dex) is 
administered to pregnant Wistar rats during mid-late gestation, to generate a model 
of fetal programming. Their offspring have a lower birth weight and altered 
cardiometabolic parameters, and these effects are also seen in a subsequent 
generation [8,12]. The effects of Dex exposure have been extensively characterised 
in previous studies [8,10,12], however the mechanism of transmission across 
generations remains elusive. In investigating potential pathways for transmission, it 
should be considered that the Dex-programming phenotype can be evoked in a 
second (F2), but not third (F3) generation without further intervention. It can also be 
transmitted through both the maternal and the paternal lines [10]. As the father is not 
present with the mother or pups after fertilisation, we hypothesise that the 
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information for the transmission of the programming phenotype may be carried in his 
sperm.  
During the period of Dex exposure, the fetal germ cells are present, and therefore 
potentially susceptible to effects of treatment. These stem cells form the progenitors 
of the spermatogenic pathway in the adult [13]. Therefore, we hypothesise that if 
these germ cells are affected by Dex exposure during their time in utero, this could 
give alterations in the sperm produced in adulthood, ultimately carrying an epi-
phenotype to the next generation.  
One mechanism by which this phenotype could be carried is through changes in 
epigenetic regulation. This confers a change in phenotype, without a permanent 
mutation of genotype, and this hypothesis is compatible with the observation that the 
effects of Dex-programming can be transmitted to a second, but not third generation 
[12]. DNA methylation has been shown to undergo dramatic genome-wide 
reprogramming during the development of the mouse fetal germ cell [14], and so we 
hypothesised that this process might be susceptible to alteration by Dex exposure. 
Thus, changes in DNA methylation might either carry the phenotype of increased 
cardiovascular risk to the next generation or be an indirect read-out of the 
transmissible agent. 
 
1.1 Fetal Programming 
A correlation between the prenatal environment and a predisposition to future 
cardiovascular disease was initially described with respect to low birth weight [2,3]. 
Lower birth weight was seen to be inversely proportional to systolic blood pressure 
and death rates from cardiovascular disease in adulthood [2,15].  This association has 
been found to be independent of factors such as smoking and alcohol consumption, 
and is identified within the normal range of birth weights [2,15]. It has therefore been 
suggested that in addition to genetic effects on growth and disease risk, the 
developing fetus may be permanently ‘programmed’ by the intrauterine environment 
for a specific adult phenotype [3,16]. In this way, the mother may transmit 
information about the external world to her unborn child, preparing it for the 
environment into which it will be born. This could be beneficial, for example, in 
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preparing offspring to cope with famine, yet if these cues are incorrect, or the 
external environment alters during the lifespan of the offspring, this may leave them 
physiologically less adapted for their surroundings, and therefore at greater risk of 
developing conditions such as cardiovascular disease [17].  Two main environmental 
factors have been proposed to induce fetal programming: fetal undernutrition; and 
exposure to glucocorticoid excess [4,8,10].  
 
1.1.1 Nutrition and Fetal Programming 
The effects of maternal undernutrition became apparent following the ‘Dutch Hunger 
Winter’ of 1944-1945. During this time, residents of the Western Netherlands 
experienced acute famine for a short period during World War Two. Later, research 
revealed that women who were pregnant during this time had babies with a lower 
birth weight and a greater risk of glucose intolerance, insulin resistance, obesity and 
cardiovascular disease in adulthood [4,5,18,19].  The exact outcome was shown to be 
dependent on the stage of gestation when exposure occurred [7,20].     
Similarly, maternal obesity or over-nutrition has been shown to produce 
programming in offspring [21,22]  It could be suggested that such an association 
simply reflects a transmission of genetic disposition between mother and child. 
However, in mothers that gained weight between pregnancies, the risk of having a 
baby that was large for gestational age was increased [23]. Conversely, offspring 
born to mothers after anti-obesity surgery had improved cardiometabolic parameters 
compared to siblings born before maternal weight loss [24]. 
An examination of the direct effects of maternal nutrition has also been achieved 
through animal studies. Maternal dietary restriction has been shown to produce 
offspring with lower birth weight, glucose intolerance, and cardiovascular 
dysfunction [9,25,26]. These phenotypes may also be transmitted to a second 
generation without further intervention [11]. Similar phenotypes were exhibited with 
maternal low-protein [27-30]  or high-fat [31,32] diet in pregnancy.  Intriguingly, 
offspring were reported to have increased preference for a high-fat diet following 
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either protein restriction or nutrient excess in utero [33-35], perpetuating a 
disposition to cardiometabolic disease. 
 
1.1.2 Glucocorticoid Programming  
A second potential stimulus for fetal programming is excessive exposure to 
glucocorticoids. These steroid hormones are crucial regulators of a diverse range of 
physiological pathways, including the stress response, metabolic pathways, response 
to infection and the maintenance of blood pressure and fluid homeostasis [36]. 
Glucocorticoids can act through two receptors: the GR and the Mineralocorticoid 
Receptor (MR). In humans GR is detectable in most tissues by 8-10 weeks gestation 
[37]. In mice, a more detailed profile of Gr expression in development has been 
obtained. At embryonic day (e) 9.5, Gr expression is low, however expression 
increases, with tissue-specific timing, as development progresses. Some tissues, such 
as liver show a rise in Gr expression by e12.5 [38]. This elevation in GR promotes 
fetal maturation, and exogenous glucocorticoids are frequently given to accelerate 
lung development in fetuses at risk of premature delivery [39]. 
The 11β-Hydroxysteroid Dehydrogenase (11β-HSD) enzymes regulate the action of 
glucocorticoids by catalysing the conversion between active and inactive forms 
(Figure 1.1). The Type 1 isoform acts as a reductase, converting inactive 
glucocorticoids to their active forms (cortisone to cortisol in humans, and 11-
dehydrocorticosterone to corticosterone in rodents) [40-42]. Conversely, 11β-HSD2 
converts active glucocorticoids into inactive metabolites, and is present in the 
placenta, serving to protect the fetus from the comparatively high levels of 
glucocorticoid in the maternal circulation. Inhibition of this second enzyme in 
pregnant rats has been shown to correspond to decreased weight at birth, with 
hyperglycemia and increased blood pressure in adult offspring [43,44]. 11β-Hsd2 
knockout mice also produced progeny with a lower birth weight and which 
demonstrated greater anxiety in adulthood [45]. Although placental 11β-HSD2 acts 
as a barrier to maternal glucocorticoid, some active cortisol/corticosterone still passes 
to the fetus. Therefore elevated maternal cortisol, in periods of stress, can still have 
an impact upon the unborn child. For example, rats exposed to restraint stress during 
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pregnancy had offspring that had lower birth weight and hyperglycemia and glucose 
intolerance at 24 months (old age) [46]. This stress was also found to alter the 
placenta itself, reducing the expression of 11β-Hsd2, and potentially augmenting 
fetal exposure to glucocorticoids [47]. Another study suggested that the effects of 
stress on 11β-HSD2 activity differ depending on the duration of the stimulus. In the 
short term, acute restraint stress for one day (e20) of pregnancy increased placental 
activity of 11β-HSD2, protecting the fetus from excess corticosterone. However in 
chronic stress (e14-e19), 11β-HSD2 activity was not altered, and could not 
subsequently be upregulated in response to acute stress [48].   Glycyrrhetinic acid, a 
component of liquorice, is known to be an inhibitor of 11β-HSD2 [49], and therefore 
studies have explored the outcome of pregnancies in Finland, where liquorice 
consumption is common [50]. Children of mothers who consumed high levels of 
liquorice were found to have greater circulating levels of cortisol than those whose 
mothers ate less or no liquorice during pregnancy [51]. Indeed, high liquorice 
consumption in pregnancy was associated with poorer cognitive performance in 
offspring at 8.1 years, constituting reduced visuospatial and verbal skills and 
impaired narrative memory compared to those whose mothers consumed no or low 
amounts of liquorice.  A greater risk of behavioural issues in offspring was also 
reported, with increased tendency for rule-breaking and aggression [50]. It was not, 

















Figure 1.1. Action of the 11β-HSD enzymes. 11β-HSD enzymes catalyse the 
conversion between active and inactive forms of glucocorticoid. 11β-HSD1 acts as a 
reductase, converting inactive glucocorticoids to their active forms (cortisone to 
cortisol in humans, and 11-dehydrocorticosterone to corticosterone in rodents) 
[41,42]. Conversely, 11β-HSD2 inactivates these glucocorticoids [53]. 
 
 
Some insight into the effects of prenatal glucocorticoid overexposure may be gained 
from epidemiological studies examining the effects of the glucocorticoid cortisol on 
offspring, elevated due to maternal psychological stress [54], for example during 
war. Such studies however, can be complicated by co-existent factors such as 
exposure to food restriction, chemical pollutants, and ionizing radiation, which could 
also impact upon fetal development [55].  For example, babies born to pregnant 
women who were physically close to the World Trade Centre (WTC) during or 
shortly after the disaster of September 11, 2001 had a lower birth weight compared to 
those born to women living out with a 2 mile radius of the WTC. Potentially 
confounding variables such as infant sex and maternal pre-pregnancy weight were 
controlled for [6]. Similarly, offspring of mothers in proximity to the WTC disaster 
were found to have a greater risk of intra-uterine growth restriction (IUGR) than 
those delivered in a different area of New York, whose mothers had not been close to 
the WTC at the time of the disaster [56]. This change could result from mothers 
being closer to the air pollution generated by the disaster, compared to control 
mothers from other areas. However, mothers geographically closer may also have 
been more emotionally affected by the disaster. The causes of IUGR and decreased 






treated with caution as there are not perfect control populations with which to 
compare their results. However, taken together with other epidemiological studies 
and laboratory data, they do contribute to our understanding of the effects of 
glucocorticoid exposure on development.  
It should also be noted that the time-point in pregnancy where maternal stress occurs 
may also influence the birth outcome. For example, Lederman et al. (2004) report 
that those in the first trimester of pregnancy during the World Trade Centre disaster 
had offspring with a shorter gestation, and smaller head circumference compared to 
those in second or third trimesters at that time [6]. However, no difference was seen 
in rates of IUGR [56]. Taken together, these studies support the conclusion that 
human maternal emotional stress can correlate with reduced fetal growth in 
offspring.  
However, whilst maternal cortisol is elevated in response to psychological stress, 
activity of 11β-HSD2 may also be upregulated, protecting the fetus from some of this 
excess of glucocorticoid [54]. Further insight is gained from studies exploring the 
effects of synthetic glucocorticoid administration, such as Dex, which is a poor 
substrate for 11β-HSD2 [57].  Exogenous glucocorticoids are routinely given to 
accelerate lung maturation in fetuses at risk of premature delivery [39]. This reduces 
the incidence of respiratory distress syndrome, but repeated doses can also restrict 
intrauterine growth [39]. The metabolic effects of such administration have yet to be 
fully elucidated [39]. 30 years after prenatal glucocorticoid treatment, offspring had 
no change in weight, incidence of cardiovascular disease or diabetes, but did have 
higher insulin levels, indicating that diabetes could become more prevalent in later 
life [58]. Similarly, another study showed that prenatal glucocorticoid treatment was 
not associated with alterations in body composition, insulin resistance or blood 
pressure at 19 years of age, however a lower glomerular filtration rate was identified, 
which could give a greater risk of hypertension and renal failure with aging [59]. 
Furthermore, babies born at term, but whose mothers had received glucocorticoid 
treatment due to a threat of premature delivery had increased cortisol levels in 
response to pain, suggesting alterations in the Hypothalamic-Pituitary-Adrenal 
(HPA) axis [60].  
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Clearly, antenatal glucocorticoid treatment is important in improving outcomes for 
children born prematurely, and although research suggests there could be some risks 
to metabolic health in later life, further studies are required to properly inform the 
assessment of these risks. Currently, antenatal administration of glucocorticoid 
continues, as the benefits to health and survival outweigh the characterised risk in 
later development. However, the effects of glucocorticoid exposure have been more 
extensively investigated in animal models. They suggest that there could be 
detrimental effects of glucocorticoid exposure which may have yet to be elucidated 
in humans [8,10]. Crucially, they also provide a well-controlled model of fetal 
programming as a whole, potentially giving insights into the relationship between 
maternal environment, low birth weight and cardiovascular disease.  
The effects of Dex administration have been studied in the developing fetus. When 
administered to pregnant rats, their offspring were shown to have a lower birth 
weight, and develop hyperinsulinemia and hyperglycemia in adulthood [8]. 
Expression and activity of Phosphoenolpyruvate Carboxykinase (PEPCK), involved 
in gluconeogenesis and upregulated in diabetes [61], was also increased in the liver 
[8].  Blood pressure was also found to be increased, along with levels of leptin, 
involved in regulating appetite and weight gain [62,63]. Dex exposure also changes 
gene expression in the livers of offspring. In late gestation, expression of Insulin-like 
Growth Factor 2 (Igf2), Cyclin-Dependent Kinase Inhibitor 1C (Cdkn1c), Growth 
Factor Receptor-Bound Protein 10 (Grb10) and H19, all important in the regulation 
of growth and development, were increased in livers of Dex-exposed fetuses [12].  
Furthermore, when the Dex-exposed offspring were weaned on to a high-fat diet they 
had increased liver triglyceride content and increased expression of genes implicated 
in fatty acid esterification and triglyceride synthesis, compared to those exposed to 
Saline control in utero. This indicates that these animals have a greater risk of 
developing fatty liver disease [64]. Fatty acid uptake was also reduced in visceral 
adipose tissue, along with an increase in the expression of GR, which could promote 
insulin resistance [65]. 
Dex administration also alters the structure and function of the renal and 
cardiovascular systems, which could contribute towards the observed change in 
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blood pressure. In Dex-exposed female offspring, hypertension was concurrent with 
increased expression of liver angiotensinogen and renin activity. This suggests an 
activation of the Renin-Angiotensin System (RAS), which regulates fluid 
homeostasis and blood pressure [66]. Increased blood pressure could also be in part 
due to an increase in contractility of arteries [67]. 
Furthermore, some studies have shown the effects of exogenous prenatal 
glucocorticoid treatment in other mammals. In sheep, administration of 
glucocorticoid to pregnant ewes resulted in increased blood pressure in lambs 
[68,69]. This corresponded to altered renal function, with increased glomerular 
filtration rate and renal sodium reabsorption [68].  It was also seen to alter vascular 
responsiveness to stimuli in the fetus [69] and early postnatal period, which could 
promote the development of hypertension [70]. At 5 months however, there was no 
change in blood pressure between Dex and control offspring, which the authors 
propose is a result of compensatory mechanisms relaxing the vasculature [71]. 
Hepatic mRNA and protein levels of 11β-HSD1 were also found to be increased in 
the fetus, which could alter the expression of glucocorticoid-dependent genes in the 
liver and augment the effects of the initial exposure [72].  
Programming effects of prenatal glucocorticoid exposure have also been reported in 
non-human primates. Glucocorticoid treatment increases the blood pressure of the 
unborn fetus in mid-late gestation [73]. Dex exposure was not found to alter the birth 
weight of offspring, but did impair growth postnatally. At 8 months, offspring had 
glucose intolerance and hyperinsulinemia, and by 12 months reduced numbers of 
insulin-producing β-cells were found in the pancreas, and blood pressure was 
increased [74].  Furthermore, 11β-HSD1 expression and activity was increased in the 
liver and pancreas of offspring, whilst Gr expression remained unchanged [75].  
Such direct studies are clearly not possible in humans, for example the measurement 
of 11β-HSD1 expression in offspring liver. However the fact that the programming 
phenotype is conserved in other primates does support the conclusion that metabolic 




1.1.3 Intergenerational Programming 
Research indicates that the effects of maternal nutrition or exposure to excess 
glucocorticoid may not only influence the first generation (in utero during the period 
of exposure), but may also be transmitted to a subsequent generation. In the Dex-
programmed rat model, a reduction in birth weight following in utero Dex exposure 
was found to be carried to a second generation, without further intervention [10]. The 
phenotype of glucose intolerance and elevated hepatic PEPCK was also seen in 
second generation (F2) males whose mothers and fathers had both been exposed to 
Dex. Intriguingly, the effect on birth weight and PEPCK activity was also seen when 
Dex-exposed first generation (F1) males were mated with control females, and vice 
versa. Thus, the phenotype may be carried through both maternal and paternal lines 
[10].   
Intergenerational transmission of the programming phenotype induced as a 
consequence of glucocorticoid programming has also recently been demonstrated in 
sheep. Dex exposure was found to result in reduced birth weight and glucose 
intolerance in both first and second generation lambs, when transmission was studied 
through the maternal line [76]. Similarly, in guinea pigs, a phenotype of altered HPA 
activity and behaviour was transmitted to a second generation through the maternal 
line [77].  
Intergenerational effects have also been reported in models of nutritional 
programming. In a mouse model of prenatal undernutrition, the phenotype of low 
birth weight was transmitted to the F2 through the paternal line, obesity through the 
maternal line, and impaired glucose tolerance through both lines [11]. Grand-
maternal protein restriction also corresponded to altered glucose and insulin 
metabolism in F2 rats [78].  Interestingly, a phenotype of impaired glucose 
metabolism in rats following maternal undernutrition was transmitted to both a 
second and third generation, through the maternal line [79]. This is in contrast to the 
Dex-programming model, where the phenotype had resolved by the third generation 
[10].  
Intergenerational transmission of a phenotype through both maternal and paternal 
lines has also been seen in human studies. Many explore the effects of nutrition, 
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which are sometimes dependent on a calculated likelihood of food availability, based 
on historical knowledge and local community records. A greater availability of food 
to the paternal grandfather during his slow growth period correlated to an increased 
incidence of diabetes in grandsons [80]. Pembrey et al. (2006) show that food 
availability to the paternal grandfather is correlated with calculated mortality risk in 
grandsons exclusively. Conversely, the diet of the paternal grandmother was 
correlated with the granddaughter’s mortality risk. This was based on diet exposure 
in the slow growth period of both grandparents, and the fetal life of the grandmother. 
Therefore a transgenerational effect was observed, with gender-specific phenotypes, 
which the authors conclude may be transmitted through the X and Y chromosomes 
[81].  Studies have also explored the effects of the Dutch Hunger Winter on 
grandchildren. Exposure to famine was not found to significantly alter the birth 
weight [20,82], or metabolic or cardiovascular disease incidence in grandchildren 
[82]. However F2 body length was decreased and adiposity increased at birth, and 
more ill-health was reported in adulthood, suggesting there were some effects of F1 
maternal undernutrition, carried in the female line to the next generation [82].  
 
1.1.4 Mechanisms of Programming 
Fetal programming therefore has been seen to occur in animal models in response to 
aberrant nutrition or excess glucocorticoid exposure, and although less extensive, 
data suggest that these effects are also seen in humans. A phenotype of low birth 
weight and altered cardiometabolic parameters may be carried in both the maternal 
and paternal lines to subsequent generations [10]. The precise phenotype exhibited is 
seen to vary, with type and timing of exposure, however some patterns have 
emerged. Many studies report a change in birth weight in offspring, with adverse 
effects on glucose and insulin regulation. It has therefore been suggested that a 
common mechanism may underlie many of the examples of programming [36]. 
Clearly in some instances of intergenerational transmission, it is possible that the 
stimulus that promoted the phenotype in the first generation may still be present 
whilst the second generation is in utero. For example, a mother who eats a high-fat 
diet in pregnancy may subsequently raise children who will also eat a high-fat diet in 
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their own pregnancies. Indeed, even if such a trait is not transmitted by behaviour 
alone, animal studies have shown that exposure to a high-fat diet in utero increases 
the offspring’s preference for unhealthy food in adulthood [34]. Therefore a 
phenotype could perpetuate across generations. For many studies, however, this is 
not a suitable explanation. Many of the studies above involve exposure to an isolated 
stimulus. For example, offspring were seen to be ‘programmed’ during the Dutch 
Hunger winter, which represented an isolated event which was not repeated during 
the pregnancies of the F1 generation.   
It could also be suggested that changes in the F1 mother could alter the in utero 
environment of her children. Studies have shown that programming can change HPA 
axis regulation or insulin responses in the F1 mother during pregnancy, so that her 
children might themselves experience an adverse environment in utero, which could 
in turn induce the programming phenotype [8,74]. This could be a valid explanation 
for some studies which show programming through the maternal line.  
It should however, be considered that a transmission of phenotype has also been 
shown through the male line, where there is no direct influence on the in utero 
environment [10]. In human studies, it could be suggested that there is some 
influence of paternal behaviour on the offspring either pre or post-natally. For 
example, an F1 father who experienced in utero malnourishment during the Dutch 
Hunger Winter could respond differently to stressful stimuli, promoting changes in 
the pregnant mother carrying his child. However, programming has been shown to be 
transmitted through the male line of laboratory rats, where the father has no 
interaction with the mother or offspring after mating [12]. A behavioural influence 
on the mother at this point cannot be ruled out, but seems less likely to produce a 
significant and reliable phenotype in the offspring born weeks later.  
We therefore hypothesise that a programming phenotype may be transmitted to an F2 
generation in the sperm of F1 males. It is interesting to note that in the Dex-
programmed rat, the phenotype differs between first and second generations. 
Although both may have changes in birth weight and cardiometabolic parameters, 
changes in gene expression differ. For example, Dex exposure increased the 
expression of Igf2 in F1 liver, whilst a decrease was seen in F2 [12].  One possible 
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explanation for these differences is that the mechanisms of programming induction 
are different between generations. The F1 fetus experiences the exposure whilst it is 
in utero, therefore the excess glucocorticoid can have a direct effect on its metabolic 
development. The second generation do not experience direct exposure, but may 
have an altered phenotype based on information carried in the germ cells (see Figure 
1.2). Therefore a programming phenotype could be carried to a second, but not third 
generation, as observed in this model [10]. Whilst it is equally possible that a 
phenotype can be carried in both maternal and paternal germ cells, it is hard to 
isolate the effects of the maternal germline from those of the intra-uterine 




Figure 1.2. Intergenerational transmission of disease risk phenotype. Whilst the F1 
generation are in utero during the period of Dex exposure in the programming 
model, their germ cells, which will one day contribute to the F2 generation are also 
present. If Dex exposure impacts upon these developing germ cells, this could be 




When considering programming by in utero exposure to excess glucocorticoid or 
altered nutrition it is worth noting that the literature broadly presents three different 
routes for programming. There are studies which present the effects of intra-uterine 
exposure on the first generation, such as those of Painter et al. (2005) who report that 
maternal malnutrition during the Dutch Hunger Winter correlated with increased 
prevalence of coronary heart disease, glucose intolerance and obesity in adult 
offspring [7].  There are others which demonstrate the effects of an intra-uterine 
exposure on a second generation through maternal or paternal lines, such as Jimenez-
Chillaron et al. (2009) who showed that maternal dietary restriction corresponded to 
reduced F2 birth weight, through the male line, and increased F2 adulthood obesity 
through the female line [11]. Here it could be suggested that there is some effect of 
the initial exposure on the developing germ cells. In a third type of study there is an 
effect demonstrated on a third generation, which has never been exposed to the initial 
insult, whether directly, whilst in utero, or indirectly, whilst the germ cells from 
which the F2 generation are formed are in utero, within the F1 pups. The effects on 
the F3 generation are less frequently reported in the literature, potentially due to the 
time and financial implications of such studies. However, for example, Benyshek et 
al. (2006) report that maternal protein restriction alters glucose metabolism in the 
third (F3) generation [79].  In the Dex programming model, there are observed 
effects on the F1 and the F2, but not the F3, thus there is no reported effect on pups 
which have had no direct or indirect exposure to Dex treatment [10]. We propose 
therefore that the effects seen in the F2 are carried in the germline of the F1 pups. If 
indeed the F2 phenotype results from germline exposure this effect is 
transgenerational, but not truly inherited, in the sense that there has been some 
exposure, in the form of F1 germ cells, to the initial insult. 
I therefore sought to investigate the transmission of the programming phenotype in 
the Dex model. The male line was studied as it allowed the hypothesis of 
transmission in the germline to be studied, without the potential confounding factor 





1.2 Mechanism of Intergenerational Transmission – the Developing Germ 
Cell 
Since sperm is not found in the fetal male, F1 in utero Dex exposure cannot directly 
affect the sperm itself, but could change the developing sperm progenitor cells, or 
germ cells. These germ cells will form the progenitors of the spermatogenic pathway 
in adulthood, so that if these germ cells are changed whilst they are in utero during 
F1 fetal exposure, this could later be transmitted through the spermatogenic pathway 
to a second generation. 
The process of spermatogenesis allows around 300 million sperm to be produced in 
the testes daily from puberty [13]. This process occurs in the seminiferous tubules 
within the testis, which contains germ cells at different stages of maturation and 
somatic Sertoli cells, which serve to support germ cell development [83]. Fetal germ 
cells become the progenitor stem cells of the spermatogenic pathway, termed 
spermatogonia, and they exist around the basal circumference of the seminiferous 
cord. These cells undergo mitotic division, followed by two rounds of meiosis, 
progressing through various stages of maturation, and migrating towards the central 
lumen of the tubule as they do so (Figure 1.3) [84]. The process of spermatogenesis 
is cyclical, with different cell types being present within different sections of the 
tubule, depending on its corresponding cycle stage. Each stage has a defined 
duration, and the entire process is complete within 12.8 days in rats [13,85]. Mature 
spermatozoa are released into the seminiferous tubule lumen, and progress to the 










Image: Rose et al. Unpublished  
Figure 1.3. Primordial germ cells form the progenitors for adult spermatogenesis. 
This process is initiated by the mitotic division of the spermatogonia, maintaining the 
progenitor population,  before some are converted into sperm through two rounds of 
meiotic division [86]. Bar = 10µm. 
 
 
Some studies have shown that programming stimuli can affect reproductive 
development in male offspring. For example, maternal protein restriction in rats 
produced male offspring with an increased Ano-Genital-Distance (AGD), indicating 
increased masculinisation, which may result from the increase in maternal serum 
testosterone levels, observed at e19. Testis descent was also delayed and testis 
weight decreased at all ages [87].  At 70 days of age, concentrations of luteinising 
hormone and testosterone were decreased, and sperm count and maturation was also 
decreased at maturity [87]. Furthermore, maternal restraint stress in late gestation 
was found to reduce the testis weight of male rats, corrected for body weight [47]. In 






to decrease, but this was not corrected for body length, and pups were of lower 
weight [47]. The authors suggest the change in testis weight could be due to effects 
on steroid production in development. Indeed maternal restraint stress was found to 
reduce plasma testosterone in pups in late gestation, and the authors suggest that this 
could alter sexual behaviour [88].  Prenatal stress was reported to feminise juvenile 
play behaviour in male offspring, and correlated with more feminine sexual 
behaviour [89]. A correlation between reported maternal stress and gender role was 
not found in human children [90].   
Therefore environmental factors may influence the development of the testis as a 
whole in addition to mating behaviour of offspring. In the Dex-programmed rat, Dex 
exposure was not found to change intratesticular testosterone in fetuses at e17.5, nor 
the AGD or testis weight of adult offspring, although it did augment the detrimental 
effects of the endocrine disruptor Di(n-butyl) Phthalate (DBP) [91]. It cannot be 
ruled out that Dex may have an effect on plasma testosterone levels during the fetal 
surge between e17.5-e18.5 [88]. It has been observed that Dex-exposed F1 males 
appear less aggressive in mating, but do still mate shortly after being paired (Drake et 
al., unpublished observation). The Dex males are clearly still fertile, and produce as 
many pups per litter as control rats. It may therefore not be important that gross 
changes in the testis were not observed previously, as a phenotypically programmed 
offspring is still produced. I hypothesise that the sperm itself, and the germ cells 
from which it is derived, are of the most relevance.  
Investigating this hypothesis is challenging, in that it is difficult to access pure 
populations of fetal germ cells, separating them from the surrounding somatic cells 
of the testis. We recently obtained Germ Cell Specific-Enhanced Green Fluorescent 
Protein (GCS-EGFP) rats that have EGFP expression specifically in the male and 
female germlines [92]. This allowed me to use Fluorescence-Activated Cell Sorting 
(FACS) to purify germ cells for study.  
Recent studies have suggested that there may be some link between epigenetic 
regulation in the germ cell, the subsequent sperm and the resulting offspring [93], 
which will be reviewed later. Along with them, I hypothesise that one kind of 
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epigenetic regulation that could be changed in the germline with programming is 
DNA methylation.   
 
1.3 Introduction to Epigenetics 
Epigenetics was first defined as “the science concerned with the causal analysis of 
development” by Conrad Waddington in 1952 [94]. More recently Berger et al. 
(2009) proposed that “an epigenetic trait is a stably heritable phenotype resulting 
from changes in a chromosome without alterations in the DNA sequence” [95]. This 
may constitute modifications to DNA itself, or a change to the structure of 
chromatin, for example by histone modification. Histone proteins form the central 
core of a nucleosome, consisting of 146 base-pairs (bp) of DNA wound around an 
octomer of histone proteins, with two copies of histones H3, H4 and the dimer H2A-
H2B [96-98]. Each core histone has an N-terminal tail which protrudes from the 
nucleosome, the amino acids of which are subject to post-translational modification, 
such as acetylation, phosphorylation or mono-, di- or tri-methylation [99]. Thus, 
H3K4me3 would constitute tri-methylation of lysine 4 of the tail of a H3 histone 
protein [98].  This in turn influences chromatin compaction, the interaction of 
transcription factors with DNA and ultimately regulates whether genes are expressed 
or silenced [100]. Non-coding RNA (ncRNA) sequences can also influence gene 
expression. For example micro RNA (miRNA), the most extensively characterised 
class of ncRNA, are around 22 nucleotides in length and can regulate expression at 
the level of translation. miRNA has sequence specificity for mRNAs and can either 
facilitate the binding of a silencing complex, or target mRNA for degradation [101].   
 
1.3.1 DNA Methylation 
One of the most extensively characterised forms of epigenetic regulation is DNA 
methylation. DNA methylation involves the addition of a methyl group to the 5’ 
position of a cytosine base to form 5-methylcytosine (5mC). DNA methylation was 
first reported by Wheeler and Johnson in 1904 [102], but it was not until 1925 that it 
was demonstrated to exist in nature, in a study of the bacterium Tubercle bacillus 
[103]. Paper chromatography was then used to prove its existence in calf thymus 
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DNA in 1948, the first demonstration of methylation in mammalian cells [104]. A 
fundamental advance in the field of DNA methylation research was made in 1975 
when Holliday and Pugh, and independently, Riggs proposed that this cytosine 
modification might be key in regulating gene expression [105,106]. 5mC is now 
recognised as a meiotically and mitotically heritable epigenetic modification with an 
important role in transcriptional regulation [95]. DNA methylation is found in 
bacterial, plant and mammalian cells, but is not ubiquitous, and is undetectable for 
example, in yeast. The degree of cytosine methylation was found to vary between 
species, with 14% of total cytosines methylated in Arabidopsis thaliana, 7.6% in 
mice, 2.3% in Escherichia coli and only 0.034% in Drosophila melanogaster [107]. 
One way in which DNA methylation mediates effects on gene expression is through 
altering the interaction of DNA with transcriptional elements, such as RNA 
polymerase II, reducing transcriptional efficiency within the gene body [108]. DNA 
methylation has also been found to recruit proteins such as the Methyl-CpG Binding 
Domain Proteins (MBDs), which subsequently promote the interaction of other 
factors which may, for example alter chromatin structure, and therefore DNA 
accessibility to transcriptional machinery [109]. For example, DNA methylation 
recruits the Methyl-CpG-Binding Protein 2 (MeCP2) which in turn recruits histone 
deacetylase, therefore inducing chromatin remodelling to produce a repressive state 
[109].    
In mammals, this modified cytosine predominantly exists in a Cytosine-Phosphate-
Guanine (CpG) dinucleotide, where a cytosine base is located next to a guanine in 
the DNA sequence [110]. Whilst most individual CpGs throughout the mammalian 
genome are methylated, regions of high CpG density are predominantly 
unmethylated; approximately 50% of these CpG islands occurring at annotated 
transcription start sites, with the remainder distributed equally between intra- and 
inter-genic regions in mice and humans [111,112]. Intriguingly, GpG islands out 
with known transcription start sites have a greater incidence of methylation during 
development, indicating that they may regulate the expression of developmentally 
relevant genes [112]. Methylation has also been demonstrated in CpG island ‘shores’ 
– regions up to 2kb from a CpG island, which were found to have differential 
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methylation in colon cancer [113]. Differential methylation at CpG island shores had 
a greater correlation with gene expression than that associated with CpG islands 
themselves [114]. Much less frequently, non-CpG methylation occurs, but its precise 
function remains elusive [115]. It has been reported to exist predominantly in 
pluripotent cells, with decreased identification upon cellular differentiation, and 
subsequent reappearance with induced pluripotency [115,116].   
Cytosine modification contributes to the regulation of transcription, with promoter 
DNA methylation characteristically associated with gene silencing [117]. One such 
role of this regulation is in the inactivation of the paternally inherited X chromosome 
in females. This second X chromosome is inactivated (Xi) rendering the majority of 
genes transcriptionally silent in early embryogenesis, in a process that is yet 
undefined, but has very recently been suggested to involve the Long Interspersed 
Nuclear Element 1 (LINE1) retrotransposon [118,119].  DNA methylation then 
contributes to the maintenance of this silencing throughout development [118]. The 
active X (Xa) chromosome has approximately two times more allele-specific DNA 
methylation than the Xi, however this predominantly exists in gene bodies, with 
corresponding hypomethylation at gene promoters [120]. The majority of CpG 
islands on the Xi were found to have increased methylation, and were associated 
with transcriptionally silent genes, whilst 7% were found to have reduced 
methylation, and escaped inactivation [118].  
DNA methylation also has an important role in the silencing of retrotransposons, 
mobile genetic elements capable of moving around the genome via RNA 
intermediates. Three classes exist in mammals; LINEs, Short Interspersed Nuclear 
Elements (SINEs) and Endogenous Retroviruses (ERVs), which are sometimes 
flanked by a Long-Terminal Repeat (LTR) region (reviewed in [121]). DNA 
methylation is thought to protect the genome from mutation through transposition, by 
silencing of these retrotransposons [122,123].   
Imprinting confers the expression of genes in a parent of origin-specific manner 
[124]. One mechanism which can contribute to imprinting is DNA methylation, 
where one allele of the imprinted gene is unmethylated, whilst the other is 
methylated at key regulatory regions, the pattern of which is inherited from the 
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parental genome. Intriguingly, the pattern of methylation at imprinted genes may 
reflect the competing interests of the parent from which it originates, as first 
proposed in the study of flowering plant endosperm [125,126]. Therefore, it has been 
hypothesised that imprinting from the paternal line may promote the expression of 
growth factors, promoting the maximum growth of his offspring. Conversely, 
imprinting from the maternal line may promote the moderation of growth, balancing 
the need for fetal development, with the conservation of the mother’s own resources 
[127,128]. Very recently, this theory was suggested to be overly simplistic, and that 
instead of conflict, imprinting may for example represent a benefit of offspring 
exhibiting a phenotype more similar to one parent [129]. 
The DNA Methyltransferase (DNMT) enzyme family catalyse de novo and 
maintenance methylation.  DNMT1 is the key enzyme involved in maintaining DNA 
methylation, and imprinting. When DNA is replicated, DNMT1 methylates the 
newly replicated CpGs corresponding to methylated sites on the mother strand of 
DNA. It is attracted to these sites by the proliferating cell nuclear antigen-interacting 
binding partner Nuclear Protein 95 (NP95) and serves to methylate hemimethylated 
CpGs [130,131]. Loss of DNMT1 is associated with a reduction in levels of DNA 
methylation, and subsequent embryonic lethality [132].  A loss of NP95 was shown 
to have a similar effect [131]. DNMT1 and its ovarian isoform DNMT1o are 
involved in the maintenance of this imprinting in mice [133,134]. Partial loss of 
DNMT1 in transgenic mice therefore corresponded to a dysregulation of the 
imprinted genes H19, Igf2 and the Igf2 receptor (Igf2r) [135]. The DNMT3 family 
are involved in de novo methylation, and will be discussed in section 1.4.2.   
 
1.3.2 Different forms of methylation 
To date, four different types of methylation have been identified in mammalian and 
plant cells and it has been suggested that these variants may have different effects on 
gene expression. 
The Ten-Eleven-Translocase (TET) dioxygenase enzyme family has been shown to 
oxidise 5mC to 5-hydroxymethylcytosine (5hmC) (Figure 1.4) [136,137]. 5hmC was 
first identified in a study of bacteriophages in 1952 [138], and in mammals in 1972 
22 
 
[139], however the latter was subsequently refuted by other researchers who failed to 
replicate this finding [140]. In 2009, 5hmC was identified in mouse brain, giving 
greater certainty of its existence, and reigniting interest in this form of methylation 
[141]. Some studies have also reported the presence of 5hmC in plants [142,143], 
whilst other data suggest that it is absent from the plant genome, at least in some 
species [144].  5hmC has widespread distribution, with tissue-specific patterns of 
localisation. This modification is primarily associated with euchromatin and located 
in the body of transcribed genes, with 5hmC levels having a positive correlation with 
the level of gene transcription [145-147]. Intriguingly, however, this correlation is 
only relevant within a given tissue. Thus, the absolute level of 5hmC, corresponding 
to high levels of transcription may differ greatly between tissue types [145]. In 
contrast to 5mC, 5hmC is also enriched at some CpG-rich Transcription Start Sites 
(TSS) in Embryonic Stem (ES) cells [146,147].  Decreased levels of TET expression 
during differentiation is associated with a decrease in 5hmC at the gene promoters of 
ES cells, and a corresponding increase in 5mC levels and gene silencing [147]. TET 
1 and 2 knockout mice also have decreased 5hmC, increased 5mC levels and 
abnormal imprinting. Mice are however viable, suggesting that TET 3 may be able to 
partially compensate for this knockout [148].  
Two additional forms of methylation have been described, termed 5-formylcytosine 
(5fC) and 5-carboxylcytosine (5caC). 5fC can be produced from 5hmC by further 
oxidation by the TET enzyme family (Figure 1.4). In the same way, 5caC can then 
by produced from 5fC [149]. These additional methyl forms may form part of a 
demethylation pathway, where 5mC is progressively oxidised to 5fC and 5caC, 
which are then removed, giving unmodified cytosine. This has been referred to as 
active demethylation. For example, the base excision enzyme Thymine DNA 
Glycosylase (TDG) has been shown to recognise and act upon 5fC and 5caC, and 
depletion of TDG in mouse ES cells corresponds to an accumulation of 5caC 
[150,151]. Very recently this depletion was found to promote the accumulation of 
both 5fC and 5caC at many proximal and distal gene regulatory elements [152]. 
Conversely, overexpression of TDG results in depletion of 5fC and 5caC [153].  
Resulting 5fC or 5caC may then be a target for the Base Excision Repair (BER) 
pathway, leaving unmethylated cytosine to complete the demethylation process. 
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Intriguingly, plants express DNA glycosylases that are able to act on 5mC directly, 
removing DNA methylation [154,155]. However animals do not have a form of 
DNA glycosylase that can act directly on 5mC, therefore TET enzyme conversion 
through 5hmC to 5fC and 5caC might be required for a TDG mediated demethylation 
[151].  Very recently, plants have also been shown to contain 5fC and 5caC, despite 




Adapted from a publication resulting from this thesis - Rose et al. (2013) [156]. 
 
Figure 1.4. The proposed conversion of 5mC to 5hmC, 5fC and 5caC. A cytosine 
base is converted to 5mC by the addition of a methyl group to its 5’ position by the 
DNMT family. TET enzymes have been shown to produce each form of methylation 
by progressive conversion from 5mC [136,149]. 5fC and 5caC may then be targets 
for removal by TDG and the BER pathway.  Research indicates that each form may 





Conversely, it has been suggested that the Activation Induced Deaminase/ 
Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 
(AID/APOBEC) enzyme may deaminate 5mC to produce Thymine (T). As the 5mC 
would originally have been paired with a guanine (G) base in the double helix, this 
would leave a T-G mispair [158-160]. This would then be recognised by TDG, or 
another glycosylase that recognises T-G mispairing – Methyl Binding Domain IV 
(MBD4). Both would remove the thymine from the mispair, preparing for the BER 
pathway to replace with a cytosine. This would reinstate a C-G pairing, meaning that 
ultimately an unmodified cytosine had replaced 5mC [151,160-163].  
Another potential pathway could involve the TET-mediated conversion of 5mC to 
5hmC, followed by deamination to 5‐hydroxymethyluracil (5hmU) by 
AID/APOBEC [164]. 5hmU could then be excised by TDG [163], or another DNA 
glycosylase, Single-Strand Selective Monofunctional Uracil DNA Glycosylase 1 
(SMUG1) [165].  More recently, however, Nabel et al. (2012) showed that 
AID/APOBEC has greatly reduced activity on templates containing 5mC compared 
to unmodified C, and no detectable activity on 5hmC in vitro. Furthermore, when 
AID/APOBEC was overexpressed, no deamination products of 5hmC were detected, 
but 5fC and 5caC were found [153].  This therefore makes the theory of 
demethylation by deamination of 5hmC less plausible. Whilst the primordial germ 
cells (PGCs) of AID deficient mice were found to have decreased demethylation 
relative to controls, the process did still occur. This suggests that if indeed 
demethylation occurs via AID, there must be additional AID-independent pathways 
involved [166] .   
Some research has also suggested that the process of demethylation may occur by 
passive dilution of the oxidative products of 5mC, rather than active removal. Both 
5fC and 5caC have a strong detection by immunofluorescence in the early stage 
zygote, with concentrations depleting gradually with increasing numbers of cellular 
division [157]. Similarly, 5hmC was found to undergo replication-dependent dilution 
[167]. This led the authors to conclude that 5hmC, 5fC and 5caC might have some 
functionality in the early stage zygote, due to their long-lasting presence. Indeed, 
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Iqbal et al. (2011) demonstrate that 5hmC persists in one- and two-cell and cleavage 
stage embryos, rather than being rapidly removed [168]. 
However, in a very recent study, Wang et al. (2014) sequenced methylated cytosines 
in the oocyte, sperm and four-cell embryo. They show that there is a rapid reduction 
in 5mC, 5hmC and 5fC between gametes and four-cell embryos, leading them to 
conclude that active demethylation occurs after fertilisation, independent of cellular 
replication [169]. They found that only ~10% of demethylated sites had a 
corresponding enrichment for 5hmC, with a similar distribution for 5fC. They did 
detect all known forms of methylation in the 2 stage embryo, but conclude that active 
demethylation occurs, rather than passive dilution. They also demonstrate the 
presence of 5hmC and 5fC on both maternal and paternal alleles [169]. This 
contradicts previous work indicating that oxidized 5mC derivatives are only present 
on the paternal genome in the early embryo. For example, Iqbal et al. (2011) indicate 
that in the early stage zygote, the paternal pronucleus has enriched 5hmC and little 
5mC, whilst the converse was shown in the maternal pronucleus [168]. This is 
supported by other studies [170].    
Wang et al. (2014) used more advanced, base-specific techniques that were not 
available when 5fC and 5caC were first discovered in 2011. Even though this work 
suggests that demethylation occurs rapidly, this may not negate the suggestion that 
5hmC, 5fC and 5caC may have functionality in the early stage zygote. Their 
functionality could exist before the 2 cell stage, or indeed, the 5hmC, 5fC and 5caC 
that was detected at the 2 cell stage, even though not found at every site of 
demethylation, could still be functionally active. Furthermore, a very recent study 
identified that 5fC and 5caC is produced extensively across the genome, with 
accumulation at major satellite repeats in mouse ES cells [152]. Much has still to be 
investigated regarding this potential functionality, but the presence of 5fC has been 
shown to correlate with increased transcription in ES cells, suggesting a role in 




1.4 Epigenetic Reprogramming 
DNA methylation has been shown to change throughout the development of the 
fetus. Germline epigenetic reprogramming corresponds to the genome-wide erasure 
and subsequent re-establishment of methylation during the development of the fetal 
germ cell [14]. This has been shown to occur at the majority of the genome, but 
certain key regions are thought to be resistant to reprogramming. For example, the 
maintenance of methylation of retrotransposons during the phase of reprogramming 
may protect the genome from their undirected activation and transposition [172]. 
This process of epigenetic reprogramming is crucial to remove epimutations, erase 
and re-establish parental imprints and promote the totipotency required in this cell 
lineage [14,173]. This ultimately ensures that the correct epigenetic marks are 
established in the germline, particularly as they may be transmitted to future 
generations. The vast majority of studies on epigenetic reprogramming have been 
conducted in mice.    
 
1.4.1 Demethylation 
In mouse studies, PGCs are first identified at e7.25 [174]  and migrate into the 
genital ridges by e11.5 [175]. At e13.5 PGC replication is complete, and male germ 
cells exhibit mitotic arrest, whilst female germ cells enter meiotic prophase [173]. 
Many studies indicate that during this development, PGCs exhibit dramatic erasure 
of DNA methylation, despite the continued expression of the maintenance 
methyltransferase DNMT1 [14]. This demethylation occurs simultaneously in both 
male and female germ cells, at the majority of genes studied, although female-
derived embryonic germ cell lines were found to have less methylation than those 
from males [176]. This could reflect changes in germ cell DNA methylation 
occurring after specification [176].  
DNA demethylation is thought to occur rapidly between e11.5-e12.5 for the majority 
of genes (Figure 1.5) [14,177]. However, some studies suggest that the 
demethylation of some loci may occur before e11.5, potentially whilst PGCs are still 
migrating to the genital ridge [177,178]. Demethylation has been reported to be 
initiated as early as e8 at some genes, and at the majority of genes by e9.5, with 
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rapid, bulk demethylation around e11.5 [179-181]. By e13.5 global methylation is 
reduced by around 90 % [182].  Hackett et al. (2013) showed that some imprinted 




Adapted from a publication resulting from this thesis - Rose et al. (2013) [156]. 
Figure 1.5. Schematic of epigenetic reprogramming in the mouse. Bulk DNA 
demethylation may be initiated as early as e8 at some genes with bulk DNA 
demethylation occurring between e11.5 and e12.5 [14]. Demethylation occurs across 
the majority of the genome, whilst some regions remain resistant to reprogramming, 
particularly those corresponding to retrotransposons [179]. Remethylation 
predominantly occurs prenatally in male and postnatally in female germ cells 
[178,184]. 
 
This DNA demethylation phase could be mediated by any of the methods outlined 
above. In particular, the activity of TET enzymes may promote conversion of 5mC to 
its oxidative forms during PGC migration. TET1 has been shown to be expressed in 
PGC, along with components of the base excision pathway [182]. More recently 
TET1 and TET2 (but not TET3) were found to be expressed in PGC, peaking at 
e10.5-e11.5. A decrease in 5mC was associated with a corresponding increase in 
5hmC. Intriguingly, 5hmC was seen to persist in germ cells between e11.5-e13.5, 
after 5mC concentrations had decreased, suggesting that 5hmC removal might be 
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replication-dependent [183].  The increase in TET1 expression and initiation of 
demethylation happened asynchronously between individual PGCs [183]. It should 
be noted, however, that no enrichment of 5fC or 5caC was seen in the PGCs in this 
study [183]. Furthermore, e11 germ cells isolated from TDG knockout mice show 
hypermethylation of both the maternal and paternal alleles of IGF2 Differentially 
Methylated Region (DMR) 2, in contrast to the wild-type control PCGs where the 
maternal allele is demethylated. This suggests that an absence of TDG disrupts PGC 
demethylation during epigenetic reprogramming [185]. Recent mRNA studies have 
also indicated that TDG is expressed in mouse germ cells from e9.5-e13.5, with 
concentrations depleting over this time period [186].    
Kagiwada et al. (2013) also show that the PGC cell cycle is faster than previously 
suggested, and report rapid proliferation between e10.5-e12.5.  This makes the 
involvement of partially passive mechanisms, dependent on cell replication, more 
plausible during epigenetic reprogramming [186]. Furthermore, based on this study, 
Hackett et al. (2013) calculate the rate at which a replication dependent removal of 
DNA methylation would occur, and find that the imprinted genes studied exhibited 
demethylation at that predicted rate [183]. Indeed RNA-sequencing results indicated 
that expression of NP95 was repressed at e11.5, and whilst immunofluorescence 
studies indicated that DNMT1 was found in germ cell nuclei at e13.5, NP95 had a 
solely cytoplasmic localisation. This suggests that during remethylation the actions 
of NP95 and DNMT1 have been physically uncoupled, meaning that DNMT1 is not 
targeted to methylate newly formed DNA strands during cellular division, facilitating 
passive demethylation [187]. Furthermore, DNMT3a and 3b were not expressed in 
PCGs at e11.5, preventing a remethylation of loci that have been demethylated, and a 
cyclical phase of demethylation/remethylation [182]. Additionally, the 
AID/APOBEC complex involved in active demethylation was shown to have a very 
low PGC expression during the period of demethylation in the mouse [182,186].   
It has therefore been proposed unlikely that demethylation during epigenetic 
reprogramming is dependant exclusively on active mechanisms, partially because an 
active, genome-wide demethylation, which might involve DNA double strand 
breaks, would be very costly energetically [188]. Also, the lack of AID/APOBEC, 
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coupled with the presence of TDG and TETs 1 and 2 suggests that at least some 
demethylation occurs through the conversion of 5mC to oxidised states [183]. It has 
been suggested that the demethylation phase could involve a combination of both 
active and passive mechanisms [188]. Indeed Seisenberger et al. (2012) indicate that 
there is a second wave of demethylation during epigenetic reprogramming with 
certain genomic loci, particularly those conferring long-term methylation, such as 
imprints, remaining methylated until the later phase [187].  It is possible therefore 
that these regions are protected from passive demethylation, but are subject to a 
subsequent active demethylation [188]. As the late demethylating sites have an 
enrichment of binding sites for Zinc Finger Protein 57 homolog (ZFP57) [189], 
which is involved in the maintenance of methylation at certain imprinted regions 
during methylation loss in the embryo [190], this could be protecting some regions 
from early methylation loss during epigenetic reprogramming. Hackett et al. (2013) 
suggest that epigenetic reprogramming most likely involves multiple mechanisms, 
with some functional redundancy. This would account for the continued 
reprogramming and fertility that occurs in mice with knockouts in some of these 
components, for example TET1. It may also allow demethylation to occur so 
comprehensively across the genome [183].   
Although this phase of demethylation is thought to occur across the majority of the 
genome [166,180], studies have suggested that certain regions, particularly those 
corresponding to transposable elements, are resistant to epigenetic reprogramming. 
During a bisulfite sequencing study LINE1 was found to be demethylated during 
epigenetic reprogramming in the mouse PGCs [172]. However Intracisternal A-
Particle (IAP) retrotransposons, which exist as part of the ERV family, have been 
found to be more resistant to demethylation [14,172,180], although there is some 
demethylation at these loci, which is greater in female germ cells [184]. Very 
recently, a subset of IAP retrotransposons has been found to be significantly more 
methylated than other family members during reprogramming. IAP Long Terminal 
Repeat 1 (IAPLTR1) is the most active IAP subclass and therefore poses the greatest 
risk of undirected retrotransposition [183,191]. Furthermore, a subset of the Long 
Terminal Repeat-Endogenous Retrovirus 1 (LTR-ERV1) family of rare 
retroelements were found to be resistant to demethylation [180]. Interestingly, this 
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subset was longer, and had a greater CpG content than other members, suggesting 
that they had been more recently inserted into the genome. Methylation was also 
found at these genes at e14.5 and e15.5, suggesting that they do not simply show 
delayed demethylation. Similarly, some single-copy regions, a proportion of which 
were located next to IAPs in the genome, remained methylated at these time-points 
[180].   
The expression of retrotransposons clearly has to be tightly controlled, due to their 
ability to move around the genome. The persistent methylation of these elements 
may therefore serve to protect against epimutations during the period of epigenetic 
reprogramming [172]. However, the DNA methylation state of LINE1 was not found 
to correlate directly with the degree of gene expression, indicating that transposable 
elements may be regulated by other mechanisms, in addition to methylation [187].  
In mouse ES cells, retrotransposon expression was also found to be regulated by 
Histone Deacetylase Inhibitor 1 (HDAC1). Knockout of the polycomb repressor 
complexes was also shown to increase expression of some subsets of 
retrotransposons [192]. It is also interesting to consider that the phase of 
demethylation also reactivates the second X chromosome in female PGCs between 
e11.5-e13.5 [193]. Clearly it is important that the activation of such genes that are 
normally canonically silenced is tightly regulated.   
Furthermore, during an epigenetic disruption and recovery screen, Hackett et al. 
(2012) identified a group of germline specific genes, the expression of which is 
exclusively regulated by promoter DNA methylation. This collection of genes, 
including Testis Expressed 19.1 (Tex19.1) and Piwi-like RNA-mediated Gene 
Silencing 2 (Mili) are termed germline-defence genes, and are thought to protect the 
genome from transposon activation during demethylation. They are transcribed as a 
result of demethylation during epigenetic reprogramming, and are therefore available 
to protect the genome from the potential side-effects of methylation loss, such as 
transposon-mediated epimutations [179]. 
Changes in histone modifications may also serve to protect the genome. In parallel 
with a loss of methylation during epigenetic reprogramming, chromatin remodelling 
has been shown to occur. Detection of H3-K9 dimethylation (H3K9me2), which is 
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associated with gene silencing, was significantly reduced at e8, as examined by 
immunohistochemistry in germ cells. Conversely, the levels of H3K27me3, also 
associated with transcriptional repression, were increased between e8.5 and e9, and 
found to be maintained at e12.5 [181]. Intriguingly, a loss of H3K9me3 occurred in 
parallel with a G2 arrest of cell cycle. RNA Polymerase II-dependent transcription 
was also repressed, until H3K27me3 levels were increased [194]. A loss of 
H3K9me2 is thought to correspond to a decrease in the G9a-Like Protein (GLP) 
methyltransferase, which is involved in H3K9 di-methylation. A mechanism for 
H3K27me3 upregulation remains elusive [195]. The reciprocal relationship between 
these histone modifications may serve to repress gene expression, and therefore 
provide another means of genome protection during epigenetic reprogramming 
[194].    
 
1.4.2 Remethylation 
The re-establishment of DNA methylation in germ cells has been much less 
extensively characterised. In mice, methylation has been shown to increase from 
e15.5 at some imprinted loci and repetitive elements, with global remethylation re-
established by e18.5 [178,184,196].  Interestingly, whilst the imprinted genes H19, 
Ras Protein-Specific Guanine Nucleotide-Releasing Factor 1 (Rasgrf1), and Small 
Nuclear Ribonucleoprotein Polypeptide N (Snrpn) were found to be remethylated by 
e17.5, their DMRs were only fully methylated in mature sperm, indicating that 
methylation is augmented postnatally in male mice [196].   
Whilst there is variability in the time-points studied, research does indicate that 
remethylation is at least initiated prenatally in male germ cells. Conversely, data 
suggests that remethylation occurs postnatally in females. Whilst remethylation of 
repetitive elements was seen between e15.5 and e17.5 in male germ cells, their 
female counterparts remained demethylated [184]. The remethylation of imprinted 
genes also occurs postnatally in females [197]. Interestingly, the timing of 
remethylation may also be dependent on the parent-of-origin. A bisulfite sequencing 
study in male germ cells revealed that remethylation of the paternal allele of H19 is 
completed prenatally, whilst the maternal allele is remethylated postnatally [198]. 
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Thus, the parental origin of unmethylated alleles can still be identified, although the 
mechanism by which this occurs remains elusive. This could, for example, involve 
the ZFP57/ Krüppel Associated Box-associated Protein-1 (ZFP57/KAP1) complex 
which interacts with imprinting control regions in a parent-of-origin dependent 
manner, and is involved in the recruitment of DNMT1, 3a and 3b [189].    
The DNMT3 family mediate remethylation during the period of epigenetic 
reprogramming. The DNA methyltransferases DNMT3a and DNMT3b are both 
active in male and female germ cells during the period of remethylation [199]. 
Germline-specific DNMT3a knockout mice have disrupted paternal and maternal 
imprinting. Males have impaired spermatogenesis, and a lack of methylation at some 
paternally imprinted genes. Offspring of female knockouts had an embryonic lethal 
phenotype, with a lack of methylation at maternally imprinted alleles. However, 
germline-specific DNMT3b knockout mice had no detectable defects in imprinting 
or germ cell function [199]. Although its role appears less pivotal, DNMT3b is 
exclusively required for the remethylation of satellite repeats in male germ cells. 
DNMT3b works with DNMT3a in methylating the long interspersed repeats IAP and 
LINE1, and the DMR of the imprinted gene Rasgrf1 [200].  
Furthermore, a cofactor of the DNMT3 family, DNMT3L, can promote the activity 
of DNMT3a and 3b by around 15 fold [201]. DNMT3L interacts with DNMT3a to 
promote its binding to DNA, which may be mediated through a conformational 
change at the active site. After DNA has bound, DNMT3L will leave DNMT3a. 
DNMT3a  then resumes a normal, closed structure, meaning that DNA is only 
released slowly from the complex, prolonging the interaction between DNA and 
DNMT3a [201]. Although catalytically inactive itself, DNMT3L-deficient 
prospermatogonia showed hypomethylation in imprinted genes and repetitive 
elements in germ cells.  At postnatal day (PND) 0-2 in germline DNMT3L-deficient 
mice, the DMR of Rasgrf1 was unmethylated, whilst the H19 and Delta-like 
Homolog 1/ Gene Trap Locus 2 (Dlk1/Gtl2) DMRs were remethylated. This 
persisted at PND17 [200]. Kato et al. (2007) also report that DNMT3L-deficiency 
affected the remethylation of repetitive elements, including IAP and LINE1 at 
PND0-2. DNMT3L deficient germ cells had around 30% of the levels of DNA 
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methylation of wild-type controls at e16.5. However, by PND6, half of those sites 
that previously lacked methylation had been remethylated. Loci normally 
remethylated first were reported to be less susceptible to perturbation by DNMT3L 
deficiency, suggesting that other mechanisms might be more predominant in the 
remethylation of these sequences [202]. DNMT3a and 3L therefore have the greatest 
expression prenatally in male germ cells with DNMT3L deficiency impeding 
remethylation [202]. DNMT3b mRNA expression increases postnatally in both 
sexes, peaking at PND6 [203].  This represents different stages in PGC development, 
with remethylation occurring prenatally in male, and postnatally in female germ cells 
[184,197]. Therefore whilst a PND6 increase in DNMT3b may facilitate 
remethylation in females, in males this may work in conjunction with DNMT1 to 
maintain DNA methylation during rapid division of spermatogonia [203].  
In females however, DNMT3a expression remains constant throughout development, 
and DNMT3L was found to have very high expression in the postnatal female 
germline, during the period of remethylation [203]. Levels of DNMT3a, 3b and 3L 
were found to accumulate with increasing oocyte diameter postnatally, during the 
period of remethylation [204]. When DNMT3a was knocked out in postnatal 
oocytes, maternal imprinting was disrupted, and this was then transmitted to the next 
generation. However, repetitive elements were remethylated between fertilisation 
and e9.5 [205]. Conversely, no effect of DNMT3b knockout was seen on 
remethylation of imprints or repetitive elements.  DNMT3L deficiency corresponded 
to decreased methylation of IAP and LINE1 (45.8% and 16.1% methylation 
respectively), in comparison to wild-type controls (62.9% and 32.6% methylation 
respectively) [205].  Whilst Lucifero et al. (2007) also demonstrated aberrant 
methylation of imprinted genes in DNMT3L-deficient oocytes, they report normal 
remethylation of IAP and LINE1 [204]. This discrepancy could reflect the fact that 
Kaneda et al. (2010) studied fully mature oocytes (the exact time-point of which is 
not reported), as opposed to PND15 in Lucifero et al. (2007), so there could be a 
change in methylation state between these time-points. In either case it appears that 
at least some IAP and LINE1 remethylation can occur with depletion of DNMT3L. 
This is in contrast to male germ cells, where DNMT3L is required for the 
remethylation of these transposable elements [200], and suggests that the action of 
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DNMT3L at these elements is sex-specific [204]. Sex-specificity is also exhibited in 
the postnatal accumulation of the oocyte-specific DNMT1o. Furthermore, depletion 
of either this methyltransferase, or of DNMT3L corresponds to an increase in 
expression of DNMT3b, presumably as part of a compensatory mechanism [204].     
 
1.4.3 Reprogramming in other Mammals 
It is not known to what extent epigenetic reprogramming occurs in species other than 
the mouse. One study indicates that this process also occurs in the pig, and reports 
demethylation happening asynchronously between genes. For example, 
demethylation was shown to be complete at e22 for DMR2 of the IGF2 receptor  
(Igf2r), but found to occur gradually between e22-e42 in the Igf2-H19 regulatory 
region, suggesting that it is not always a rapid process, and that there is variation 
between genes [206]. In the same study, global H3K9me2 was found to have a low 
level by e15, and be absent by e21 in PGCs, as analysed by immunofluorescence. 
Conversely, H3K27me3 was at a high level between e15-e21, suggesting that histone 
dynamics are comparable to the mouse. Cell cycle was also studied by introducing a 
fluorescent DNA stain into isolated PGCs, and analysing the relative amount of DNA 
in each cell by flow cytometry. As the amount of DNA in the cell varies depending 
on the stage of cell cycle, the proportion of cells at each stage of cell cycle could then 
be calculated. At e17, 44% of male germ cells were found to be in G2 cell cycle 
arrest [206]. Therefore the overall dynamics of epigenetic reprogramming seem 
comparable between mouse and pig.  
Due to a lack of tissue availability there are few published studies in humans. One 
study used pre-invasive Carcinoma in-Situ (CIS) cells, which the authors report is a 
neoplastic equivalent of a male fetal germ cell [207]. In contrast to fetal germ cells, 
CIS cells were found to have low levels of DNA methylation, concurrent with a low 
expression of both H3K9me2 and H3K27me3 repressive histone modifications 
[207], the latter of which is increased globally in mouse germ cells to protect the 
genome during epigenetic reprogramming [181]. Conversely, high levels of H3K4 
methylation, H3K9 acetylation and H2A.Z were detected, which are collectively 
associated with active transcription [207]. High levels of polymerase II activity were 
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also reported. Similar results were found in fetal testes from weeks 21-24, where 
global DNA methylation was undetected by immunohistochemistry. However, 
polymerase II activity was not studied in these tissues [207]. The authors also 
describe the detection of H3K4 methylation as being much more limited in fetal 
germ cells, compared to CIS cells, with only around 20% of germ cells having a 
positive detection for H3K4me2/3. They also report that at week 21-24 the fetal germ 
cells have finished migrating, but liken their epigenetic profile to that of migrating 
PGCs in mice [207]. Clearly this state of chromatin decondensation and active gene 
expression could promote chromatin instability and the subsequent malignant state 
that might be expected in CIS cells. It is however, intriguing that such a state would 
exist during the reprogramming of human fetal germ cells. Almstrup et al. (2010) 
suggest that these CIS cells should be reflective of the normal fetal state as previous 
studies have confirmed that they are derived from PGCs, and because they 
previously found them to have very similar gene expression profiles [208]. 
Furthermore, their studies in fetal testes do support the conclusion that they have a 
similar epigenetic profile at weeks 21-24, and that it differs to that reported in mice. 
Wermann et al. (2010) also identified hypomethylation in human male fetal germ 
cells at week 15, and suggest that remethylation occurs progressively from week 20 
to term. Consistent with studies in mice, 5mC detection was low in pre- and post-
natal germ cells in females [209].  
Therefore epigenetic reprogramming appears to occur in species other than the 
mouse, but the mechanisms of reprogramming and of protecting the genome may 
vary. Clearly a great variation in the length of gestation necessitates that the time-
points of epigenetic reprogramming will differ. This in itself might mean that 
different mechanisms are optimal for different species. In terms of human health, it 
should be considered that whilst the phase of epigenetic reprogramming may occur 
over a much longer time period than in the mouse, there is a greater window in which 





1.4.4 Potential for Alteration of Germline Methylation 
As epigenetic reprogramming is clearly such a tightly regulated process, with the 
potential to influence the next generation, it is important that it is conducted 
correctly. The male germline may be particularly susceptible to disruption given that 
methylation is re-established during in utero development. Furthermore, the male 
germline also undergoes many rounds of mitosis after reprogramming, giving greater 
risk of methylation errors during replication [188].  
In recent years there has been an increase in knowledge of the sperm methylome. 
Molaro et al. (2011) used bisulfite sequencing to demonstrate that the majority of 
promoters are unmethylated in human sperm [210]. Furthermore, Hammoud et al. 
(2014) explored DNA methylation in germline cells in different stages of 
spermatogenesis, and found that it remained strikingly conserved throughout this 
process. However, pluripotency genes were found to be ‘poised’ by DNA 
hypomethylation and the presence of bivalent chromatin, ready for expression after 
fertilization [211].  
Some studies give an initial indication that in utero exposures may influence the 
germline methylome in offspring. Radford et al. (2014) explore the effects of 
maternal undernutrition during the period of germ cell remethylation in the mouse. 
As might be expected, the total amount of DNA methylation across the genome was 
not altered between groups in the sperm of offspring. However, some loci were 
found to be hypomethylated following maternal undernutrition [93]. Intriguingly, 
these loci were also found to be hypomethylated in male fetal germ cells at e16.5, 
suggesting aberrant remethylation in the mouse. This therefore supports the theory 
that alterations in epigenetic reprogramming of fetal germ cells could correspond to 
alterations in adult sperm. This is in keeping with Yamaguchi et al. (2013) who 
demonstrate that the methylation profiles of imprinted genes in the sperm of TET1 
knockout mice correspond to those for the fetal germ cells at e13.5 [212].   
Of the regions seen to be hypomethylated in F1 sperm in the undernutrition model, 
43% are known to be resistant to whole embryo reprogramming, suggesting that 
these changes could influence the phenotype of the next generation [93]. Some of 
these DMRs corresponded to changes in gene expression of neighbouring genes in 
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offspring, whilst others did not. This study suggests that even the regions of 
hypomethylation that do not appear to correlate with changes in gene expression  in 
offspring could ultimately influence the phenotype, for example by altering 
chromatin compaction [93].   
A folate-deficient diet fed to male mice altered methylation of genes associated with 
development and diabetes [213]. Conversely, in another study in which adult male 
mice were fed a low-protein diet, there was a high correlation in methylation profiles 
of their sperm to that of controls, despite the fact that a low-protein diet correlated 
with altered liver gene expression in offspring [214]. This could be due to differences 
in the specific diet given, or more crucially, the point of exposure. In Radford et al. 
(2014), and indeed our programming model, the initial insult is given in utero, during 
epigenetic reprogramming, and not to the adult. Because this is a time-point of 
change in the DNA methylation profile, it could potentially be more susceptible to 
disruption [93].   
Indeed, exposure of the rat fetus to the endocrine disruptors vinclozolin or 
methoxychlor was seen to alter DNA methylation in the sperm of the adult male. 
Sperm count and fertility were also decreased, and this phenotype was reported to be 
conserved in F2-F4 offspring [215]. Testis weight was not altered in adulthood, 
however there was a decrease in testis spermatid and epididymal sperm numbers, 
reduced sperm motility, and increased germ cell apoptosis [215,216]. This appeared 
to correlate with disease phenotype in subsequent offspring [217]. When studying the 
rat fetal testis directly, gene expression was found to be altered in the F1-F3 
generation. The number of genes affected was dramatically reduced with each 
subsequent generation (F1 2071 genes, F2 1375 genes, F3 566 genes), with 196 
genes similarly affected, across all 3 generations [218]. This is in keeping with the 
Dex-programmed rat, where changes in gene expression are seen to differ between 
generations, potentially as a reflection of differences in exposure to stimulus [12]. 
Although DNA methylation in the testis was not studied directly, the expression of 
DNMT3a was decreased in F1 and F2, and DNMT3L and DNMT1 decreased in F1-
F3 testis following vinclozolin exposure. This suggests that there could be 
corresponding changes in DNA methylation [218]. Confusingly, however, Anway et 
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al. (2008) report that the vast majority (~90%) of genes had a decrease in expression 
of vinclozolin at e16, rather than the increase that might be expected from a lack of 
methylation [218]. This suggests that although DNA methylation may be affected, 
other factors are more dominant in regulating gene expression in this model.  
However, the authors subsequently went on to show changes in DNA methylation in 
sperm in the F1-F3 adult offspring of the vinclozolin model in rats [219] and mice 
[220]. In rats, differential methylation was reported at a wide variety of promoters, 
including transcriptional repressors, inflammatory mediators and olfactory receptors, 
whilst in mice, changes were reported in regulators of transcription and of the 
extracellular matrix and cytoskeleton. There was however no correlation between 
genes identified in rat and those in mice [219,220].  
However, another group studied the vinclozolin model, and reported no effect on 
spermatid/sperm count or motility, or on germ cell apoptosis in F1-F3 offspring of 
the vinclozolin-exposed rat [221]. It should be considered that the route of 
vinclozolin administration is different between these studies, with Schneider et al. 
(2008) giving oral administration whilst Anway et al. give intraperitoneal injection. 
The exact timing of sacrifice of the adult males may also vary between the studies, 
with Anway et al. (2005) reporting sacrifice between PND 60-180, whereas the 
timeframe was much narrower (PND 127-134) for studies by Schneider et al. (2008). 
The former also used Sprague Dawley rats, whilst the latter conducted studies in 
Wistar [215,221]. It is therefore difficult to be sure exactly why these studies differ, 
and which reflects the most biologically relevant characterisation of the effects of 
vinclozolin exposure.    
It should be considered that changes in DNA methylation in the germline may not be 
fully heritable, particularly as both the fetal germ cell and the early-stage zygote 
undergo epigenetic reprogramming. However, as discussed previously, imprinted 
genes may be resistant to this demethylation, and therefore represent key targets for 
epigenetic inheritance, particularly as they often confer growth and developmental 
regulation [188,190]. More recently, it has also been shown that other gene regions, 
particularly those corresponding to repeat regions, are resistant to reprogramming, 
and their methylation patterns could therefore be directly inherited [183]. It is also 
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intriguing that remethylation can occur in a parent-of-origin specific manner, 
suggesting that a ‘memory’ of origin, and potentially DNA methylation patterns 
remains, even in reprogramming [198]. Furthermore, if the period of exposure occurs 
during remethylation, after bulk erasure has taken place, there may be less potential 
for correcting any disruption.   
Some studies have shown a phenotype resulting from changes in sperm DNA 
methylation. Pre-diabetic adult mice were found to have alterations in methylation in 
their sperm which correlated with methylation patterns in the pancreatic islets of 
their subsequent offspring. This supports the theory that inducing changes in the 
sperm methylome correlates with changes in the phenotype and methylome of 
offspring [222].  Neonatal stress in mice, by maternal separation, was found to alter 
methylation profiles at certain target genes in subsequent adult sperm, which had 
corresponding changes in the brains of their offspring [223]. 
Little is known about the effects of the Dex-programming model on germline 
methylation. The effects of Dex exposure on the fetal germ cell have not previously 
been studied and little is known about the effect on sperm. One study used a 
candidate gene approach to look at methylation of Igf2 and H19 in F1 sperm 
following fetal Dex exposure, but found no difference in methylation between groups 
[12].  However it may be that the specific target genes, or the regions within them, 
that were studied are not reflective of the genome as a whole. Indeed, a 
transgenerational effect of increased H19 gene expression in F2 liver was 
subsequently only seen carried through the maternal line. My study therefore seeks to 
build on this work by giving a more global characterisation of the effects of Dex on 
the adult sperm.  
Knowledge of such processes in humans is more limited. However male infertility 
has been shown to correspond to decreased methylation at the DMRs of Igf2 and the 
Igf2/H19 imprinting control region in sperm [224,225]. Conversely, methylation of 
the Mesoderm-Specific Transcript (Mest) imprinted gene was increased [225]. Two 
other studies have similarly reported hypomethylation of H19 and hypermethylation 
of Mest in infertility [226,227]. Interestingly, a recent study showed that gestational 
diabetes produced offspring with decreased Mest methylation in cord blood and 
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placenta, and that Mest methylation negatively correlated with obesity in adulthood. 
[228]. H19 hypomethylation has been associated with Silver-Russell Syndrome, 
conferring growth retardation both pre and post-natally, amongst other symptoms 
[229].   It therefore seems that the methylation of genes for growth and metabolism 
can be altered in sperm.  
Research has also shown that there are other epigenetic marks which may be 
influenced in the germline. As previously discussed, histones undergo alteration 
during the period of epigenetic reprogramming in germ cell development. Therefore 
these modifications could also be susceptible to change during this critical period of 
development. Histones are removed and replaced with protamines during 
spermatogenesis, promoting the formation of highly compacted chromatin [230]. 
This may protect the paternal DNA from chemical and physical damage, and help 
sperm to have a hydrodynamic shape, facilitating swimming [231].  Nucleosomes 
containing histones are found in 1% of the paternal mouse genome [232], and 15% of 
the human genome in mature sperm [233].  This suggests the potential for 
inheritance of histone marks, which intriguingly, are particularly enriched in GpG- 
rich loci which lack DNA methylation [234]. Indeed, Hammoud et al. (2009) report 
that some histones, including H3K4me3 and H3K27me3 were found to be retained in 
mature sperm at some promoters, particularly those corresponding to developmental 
genes [235]. H3K4me3 levels were also increased at imprinted genes such as Igf2 
and H19, in comparison to other regions [235]. However, very recent studies have 
largely contradicted this work, suggesting that the majority of sperm histones are 
located in gene-poor regions, with few being associated with developmental 
regulators [236,237].  However, they were reported to associate with repetitive 
elements, including LINE1 in human sperm [237].      
A low-protein diet corresponded to changes in levels of histone H3K27me3, 
although only at 2 gene loci [214]. Acetylated H3K9 was also increased in 
developing spermatids following diet-induced obesity in mice [238]. Folate 
deficiency also reduced H3K4 and H3K9 monomethylation and H3K9me3 levels in 
the sperm epigenome [213]. Although corresponding changes in offspring histone 
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levels were not examined, this suggests that there is a possibility for changes in 
histone levels to influence the next generation.  
RNA is also found in mature sperm, some of which have relevance for embryonic 
development after fertilisation [239]. A high-throughput sequencing study indicated 
that sperm contain both mRNA and Small Non-Coding RNA (sncRNA) and two of 
the most highly expressed sncRNA were found not only in sperm, but also in 
embryos, at the one-cell and preimplantation stages [240,241]. This indicates that 
they may have some role in early development. Indeed, when transgenic mice 
expressed the miR-124 miRNA in sperm, or when this miRNA was injected directly 
into a fertilised mouse egg, pups had a 30% increase in birth weight [242]. Similarly 
injection of miRNA into a fertilised egg produced offspring with variations in tail 
colour [243] or cardiac function [244]. The latter phenotype was also found to be 
inducible by fertilisation of an egg with sperm containing the miR-1 miRNA, which 
correlated with decreased expression of the Cyclin-Dependent Kinase 9  (Cdk9) 
gene, involved in regulating cardiac growth [244]. 
Very recently, Gapp et al. (2014) explored the effects of traumatic stress in early 
postnatal life on the expression of sncRNA. An intergenerational phenotype was 
exhibited in this model, with the F2 generation having lower baseline plasma insulin 
and glucose, and reduced plasma glucose rise during a Glucose Tolerance Test 
(GTT), indicating insulin hypersensitivity [241].  Exposure to traumatic stress 
affected the expression of a range of sncRNA in F1 sperm, and in F2 plasma and 
hippocampus. RNA from sperm of stressed F1 males was then injected into control 
fertilised eggs, giving offspring with a similar phenotype to those exposed directly to 
the stressful stimulus. This adds weight to the suggestion that the phenotype was at 
least in part carried in the sperm RNA. However, whilst dysregulation of miRNA 
expression was resolved by the F3 generation, these animals still displayed a 
behavioural phenotype, and so the authors suggest this might be the involvement of 
other epigenetic mechanisms such as DNA methylation [241].   
Thus, the transmission of the programming phenotype may involve a combination of 
epigenetic mechanisms. I decided to focus on DNA methylation because it undergoes 
dramatic remodelling in the fetal germ cell, during the period of Dex exposure, and it 
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has been hypothesised that it might be particularly susceptible to modification. The 
finding that DNA methylation is stable throughout spermatogenesis also indicates 
that patterns established in the fetal germ cells, which then become adult 
spermatogenic progenitor cells, may be maintained in sperm [211].  
Although this area has not yet been studied extensively, taken together, these studies 
support the hypothesis that a) environmental factors may influence germ cell gene 
expression and DNA methylation b) fetal germ cell methylation can influence adult 
sperm methylation patterns and c) that adult sperm methylation can impact upon the 
methylation and phenotype of the next generation. 
   
1.5 Aims and Hypotheses 
The hypothesis of my PhD was therefore that the fetal programming of 
cardiovascular disease risk confers a change in DNA methylation within the 
developing germ cell. This would then ultimately allow the phenotype to be 
transmitted to the next generation through the germline.  
 
To test this hypothesis there were four key aims: 
1. To characterise baseline epigenetic reprogramming in the male rat fetal germ 
cell, confirming that this process previously studied in the mouse also occurs 
in the rat, giving a timeframe for the phase of remethylation and exploring the 
presence of all known forms of DNA methylation. 
2. To explore the effects of Dex exposure on global methylation during the 
established timeline. 
3. To characterise EGFP expression and fetal programming in GCS-EGFP rats, 
and to use them to study gene-specific changes in methylation in fetal germ 
cells and subsequent adult sperm of rats exposed to Dex in utero.  
4. To explore gene expression and DNA methylation in the livers of Dex-




Chapter 2 Materials and Methods 
 
2.1 Materials 
2.1.1 General Chemicals 
All general chemicals were purchased from Sigma-Aldrich Ltd., UK, except the 
following:  
Agarose  Bioline, UK 
Bouins Fluid  Clin-Tech Ltd, UK 
Ethanol  VWR International, UK 
Hydrochloric Acid  VWR International, UK 
Methanol  VWR International, UK 
Xylene   Thermo Fisher Scientific, UK 
 
2.1.2 Molecular Biology 
Agilent RNA 6000 Nano Kit    Agilent, USA 
DNeasy Blood and Tissue Kit   QIAGEN, USA 
High Capacity cDNA Reverse Transcription Kit  Applied Biosystems, USA 
LightCycler 480 Probes Master Mix   Roche Diagnostics Ltd, USA 
Multiplex PCR Kit      QIAGEN, USA 
Qubit DNA High Sensitivity Assay Kit  Life Technologies, USA 
Qubit RNA Broad Range Assay Kit   Life Technologies, USA 
RNeasy Micro Kit     QIAGEN, USA 
RNeasy Mini Kit     QIAGEN, USA 
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SYBR Green Master Mix     Roche Diagnostics Ltd., USA 
TaqMan Gene Expression Assays    Applied Biosystems, USA 
100bp DNA ladder     Invitrogen, USA 
 
2.1.3  Immunofluorescence 
Alexa Fluor 488 Streptavidin    Invitrogen, UK 
Chicken anti-Rabbit Peroxidase-Conjugated  DAKO Corp., USA 
Secondary Antibody 
DAZL Antibody     AbD Serotec, UK 
DMRT1 Antibody A kind gift from Mark Murphy, 
Liverpool John Moores 
University 
DNMT3a Antibody     Abcam, UK 
DNMT3b Antibody     Abcam, UK 
DNMT3L Antibody     Abcam, UK 
EGFP Antibody     Invitrogen, USA 
Fetal Calf Serum     Biosera, UK 
Goat anti-Rabbit Alexa Fluor 555   Invitrogen, UK 
Goat anti-Rabbit Peroxidase-Conjugated  DAKO Corp, USA 
Secondary Antibody 
GR M20 Antibody     Santa Cruz Biotechnology, USA 
ImmPress Diaminobenzidine (DAB)   Vector Laboratories, USA 
ImmPress Ig (peroxidase) Polymer Detection Kit  Vector Laboratories, USA 
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Normal Sera (horse, goat, rabbit, chicken)  Biosera, UK 
Perkin Elmer-TSA-Plus Cyanine 3 System Perkin Elmer Life Sciences, 
USA 
Perkin Elmer-TSA-Plus Cyanine 5 System Perkin Elmer Life Sciences, 
USA 
PermaFluor Aqueous Mounting Medium  Thermo Fisher Scientific, USA 
Rabbit anti-Chicken Peroxidase   Sigma, USA 
-Conjugated Antibody 
Surgipath APEX Superior Adhesive    Leica Microsystems Ltd., UK 
microscope slides 
TDG Antibody     Sigma, USA 
Vasa Antibody     Abcam, UK 
Vimentin Antibody     Dako Corp., USA 
5mC Antibody     Eurogentec, UK 
5hmC Antibody     Active Motif, Belgium 
5fC Antibody      Active Motif, Belgium 
5caC Antibody     Active Motif, Belgium 
 
2.1.4  Animals 
GCS-EGFP Sprague Dawley Rats Bob Hammer, University of 
Texas South Western, USA 
Soya Free Diet (RM3 (E))    Special Diets Services, UK 
Sprague Dawley Rats     Charles River, UK 
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Standard Laboratory Chow    Special Diets Services, UK 
Wistar Rats      Charles River, UK 
 
2.2 Equipment 
Agilent 2100 Bioanalyzer System   Agilent, USA 
BXT-20.M Transilluminator    Uvitec, UK 
Cell strainer (70µm)      Becton Dickinson Falcon, USA 
Comfort Thermomixer    Eppendorf, Germany 
Decloaking Chamber      Biocare Medical, USA 
DNA Speed Vac DNA 110     Savant Instruments Inc., USA 
Electrophoresis PowerPac 300   Biorad Laboratories Inc., UK  
Eppendorf Centrifuge 5415C    Eppendorf, Germany 
FACSAria II Special Order System sorter  Becton Dickinson Falcon, USA 
G-storm thermocycler     Gene Technologies, UK 
Humidity Chamber     Fisher Scientific, UK 
Labofuge 400R Centrifuge    Heraeus, UK 
LSM 710 Meta confocal microscope    Carl Zeiss Ltd., UK 
Microtome (RM2125RTF)    Leica, Germany 
Nanodrop ND-1000 Spectrophotometer  ThermoScientific, USA 
OPTImax Plate Reader    Molecular Devices, UK 
pH Meter (3510)     Jenway, UK 
PRO 200 homogeniser    PRO Scientific Inc., USA 
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Provis AX70 microscope     Olympus Optical, UK 
Qubit 2.0 Fluorimeter     Life Technologies, USA 
Roche 480 LightCycler    Roche Diagnostics Ltd., UK 
Rotamixer Vortex Hook and Tucker Instruments, 
UK 
Rotary Microtome     Leica Microsystems Ltd., UK 
Sub-cell 96 electrophoresis tank   Biorad Laboratories Inc., UK 
 
2.3 Software 
Image J National Institute of Health, 
USA 
Photoshop CS5.1     Adobe Systems Inc., USA 
SPSS Statistics 21 International Business Machines 
Corporation (IBM), USA  












Agarose gel 1.2% (for RNA) or 2 % (for DNA) agarose (Bioline, UK) was 
dissolved in 0.5 X TBE whilst heating. 5-10 µl (depending on 
gel volume) of GelRed Nucleic Acid Stain (Biotium, USA) 
was then added to the solution. 
0.5M EDTA  23.265g of EDTA (Ethylenediaminetetraacetic acid) was 
dissolved in MilliQ water (Millipore, USA) to give a final 
volume of 250ml. Solution was adjusted to pH 8.0 using HCl.
  
Orange G 30ml of glycerol and 0.25g of Orange G (Sigma) were 
combined, and made up to 100ml with Polymerase Chain 
Reaction (PCR)-grade H2O. 
PBS 1 Phosphate Buffered Saline (PBS) tablet was dissolved in 
200ml MilliQ water, giving 0.01M phosphate buffer, 0.0027M 
Potassium Chloride, 0.137 M Sodium Chloride. 
TBS 60.5g Tris and 87.6g NaCl were dissolved and made up to 1l 
in MilliQ water to give Tris Buffered Saline (TBS).  
10 x TBE 108g of tris, 55g of boric acid and 40ml of 0.5M EDTA were 
combined, then made up to 1 litre with MilliQ water to give 
Tris/Borate/EDTA (TBE). 
TE 2.5ml of 1M Tris (pH8) and 0.5ml of 0.5M EDTA was 








2.5  Animals 
All animals were maintained in an environment of controlled humidity, temperature 
(22°C), and lighting (artificial light between 7.00am-7.00pm), and had constant 
access to standard laboratory chow and water, except where indicated. All 
procedures were licenced by the UK Home Office, and completed in accordance with 
the UK Animals (Scientific Procedures) Act 1986. 
 
2.5.1   Wistar Rats 
2.5.1.1  F1 Metabolic Studies 
Female Wistar rats with an initial mass of 200-250g were acclimatised to the 
research facility for two weeks before breeding. These animals were then 
individually housed with a stock Wistar male of similar age. Following expulsion of 
a vaginal plug (e0.5), females were housed individually for the duration of gestation 
(21-22 days), and body mass recorded daily. Subcutaneous injections were 
administered to pregnant females every morning, before 9.30am from e15.5-e22.5 
inclusive. Dex (≥97% purity, Sigma) suspended in ethanol (4%) and normal Saline 
(0.9%) was given to the Dex treatment group (dosage of 100 µg Dex per kg of rat 
body mass), and an equivalent volume of ethanol (4%) and Saline (0.9%) to the 
Saline control group.  
At e20.5, a proportion of mothers were sacrificed by cervical dislocation, and pups 
and placentas excised from the womb and weighed. Placental labyrinth and new-born 
liver were extracted from 6 pups, and snap frozen on dry ice. 
The remaining dams were maintained until the end of gestation. Pups were delivered 
naturally between e21.5-e23.5, and weight recorded, before culling to 8 per litter, 
retaining similar numbers of both sexes. Livers were collected from supernumerary 
pups on the day of birth, and snap frozen on dry ice, before storage at -80°C.  
At both the peripubertal stage (28 days) and at maturity (over 90 days) one quarter of 
males were sacrificed by decapitation, following CO2 asphyxiation. Liver, kidney, 
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spleen, heart and retroperitoneal and mesenteric fats were harvested, snap frozen on 
dry ice, and stored at -80°C. 
 
2.5.1.2 F1 Baseline Epigenetic Reprogramming Studies 
Tissues for baseline epigenetic reprogramming studies were collected by Prof 
Richard Sharpe’s Lab group, where all animals are maintained on Soya-free research 
diet (RM3(E) soya free, Special Diets Services, UK). Pregnant dams were killed by 
CO2 asphyxiation and subsequent cervical dislocation at experimental time-points of 
e14.5-e19.5 and e21.5 (gestation is ~22 days in our colony). A further time-point 
(e20.5) was added as part of the current study. At e14.5-e19.5, pups were sexed by 
dissection, and at e20.5 and e21.5, by examining the AGD which is two-fold greater 
in males relative to females. Testes were removed from all male pups, and fixed for 1 
hour in Bouins Fluid (Clin-Tech, UK). Tissues were then stored in 70% ethanol, 
before embedding in paraffin wax by the Shared University Research Facilities 
(SURF) histology group, The University of Edinburgh. Embedded tissues were then 
cut into 5µm thick sections using a microtome (Leica Microsystems, Germany), and 
mounted onto Surgipath APEX Superior Adhesive microscope slides (Leica 
Microsystems), before drying in the oven at 50 °C overnight. 
 
2.5.1.3  F1 Methylation and Glucocorticoid Testis Time-line Studies 
Virgin females were mated to males (both Wistar), and Dex and Saline solutions 
administered as outlined above. At time-points of e18.5, e19.5, e20.5 and e21.5 
pregnant dams were sacrificed, and pups removed and weighed. Testes were 
removed by microdissection and processed as previously.  
 
2.5.2 Sprague Dawley GCS-EGFP Rats 
Sprague Dawley GCS-EGFP homozygous males, developed by Cronkhite et al. 
(2005) and supplied by Professor Bob Hammer (University of Texas Southwestern) 
[92], were crossed to wild-type females. Embryo transfer was performed into 
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recipient wild-type females to allow transfer into a clean animal facility. This was 
conducted by technical staff at the Biomedical Research Facility Animal Unit, The 
University of Edinburgh.  Hemizygous offspring from these crosses were 
subsequently bred in order to establish a homozygous colony.  Testis, Liver, heart, 
kidney and spleen were collected from founder males. Some tissue was snap frozen 
for RNA studies, and further samples were stored in formalin for 24 hours before 
storage in 70% ethanol. Tissues were then embedded in paraffin wax and 
microtomed to give 5µm sections, by SURF technicians. 
 
2.5.2.1  F1 Fetal Germ Cell Studies 
GCS-EGFP virgin females were mated with GCS-EGFP males, and sacrificed at 
e19.5, following the protocols above. Testes were extracted by microdissection and 
pooled to give one sample per litter. 100 µl of collagenase IV (Sigma) (1mg/ml in 
Hank’s Balanced Salt Solution (HBSS, Life Technologies, USA)) was added to a 4-
well plate, along with 6-8 fetal testes. Tissue was disaggregated using hypodermic 
needles, and the resulting suspension placed into a 1.5ml eppendorf. The well was 
then washed with 4 x 100µl of collagenase, subsequently added to the eppendorf. 
The resulting solution was placed on a Comfort Thermomixer (Eppendorf, Germany) 
at 37 °C and 650 rpm for 5 min to promote tissue disaggregation. Samples were then 
mixed before a further 2 x 5 min of thermomixing, yielding a single-cell suspension. 
Cells were then pelleted by centrifuging for 5 min at 1200 xg, and re-suspended in 
PBS to remove the collagenase. Cells were pelleted by further centrifugation before 
re-suspension in PBS supplemented with 2% fetal calf serum (FCS, Biosera, UK), 
inhibiting the action of residual collagenase. A further centrifugation step was 
performed before final re-suspension in 500 µl PBS/2% FCS. The solution was 
passed through a 70µm strainer (Becton Dickinson Falcon, USA) to remove any cell 
clumps that might damage the FACS machine.  Germ cells were then isolated from 
the suspension by FACS sorting for EGFP using a BD FACSAria II Special Order 




2.5.2.2 F1 Adult Sperm Studies 
In order to generate pure sperm samples from first generation adult rats, GCS-EGFP 
virgin females were mated with GCS-EGFP males, and Dex and Saline solutions 
administered to pregnant dams from e15.5 as previously.  Pups were delivered 
naturally between e21.5-e23.5, and weight recorded, before culling to 8 per litter, 
retaining similar numbers of both sexes. These pups were then weaned at PND 21-
23, and subsequently maintained on standard laboratory chow.  
Males were culled at 90 days, and epididymes removed. Each epididymis was nicked 
4 times, evenly spaced along the length of the structure, and placed in a separate 
15ml Falcon tube containing 5ml swim buffer (10% FCS, 2% Bovine Serum 
Albumin (BSA) in F12/DMEM (Life Technologies)). Samples were gently rocked 
for 45 min with occasional mixing, allowing the sperm to swim out of the 
epididymis. The epididymis was then removed from the tube, and sperm cells were 
pelleted by centrifugation for 7 min at 600 xg. The swim buffer was then removed, 
before the pellet was re-suspended in 2.5ml of 2% FCS/PBS. Sperm samples from 
both epididymes were combined, yielding 1 sample per animal. Resulting solutions 
were then passed through a cell strainer, and then kept on ice until FACS sorting. 
Pure populations of sperm were isolated from contaminants by sorting for EGFP 
expression as above. 
 
2.5.2.3  Producing a Second Generation 
In order to ensure that transgenerational effects on birth weight would be found in 
GCS-EGFP rats, as in studies of Wistar rats, a second generation were bred. In order 
to limit use of animals and resources, only 2 of the potential 4 crosses (shown in 
Figure 2.1) were bred. A Saline mother to Dex father cross (denoted SD) was chosen 
as this parentage was shown to have the greatest phenotypic effect in Wistar studies. 
This also allowed programming through the male line, a particular focus of this PhD, 
to be examined. Saline mothers were also mated with Saline fathers to give control 
offspring (denoted SS). Parents were mated as previously, and pregnancies allowed 
to progress without intervention. Pups were sexed and weighed at birth, before 
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animals were killed by decapitation, and livers from 3 males per litter extracted and 
snap frozen as previously.  
 
 
Figure 2.1. Producing a second generation. Pregnant dams (F0) were injected with 
either Dex or Saline (Sal) solutions from e15.5. Their offspring (F1) were then 
termed Dex or Saline based on this exposure in utero. They could be mated to 
produce 4 possible combinations of parentage for the 2
nd
 generation (F2); Saline 
mother x Saline father, Saline mother x Dex father, Dex mother x Saline father, Dex 
mother x Dex father. This would give offspring denoted SS, SD, DS and DD 
respectively.  For GCS-EGFP studies only SS and SD crosses were bred. Blue 







2.6.1  Sex-determining Region Y 
Genotyping for the Sex-determining Region Y (Sry) was conducted to identify male 
pups from Wistar F1 and F2 metabolic studies. DNA was extracted from limb tissue, 
as outlined in section 2.14, and diluted 1:10 in PCR-Grade H2O. Samples were then 
analysed using Sry primers (see Table 2.1) and the Multiplex PCR Kit (QIAGEN, 
USA), following manufacturer’s instructions. Thermocycling was conducted on a G-
Storm thermocycler (Gene Technologies, UK) with 10 min incubation at 95°C 
followed by 45 cycles of denaturation, annealing and extension (95°C, 58°C and 
72°C respectively, for 20 seconds each) and then 7 min at 72°C. Products were then 
combined with 5 µl Orange G loading buffer (30% glycerol, 0.25% Orange G 
(Sigma)) (1:1 v/v) and run on a 2% agarose/0.5% TBE gel, submerged in 0.5% TBE 
in an Sub-Cell 96 tank (Biorad, UK), with attached Power Pac 300 (Biorad). DNA 
ladder (100 base pairs, Invitrogen, USA) was run in parallel, as a marker for band 
size. The gel was run at 100V for 45 min, before imaging using a BXT-20.M 
Transilluminator (Uvitec, UK).  Product size was then compared to the DNA ladder, 
and a positive and negative control, taken from known males and females 














Figure 2.2. Sry genotyping. Samples from pups of unknown sex were genotyped, 
with a positive band for the Sry gene indicating male origin. Gel shows a female 
sample (FS), male samples (MS), a no-template PCR control (NTC), and controls of 
known female (Neg) and male (Pos) origin. Positive bands are seen for the male 
control, and not the female control, confirming that sex differences are being 
identified.  
 
2.6.2   GCS-EGFP 
DNA was extracted from ear clips as outlined in section 2.14, and diluted 1:10 with 
dH2O.  The presence of the EGFP insert was then determined using EGFP primers 
(see table 2.1) and the Multiplex PCR kit. Thermocycling was conducted and 
products run on a gel as above. Product size was compared to the DNA ladder and 
positive and negative controls, from rats known to be homozygous, or negative for 












Figure 2.3. Genotyping for GCS-EGFP. Offspring of colony establishment process 
were genotyped to confirm the presence of the EGFP insert. A positive band was 
seen for a sample from a known homozygote positive control (Pos), but not from a 
Wistar rat (Neg). Samples from offspring (GFP) had a positive band, indicating the 
presence of the EGFP insert. A band was absent from the no-template PCR control 
(NTC) sample.  
 
2.7 Immunohistochemistry 
All tissue sections for immunohistochemistry were dewaxed in xylene, and 
rehydrated by incubation in progressively more dilute ethanol solutions (100%, 95%, 
and 70%). All washes were in TBS, and all antibody and reagent incubations 
performed at room temperature, in a humidity chamber, unless otherwise stated.  
 
2.7.1  Preparation for Methylation Staining 
The following procedures were conducted in preparation for all methylation 
immunohistochemistry protocols, unless otherwise stated. Following re-hydration, 
endogenous peroxidase activity was blocked by a 30 min treatment of incubating 
tissues in 3% (v/v) Hydrogen peroxide/methanol. Tissue was permeabilised, to allow 
               EGFP               Pos      NTC           Neg  
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antibody access, with 1% Triton X-100 (Sigma, UK) in TBS for 30 min. DNA was 
then denatured to further increase antibody availability, by a 15 min incubation in 
4M Hydrochloric Acid (HCl)/TBS, preheated to 37°C. Slides were washed with 
0.1% Tween (Sigma) in TBS.  
 
2.7.2 5mC and 5hmC Immunohistochemistry 
Following preparation above, tissues were blocked with normal horse serum (NHS; 
Biosera) diluted 1:5 with 5% (w/v) BSA in TBS (NHS/TBS/BSA), before incubation 
with 5mC (1:300, mouse, Eurogentec, UK) or 5hmC (1:300, rabbit, Active Motif, 
Belgium) antibody overnight at 4°C. Slides were then washed and antibody detected 
using the ImmPress anti-mouse or anti-rabbit Ig (peroxidase) Polymer Detection Kit 
(Vector Laboratories, USA) and ImmPress Diaminobenzidine (DAB, Vector 
Laboratories) following manufacturers’ instructions. Slides were counterstained with 
Surgipath Hematoxylin Harris (Leica), dehydrated in ethanol and mounted in Pertex 
media (Cell Path, UK).  
 
2.7.3 5mC and 5hmC Double Immunofluorescence 
Following preparation as above, tissues were blocked with Normal Goat Serum 
(NGS; Biosera) diluted 1:5 with 5% (w/v) BSA in TBS (NGS/TBS/BSA), before 
incubation with 5mC (1:100) antibody overnight at 4°C. Slides were washed before 
the addition of goat anti-mouse biotinylated secondary antibody (1:500, Dako Corp., 
USA), subsequently detected during a 60 minute incubation with Alexa Fluor 488 
streptavidin (1:200, Invitrogen).  Following further washing, slides were blocked 
with NGS/TBS/BSA and incubated with 5hmC (1:50) antibody overnight at 4°C. 
Goat anti-rabbit Alexa Fluor 555 (1:200, Invitrogen) was used to detect the primary 
antibody, before mounting in PermaFluor Aqueous Mounting Medium (Thermo 




2.7.4  Seeking a Nuclear Counterstain 
The HCl treatment required for antigen retrieval in these studies was found to 
prevent the specific binding of 4',6-diamidino-2-phenylindole (DAPI) to nuclei. 
Therefore, in order to optimise a method for nuclear counterstaining compatible with 
these protocols, some tissue sections were taken through the methylation staining 
preparation protocol, before incubation with Sytox Green (Invitrogen), TO-PRO 
(Invitrogen) or Propidium Iodide (Sigma) (all 1:500) for 45 min. Control slides were 
taken through the methylation staining preparation protocol, omitting incubation in 
HCl. All stains were found to be nuclear specific in control tissues, whilst neither 
Sytox Green nor TO-PRO was found to have nuclear specificity on tissue treated 
with HCl (see Figure 2.4). However, Propidium Iodide was found to be effective on 
these tissues, when imaged using maximum laser power.  
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Figure 2.4. HCl treatment affects binding of nuclear stains. e21.5 fetal testis was 
prepared for immunohistochemistry, with or without incubation in HCl. (A) Sytox 
Green (Green), Propidium Iodide (red) and TO-PRO (Blue) staining for nuclei is 
seen in tissue without exposure to HCl (arrows). (B) Using the same confocal 
microscope settings, no staining is visualised in tissue treated with HCl. (C) 
Increasing laser power reveals that Sytox Green and TO-PRO staining is no longer 






2.7.5 5fC and 5caC Immunofluorescence 
Following tissue preparation as above, tissues were blocked with NGS/TBS/BSA and 
incubated with either 5fC or 5caC (1:200 or 1:1500 respectively, both Active Motif) 
overnight at 4°C. Antibodies were detected using goat anti-rabbit Alexa Fluor 555 
(1:200) in TBS.  
 
2.7.6 Seeking a Germ Cell Specific Marker 
The HCl treatment required for antigen retrieval in these studies was found to 
prevent the binding of the germ cell marker Vasa. Therefore, another germ cell 
marker, Deleted in Azoospermia-like (DAZL), was selected, and protocols optimised 
for its use. Conditions of retrieval pH, detection method, permeabilisation and 
primary antibody concentration were all optimised, as highlighted in the summary 






Figure 2.5. Optimisation of DAZL staining. Slides were exposed to different retrieval 
pH (pH6 and pH9), detection methods (PermaBlue (PB) or DAB), permeabilisation 
conditions (with (Yes) or without (No) 1% Triton) and antibody dilutions (1:50, 
1:100, 1:200 or 1:500). The clearest staining, in conjunction with 5mC was found 
with antigen retrieval at pH9, PermaBlue detection, 1% Triton permeabilisation, and 
an antibody dilution of 1:500 (green tick). Pink dot represents pre-stained tissue. 
Blue dot indicates detection with PermaBlue and brown dot, with DAB.   
 
2.7.6.1 Optimising DAZL Retrieval pH and Detection System 
As incubation with HCl for methylation antibodies might alter the pH of tissue 
sections, it was decided that altering the retrieval pH for DAZL might buffer the 
effects of HCl and promote antibody binding. It was also hypothesised that different 
antibody detection systems might survive subsequent exposure to HCl and retain 
their colour. Therefore retrieval pH and detection systems were optimised. 
Tissue sections were de-waxed and rehydrated as above, but not taken through the 
standard methylation staining preparation protocol. Tissues were then submerged in 
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either Novocastra Epitope Retrieval Solution (pH9, Leica) or 0.01M citric acid (pH 
6, Sigma) and pressure cooked for 5 min at 125 °C in a Decloaking Chamber 
(Biocare Medical, USA). Endogenous peroxidase activity was then blocked by 
incubation in 3% (v/v) hydrogen peroxide/methanol. Tissues were blocked with NGS 
diluted 1:5 with 5% (w/v) BSA in TBS (NGS/TBS/BSA), before incubation with 
DAZL (1:50, mouse, AbD Serotec, UK) antibody overnight at 4°C.  
Slides for PermaBlue end point were then washed and incubated with goat anti-
mouse biotinylated (1:500) antibody for 30 min. Slides were washed before 
incubation with Streptavidin-Alkaline Phosphatase (1:200, Vector Laboratories) for 
30 min. Following further washing, antibodies were detected using PermaBlue 
Plus/AP (Diagnostic Biosystems, USA) following manufacturer’s instructions. 
Slides for DAB end point were also washed and antibody detected using the 
ImmPress anti-mouse or anti-rabbit Ig (peroxidase) Polymer Detection Kit and 
ImmPress DAB following manufacturers’ instructions. 
Some germ cell-specific staining was seen in all slides. Sections were then incubated 
for 15 min in 4M hydrochloric acid (HCl)/TBS, preheated to 37°C, to test resilience 
of DAZL staining. Resulting staining appeared strongest with antigen retrieval at 




Figure 2.6. Optimising retrieval pH and detection system. Characteristic germ cell 
staining was seen following antigen retrieval at both pH6 (A, arrow heads) and pH9 
(B, arrows) with either PermaBlue (blue) or DAB (brown) antibody detection. 
However, following incubation with HCl, required for subsequent methylation 











2.7.6.2  Optimising Permeabilisation with Antigen Retrieval pH 
It was hypothesised that PermaBlue staining might be affected by the subsequent 
exposure to 1% Triton normally used in 5mC staining protocols. To test this theory, 
slides were taken through all of the DAZL staining steps above, for a PermaBlue 
endpoint. Tissues were thereafter incubated for 15 min in 4M hydrochloric acid 
(HCl)/TBS at 37°C, and 50% of slides were incubated with 1% Triton/TBS for 30 
min, whilst control slides remained in TBS (Figure 2.7). All slides were thereafter 
taken through standard DAB detection for 5mC. DAZL staining remained most 
distinct in pH9 retrieval slides (Figure 2.7B). 5mC staining was largely absent in pH6 
retrieval slides (Figure 2.7A), but was clear in pH9 slides, appearing slightly sharper 
with Triton exposure. pH9 retrieval with Triton permeabilisation was therefore 
selected for DAZL/5mC protocols. 
 
Figure 2.7. Optimising permeabilisation conditions. Following antigen retrieval at 
pH6 (A) or pH9 (B), tissues were incubated with TBS (No Triton), or TBS 
containing Triton before 5mC staining. DAZL staining (blue, arrows) remained clear 
after Triton exposure in pH9 retrieval slides. 5mC staining (brown, arrowheads) was 
detected in some nuclei following pH6 retrieval and Triton treatment (A) with clear 
detection in all nuclei following pH9 retrieval (B). Bar = 20µm. 
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2.7.6.3 Optimising Antibody Concentration 
The primary DAZL antibody incubation step was performed at 1:50, 1:100, 1:200 
and 1:500 concentrations (Figure 2.8). A concentration of 1:500 was found to give 
the greatest clarity of both DAZL and 5mC staining.  
 
Figure 2.8. Optimising DAZL antibody concentration. Primary DAZL antibody was 
used at 1:50 (A), 1:100 (B), 1:200 (C), 1:500 (D). Clearest DAZL staining (blue, 
arrows) was seen at 1:500 dilution, and no inhibition of 5mC staining (brown) was 
indicated. Higher concentrations of DAZL (A,B) gave detection that prevented clear 








2.7.6.4  Final DAZL/5mC Protocol 
The final protocol for 5mC and DAZL double immunohistochemistry was therefore 
as follows: Tissue sections were de-waxed and rehydrated as above, but not taken 
through the standard methylation staining preparation protocol. Tissues were then 
submerged in Novocastra Epitope Retrieval Solution (pH9) and pressure cooked for 
5 min at 125 °C.  Endogenous peroxidase activity was then blocked by incubation in 
3% (v/v) hydrogen peroxide/methanol. All subsequent washes were in TBS, and 
antibody/serum incubations conducted in a humidity chamber (Thermo Fisher 
Scientific). Tissues were blocked with NGS diluted 1:5 with 5% (w/v) BSA in TBS 
(NGS/TBS/BSA), before incubation with DAZL (1:500) antibody overnight at 4°C.  
Slides were then washed and incubated with goat anti-mouse biotinylated (1:500) 
antibody for 30 min. Slides were washed before incubation with Streptavidin-
Alkaline Phosphatase (1:200) for 30 min. Following further washing, antibodies 
were detected using PermaBlue Plus/AP following manufacturer’s instructions.  
Tissues were incubated for 15 min in 4M hydrochloric acid (HCl)/TBS, preheated to 
37°C, then washed with 0.1% Tween in TBS. Tissue was permeabilised with 1% 
Triton X-100 in TBS for 30 min before blocking with NHS diluted 1:5 with 5% 
(w/v) BSA in TBS (NHS/TBS/BSA). Slides were incubated with 5mC (1:300) 
antibody overnight at 4°C. Slides were then washed and antibody detected using the 
ImmPress anti-mouse Ig (peroxidase) Polymer Detection Kit and ImmPress DAB 
following manufacturers’ instructions. Mounting was conducted with PermaFluor 
Aqueous Mounting Medium.  
 
2.7.7  GR Immunofluorescence 
Following re-hydration, tissues were then submerged in citrate buffer (pH6) and 
pressure cooked for 5 min at 125 °C. Endogenous peroxidase activity was then 
blocked by incubation in 3% (v/v) hydrogen peroxide/methanol. Tissues were 
blocked with NGS diluted 1:5 with 5% (w/v) BSA in TBS (NGS/TBS/BSA), before 
incubation with anti-GR M20 (1:500, rabbit, Santa Cruz Biotechnology, USA) 
antibody overnight at 4°C. Following washing, tissues were incubated with goat anti-
rabbit peroxidase-conjugated secondary antibody (GaRP, 1:200, DAKO Corp) in 
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NGS/TBS/BSA for 30 min. Following further washing, slides were incubated with 
Tyramide-Cy3 (Perkin Elmer-TSA-Plus Cyanine 3 System, Perkin Elmer Life 
Sciences, USA) (1:50 in kit diluent) for 10 minutes. Following further washing slides 
were counterstained with Sytox Green (1:500 in TBS) for 10 minutes, before 
mounting in PermaFluor.  
 
2.7.8  DNMT3a and DNMT3b Immunofluorescence 
In preparation to detect DNMT3a and DNMT3b antigens, antigen retrieval was 
conducted by pressure cooking, peroxidase activity blocked by hydrogen 
peroxide/methanol and non-specific binding blocked with NGS as for the GR 
antibody. Slides were then incubated with germ-cell-specific Vasa antibody (1:150, 
Abcam, UK) overnight at 4°C. Following washing, Vasa antibody was detected 
using GARP and Tyramide-Cy3 as previously. Antigen retrieval for DNMT3a and 
DNMT3b was conducted by boiling in 0.01M citrate buffer by microwaving for 2.5 
min following by a 20 min cooling period. This lessened potential for cross reaction 
between antibodies raised in the same species. Slides for DNMT3a detection were 
blocked in Normal Rabbit Serum (NRS, Biosera) diluted 1:5 with 5% (w/v) BSA in 
TBS (NRS/TBS/BSA) for 30 min before incubation with primary DNMT3a (1:1500 
in NRS/TBS/BSA, Abcam). For DNMT3b detection, slides were blocked in 
NGS/TBS/BSA before incubation with primary DNMT3b (1:1500 in 
NGS/TBS/BSA). Both incubations were conducted overnight at 4°C. Following 
washing, slides exposed to DNMT3a antibody were incubated with rabbit anti-
chicken peroxidase-conjugated antibody (RAChP, 1:200 in NRS/TBS/BSA, Sigma) 
for 30 min.  Slides for DNMT3b staining were incubated with GARP, as previously.  
Following further washing, all slides were incubated with Tyramide-Cy5 (Perkin 
Elmer-TSA-Plus Cyanine 5 System, Perkin Elmer Life Sciences) (1:50 in kit diluent) 
for 10 minutes. Slides were then counterstained with Sytox Green and mounted in 




2.7.9  DNMT3L Immunofluorescence 
Slides were de-waxed and re-hydrated, and taken through 0.01M citrate buffer 
antigen retrieval, and hydrogen peroxide/methanol block as previously. Tissues were 
then blocked in Normal Chicken Serum (NChS, Biosera) diluted 1:5 with 5% (w/v) 
BSA in TBS (NChS/TBS/BSA) for 30 min before incubation with primary DNMT3L 
(1:900 in NChS/TBS/BSA, Abcam) overnight at 4°C. After washing, chicken anti-
rabbit peroxidase (ChaRP, 1:200 in NChS/TBS/BSA, Sigma) was incubated with the 
slides for 30 min, before the addition of Tyramide-Cy3 as previously. Following 
further washing, slides were incubated with Sytox Green as previously before 
mounting in PermaFluor.  
 
2.7.10 DMRT1 Immunofluorescence 
Slides were taken through de-waxing, re-hydration, 0.01M citrate buffer antigen 
retrieval and hydrogen peroxide/methanol block as previously. Tissues were then 
blocked with NChS/TBS/BSA, before incubation with primary Doublesex and Mab-
3 Related Transcription Factor 1 (DMRT1) antibody (1:750 in NChS/TBS/BSA, a 
kind gift from Mark Murphy, Liverpool John Moores University) overnight at 4°C. 
Slides were washed, and then incubated with ChaRP, then Tyramide-Cy3 as 
previously. Following further washing, tissues were exposed to Sytox Green and 
mounted in PermaFluor.  
 
2.7.11 TDG Immunofluorescence 
Slides were de-waxed, re-hydrated and exposed to antigen retrieval and hydrogen 
peroxide/methanol block before blocking in NChS/TBS/BSA, as previously. Tissues 
were exposed to primary anti-Thymine DNA Glycosylase (TDG, 1:500, rabbit, 
Sigma) antibody overnight at 4°C. Following washing, tissues were incubated with 
ChaRP in NChS/TBS/BSA, then Tyramide-Cy3 as previously. Following further 
washing slides were microwaved at full power for 2.5 min in boiling 0.01M citric 
acid, before further blocking in NGS/TBS/BSA, then incubation with anti-Vasa 
(1:150) antibody overnight at 4°C. Following further washing, tissue was incubated 
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with GARP in NGS/TBS/BSA for 30 min. Following further washing, slides were 
incubated with Tyramide-Cy5, counterstained with Sytox Green then mounted in 
PermaFluor as previously.   
 
2.7.12 EGFP and Vimentin Immunofluorescence 
Immunofluorescence for EGFP and Vimentin was performed by SURF. Slides were 
dewaxed and rehydrated as above, and immunofluorescence for EGFP (1:500, 
Invitrogen), Vimentin (1:1000, Dako) and DAPI (1:1000, Sigma) conducted using a 
BOND-MAX immunostaining machine (Leica). 
 
2.7.13  Semi-Quantification of Immunofluorescence 
2.7.13.1 5mC in Dex and Saline Studies 
In order to give semi-quantification to a variation in 5mC staining visualised between 
Dex and Saline testes at e19.5, an intensity scale was devised (Figure 2.9). A grading 
of 1 corresponded to a weak, 2 a moderate, and 3 an intense positive stain for 5mC. 2 
sections were taken from each testis, spaced 50 µm apart. Slides were then stained 
for 5mC, and counterstained with Propidium Iodide, following the protocols above. 
Tile scans were taken across the entire section using a LSM 710 Meta confocal 
microscope (Carl Zeiss Ltd., UK). The file names were then changed so that their 
treatment group could not be determined, and germ cells were counted blindly, using 
both Propidium Iodide, and 5mC stains. The grading scale was used when 
quantifying 5mC, and all results were expressed as number of germ cells in grading 




Figure 2.9. Semi-quantification scale for 5mC immunofluorescence. All images were 
counted blindly, and 5mC staining in germ cells was graded as 1, weak, 2, moderate, 
or 3, intense. Bar = 50µm. 
 
 
2.7.13.2 5mC and 5hmC in Baseline Studies  
During manuscript revision, semi-quantification of 5mC and 5hmC intensity 
throughout the seminiferous tubule was conducted using Image J software (National 
Institute of Health, USA). Only complete tubules were analysed, and the region of 
interest was identified as being inside the seminiferous tubule, within the ring of 
Sertoli cell nuclei. Intensity values were expressed as the mean pixel intensity for the 
region of interest, normalised to the mean pixel intensity for the somatic cells within 





2.7.14 Negative Controls 
Negative controls were conducted to confirm that staining was specific for the sites 
of primary antibody binding, and not simply the result of background from the 
detection system. Example controls from the methylation Alexa Fluor detection 
protocols, and the tyramide detection protocols are shown in Figures 2.10 and 2.11 
respectively. Tissues were taken through the immunofluorescence protocols outlined 
above to give staining for the corresponding antigen (termed Positive). A section 
from the same testis was taken through the same protocol, substituting primary 
antibody for overnight incubation with blocking solution. Antibody detection was 
then completed as usual (termed Negative). Negative slides were then imaged using 
exactly the same laser settings as for the corresponding positive slide. Although a 
clear antibody detection is seen for the positive slides, the corresponding negatives 





Figure 2.10. Negative controls for methylation Alexa Fluor detection protocols. 
e16.5 tissues were taken through immunofluorescence protocols with (positive) or 
without (negative) incubation with the corresponding primary 5mC, 5hmC, 5fC and 
5caC antibody (A-D). Using the same confocal microscope settings, clear staining is 
seen in positive slides, whilst no staining is visualised in negative slides. Bar = 




Figure 2.11. Negative controls for Tyramide detection protocols. Examples are 
shown of e18.5 tissues which were taken through immunofluorescence protocols 
with (positive) or without (negative) incubation with the corresponding primary 
antibody (A-C). Using the same confocal microscope settings, clear staining is seen 
in positive slides, whilst no staining is visualised in negative slides. Bar = 50µm.   
 
2.7.15  Image Capture and Processing 
DAB immunohistochemistry was imaged using a Provis AX70 microscope 
(Olympus Optical, UK) and AxioCam HRc (Carl Zeiss Ltd). An LSM 710 Meta 
confocal microscope (Carl Zeiss Ltd.) was used to image immunofluorescence, and 
all figures were produced using Photoshop CS5.1 (Adobe, USA). 
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2.8 Glucose Tolerance Tests 
Rats were fasted for 19 hours before glucose tolerance testing at 9am. A scalpel was 
used to nick the tail, and a basal blood sample was drawn into a heparin-coated blood 
tube (Sarstedt, Germany). Following administration of glucose solution (2g 
glucose/kg rat) by oral gavage rats were returned to their cages. Further blood 
samples were drawn at 30 and 120 minutes after glucose administration. Tubes were 
centrifuged at 6000 rpm for 10 minutes before plasma was separated by pipette, and 
frozen at -20°C.  
 
2.9 Measurement of Plasma Glucose Concentration 
Glucose level in plasma from the glucose tolerance tests was assessed using an assay 
based on the glucose hexokinase reaction. This involves the phosphorylation of D-
glucose to glucose-6-phosphate by a hexokinase reaction, and subsequent conversion 
to gluconate-6-phosphate by a dehydrogenase enzyme (Figure 2.12). This ultimately 
yields Nicotinamide Adenine Dinucleotide (reduced) (NADH) as a by-product, the 
concentration of which can be determined spectrophotometrically [245]. 
 
 
Figure 2.12. Glucose hexokinase reaction. D-glucose within the plasma sample is 
converted to glucose-6-phosphate (glucose-6-P), and then gluconate-6-phosphate 
(gluconate-6-P) by hexokinase and dehydrogenase enzymes respectively. This 
ultimately yields NADH which can be quantified by spectrophotometry. ADP 
denotes Adenosine Diphosphate; ATP, Adenosine Triphosphate, NAD, Nicotinamide 





Samples from glucose tolerance tests (2 µl) were placed in duplicate into a 96 well 
plate. A standard curve was also added in duplicate, ranging from 0-27.75 mmol/l 
glucose, constructed using the Data Cal Multi Constituent Calibrator (Thermo Fisher 
Scientific). Infinity Glucose Reagent (200 ul, Thermo Fischer Scientific) was added 
to each well before incubation for 5-60 minutes at room temperature. The amount of 
NADH produced was proportional to the glucose concentration (see Figure 2.12), 
and was quantified by measuring alteration of UV absorbance of the solution at 
340nm, using an OPTImax Plate Reader (Molecular Devices, UK). Sample glucose 
concentrations were calculated from a standard curve of glucose concentration 
against UV absorbance.  
 
2.10 Measurement of Plasma Insulin Concentration 
Insulin concentrations in plasma from glucose tolerance tests was measured using the 
Mercodia Rat Insulin Enzyme-linked Immunosorbent Assay (ELISA) (Mercodia, 
Sweden), following manufacturer’s instructions. The UV absorbance of the resulting 
solutions was read at 450nm using an OPTImax Plate Reader.  
 
2.11 Extraction of Total RNA 
2.11.1 Extraction of RNA from Fetal Testis 
RNA was extracted from fetal testes using the RNeasy Micro Kit (QIAGEN) and 
Kontes Pellet Pestle Motor tissue ruptor (Sigma), following manufacturers’ 
instructions. During the extraction procedure, the optional on-column DNase 
treatment step was performed using the RNase-free DNase 1 set (QIAGEN), 
following the manufacturer’s protocol.  
2.11.2 Extraction of RNA from FACS-Sorted Fetal Testis Cells 
RNA was extracted from FACS-Sorted fetal testis cells using the RNeasy Micro Kit, 
as above, but homogenising by vortexing, following manufacturers’ instructions.  
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2.11.3 Extraction of RNA from Liver 
RNA was extracted from liver using an extraction method previously optimised in 
our laboratory (Khulan et al., Unpublished). 30-40mg of tissue was homogenised in 
800 µl chaos buffer (4.5M Guanidinium thiocyanate, 2% N-lauroylsarcosine, 50mM 
EDTA, pH8.0, 0.1M β-Mercaptoethanol, 0.2% Antifoam A) using a PRO 200 
homogeniser (PRO Scientific, USA). 400 µl of the resulting homogenate was kept 
for DNA extraction (as outlined in section 2.14.1), whilst RNA was extracted from 
the remaining 400 µl. 40 µl of 2M Sodium Acetate, 400 µl of acidic phenol and 200 
µl chloroform:isoamyl (all Sigma) were added in turn, with vortexing in between 
each addition. Samples were then left on ice for 10 minutes before centrifuging at 
maximum speed for 20 min at 4°C. The resulting supernatant was placed in a new 
1.5ml eppendorf, before adding an equal volume of 70% isopropanol, and inverting 5 
times to combine the solutions. The sample was immediately added to an RNeasy 
Mini column (QIAGEN), and taken through the subsequent steps in the standard 
RNeasy Mini Kit protocol (QIAGEN), with DNase treatment, as outlined above.      
 
2.11.4 Assessing Quantity and Quality of RNA 
RNA was quantified using a Qubit 2.0 Fluorimeter, and Qubit RNA Broad Range 
Assay Kit (both Life Technologies), following manufacturer’s instructions. RNA 
purity was assessed using Nanodrop ND-1000 Spectrophotometer (Thermo Fisher 
Scientific, USA).  Ultraviolet at 260/280nm and 260/230nm was examined, with a 
value of 1.8-2.1 AU deemed to indicate a satisfactory degree of RNA integrity. 
Quality was also assessed using the Agilent 2100 Bioanalyzer System with Agilent 
RNA 6000 Nano Kit (Agilent, USA) following manufacturer’s instructions. This 
gave an RNA Integrity Number, with an optimum value of 8-10, and acceptable 
values from 5-8 [246]. This number was calculated based on the ratios of 28S to 18S 
RNA bands. These bands were also examined visually, and an approximate 28S/18S 











Figure 2.13. Example Agilent gel and electropherogram. RNA was run on a 
Bioanalyzer chip, giving a gel, with bands seen for 28S and 18S (A). The ratio of 
28S/18S is approximately 2, confirming RNA integrity. Samples are also visualised 







2.11.5 Reverse Transcription 
RNA was reverse transcribed to complementary DNA (cDNA) using the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, USA), and G-Storm 
thermocycler, following manufacturers’ instructions.  
 
2.12 Quantitative Polymerase Chain Reaction (qPCR) Analysis of Gene 
Expression 
cDNA was then amplified and quantified using qPCR. cDNA (corresponding to 1ng 
RNA) was added to the correct primer/master mix combination.  Primers for SYBR 
Green Assays were combined with SYBR Green Master Mix (Roche Diagnostics 
Ltd, USA), TaqMan Gene Expression Assays with LightCycler 480 Probes 
Mastermix (Roche Diagnostics Ltd), and Universal Probe Library (UPL) primers 
with both the correct corresponding probe (Roche Diagnostics Ltd) (see Table 2.1) 
and LightCycler 480 Probes Mastermix. A standard curve for each sample set was 
established using a serial dilution of pooled cDNA. Thermocycling and fluorescent 
signal detection was conducted using the Roche LightCycler 480 (Roche Diagnostics 
Ltd.) as in Drake et al. (2010) [64], and results normalised to those of housekeeping 
genes, chosen based on consistency of expression throughout groups.   
 
2.13 Primer Sequences 
Primers for UPL based assays were designed using the UPL Assay Design Centre 
(http://lifescience.roche.com/shop/CategoryDisplay?catalogId=10001&tab=&identifi
er=Universal+Probe+Library). Sequences and target regions for SYBR Green and 
basic PCR assays were identified using UCSC Genome Browser Gateway 
(http://genome.ucsc.edu/cgi-bin/hgGateway), and suitable primers designed with 
Primer 3 (http://frodo.wi.mit.edu/primer3). All primers were synthesised by 
Invitrogen (Table 2.1). TaqMan Gene Expression Assays (Life Technologies) were 













Alcohol Dehydrogenase 1 
(Adh1) 
GAG GAT CCA 
TCC ATT TCC 
TG 
GCC GCT TTG 
CAT TTG ATT AC 
56  
Cyclin-dependent Kinase 
Inhibitor 1C (Cdkn1c) 





GCT CAG TTC 
ATG ATG CTG 
CT 
ATG CTT CGG 





AGA ACG GCA 
TCA AGG TGA 
AC 
TGC TCA GGT 




Gelsolin CTG GCC AAG 
CTC TAC AAG 
GT 
AGC CAC GAG 




   Rn0140558
4_m1 
Growth Factor Receptor-
Binding Protein 10 
(Grb10) 
CAA CCA AGA 
AGC CAA CCA 
G  
 
TCC ACG GAT 
GAG TTA ATA 





H19, imprinted maternally 
expressed transcript (non-
protein coding) (H19) 
GAT GAC AGG 
TGT GGT CAA 
CG  
 
GGC AAA GGA 







Heat Shock 70kDa Protein 
5 (Hspa5) 
ATC GGA CGC 
ACT TGG AAT 
TAT GGT TTA 
GTT TTC TTT TCA 
ACC AC 
18  
High Mobility Group Box 
2 (Hmgb2) 
   Rn0153516
7_g1 
11β Hydroxysteroid 
Dehydrogenase Type 1 
(11β-Hsd1) 
TCT ACA AAT 
GAA GAG TTC 
AGA CCA G 
GCC CCA GTG 





TCA ACG GGG 
GAC ATA AAA 
GT  
 
TCA ATT ATA 
TCT TCA ACA 





Insulin-like Growth Factor 
2 (Igf2) 
   Rn0145451
8_m1  
 
Insulin-like Growth Factor 
Binding Protein 1 (Igfbp1) 
AAT GGA TTT 
TAT CAC AGC 
AAA CAG  
 
CAT GGG TAG 











Ribosomal Protein Serine 
6 (Rps6) 
TGC TCT TGG 
TGA AGA GTG 
GA 
CAA GAA TGC 
CCC TTA CTC 
AAA 
53  
Ribosomal Protein Serine 
6 Kinase 1 (Rps6k1) 
GAA GCT CGA 
GAT CTG CTT 
AAA AA 
GAT GCG CTT 
GGA CTT CTC C 
81  
Ribosomal Protein Serine 
6 Kinase 2 (Rps6k2) 
TGG AGT GCC 
TCA GTG GTG 
ATG GCC CAG 





ACT GTT CAA 
GCA GTC AGC 
CG 
CTC CAT GAA 





Region Y)-Box 9 (Sox9) 
ATC TTC AAG 
GCG CTG CAA 
CGG TGG ACC 




CCC ACC AGC 
AGT TCA GTA 
GC 
CAA TTC TGG 






TGG ACT ACC 
GTG AAG ATG 
GTG 
TCC TGG TGT 
TGT ATG GAT GG 
66  
 
Table 2.1. Primer sequences for basic PCR and qPCR. qPCR was conducted using 
TaqMan assays (where a TaqMan assay code is given), UPL assays (where probe 
number is supplied), or SYBR Green. Primer sequences for normal PCR are also 
given. All sequences are written 5’-3’. 
 
2.14 Extraction of DNA 
2.14.1 Extraction of DNA from Liver 
Liver homogenate was prepared following the Chaos buffer extraction protocol 
outlined above. 400 µl of homogenate was then added to 300 µl of buffer AL from 
the DNeasy Mini Kit (QIAGEN), before thorough mixing by vortexing. 300 µl of 
100% ethanol was then added, before further mixing. The resulting solution was then 
added to a DNeasy Mini column, and subsequent steps performed according to the 
DNeasy Mini Kit protocol. The optional RNase A treatment, and AE elution buffer 




2.14.2  Extraction of DNA from Sperm 
As sperm are particularly resistant to the cell lysis required for DNA extraction, 
optimisation of isolation protocols had to be conducted. A method with maximum 
DNA yield was also sought, due to limited cell numbers after FACS sorting, and the 
fact that sperm have a lower DNA content than other cells due to their haploid status. 
Candidate methods 1-3 are described below: 
 
2.14.2.1 Method 1 
Extraction was based on a protocol from Griffin et al. (2013), adapted for a reduced 
starting cell number [247]. Sperm pellet was washed by re-suspension in 1ml sperm 
wash buffer (150mM Sodium Chloride (NaCl), 10mM EDTA pH8), before pelleting 
by centrifugation at 750 xg for 10 min, and removing the supernatant. This step was 
repeated before loosening the pellet by vortexing for 5 seconds and resuspension in 
600µl of lysis buffer (4.24M guanidine thiocyanate, 100mM NaCl, 1% sarkosyl, 
150mM Dithiothreitol (DTT), 200µg/ml proteinase K) (all Sigma). Samples were 
incubated at 56°C for 1 hour before inverting 3 times, and incubating for a further 
hour.  
After cooling to room temperature, 1µl of glycogen (QIAGEN) was added to bind 
the DNA, and make it easier to visualise in subsequent steps. 480 µl of isopropanol 
was then added, and each sample inverted, allowing the DNA to precipitate. DNA 
was then pelleted by centrifugation at 5000 xg for 3 min, and supernatant removed. 
1ml of 0.1M Sodium Citrate (Sigma) in 10% ethanol was then added, and left to 
wash the pellet for 30 min. DNA was pelleted at 5000 xg before removing 
supernatant. This wash step was repeated. The pellet was then washed twice without 
incubation, using 1ml of 70% ethanol, and mixing each time by inversion. All 
ethanol was removed by pipetting, taking care not to disturb the DNA pellet. 
Residual ethanol was evaporated using the DNA Speed Vac DNA 110 (Savant 
Instruments Inc., USA). DNA was then rehydrated in 100µl of TE overnight at 4°C.  
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2.14.2.2 Method 2 
Extraction was based on a protocol from Weyrich et al. (2012), without the prewash 
step that they suggest for semen [248]. This was omitted as only sperm remained in 
our samples, after FACS sorting, and in an attempt to minimise cell loss during 
sample processing. Concentrations of lysis buffer reagents were also reduced, as 
those reported were around 100 times stronger than that for other protocols, and 
attempted stock solutions reached saturation point before compounds were in 
solution. Concentrations were therefore altered to be a greater reflection of those 
suggested by other protocols.  
500 µl of lysis buffer (10mM Tris-Chloride, pH8, 50mM NaCl, 10mM EDTA, 1% 
Sodium Dodecyl Sulfate (SDS)) was added to sperm pellet. 2.5 µl of 0.5% Triton-
X100, 17.4 µl of 23mg/ml proteinase K and 21 µl of 1M DTT was then added to the 
sample before mixing, and overnight incubation on a thermomixer at 50°C and 650 
rpm.  
Cell debris was pelleted by centrifugation at 15,500 xg, before the supernatant, 
containing DNA, was transferred to a new 1.5ml eppendorf. 1 µl glycogen solution 
and 50 µl of 3M sodium acetate was combined with this supernatant, promoting 
subsequent DNA visualisation and precipitation, respectively. 1ml of ice-cold 100% 
ethanol was added to the solution, before inversion 3 times and leaving at -80°C for 
1-2 hours to promote precipitation.  
Samples were centrifuged at 15,500 xg for 20 min to pellet the DNA, before 
removing the supernatant. DNA was washed by the addition of 500 µl of 75% 
ethanol with subsequent centrifugation at 15,500 xg for 10 min. Care was taken to 
remove as much supernatant as possible, without disturbing the DNA pellet, with 
residual ethanol evaporated using the Speed Vac. The pellet was then dissolved in 
50µl TE overnight at 4°C.  
 
2.14.2.3 Method 3 
Lysis buffer (50mM EDTA pH8, 1% SDS, 500 µg/ml proteinase K) was added to the 
sperm pellet, before incubation at room temperature overnight. 25 µl of 1M DTT was 
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added to the solution before mixing, and incubation on the thermomixer at 50°C and 
650 rpm overnight. Cell debris was then removed and DNA precipitated following 
method 2 above.  
 
2.14.2.4 Method 4 
Extraction was carried out in accordance with the QIAGEN Gentra Puregene 
Handbook (2011). Clumps of cells were visible in the cell lysate, suggesting the lysis 
had been incomplete for our samples. Therefore the protocol was adapted following 
online advice from QIAGEN. 
600 µl of Cell Lysis Solution (QIAGEN) was added to the sperm pellet, before 
mixing by pipetting. As cell clumps indicated that lysis was incomplete, samples 
were incubated at 37 °C for 1 hour before the addition of 3.9 µl of 23mg/ml 
proteinase K, and an additional 300 µl of Cell Lysis Solution. Samples were 
incubated on the thermomixer at 55°C and 650 rpm overnight.    
0.9 µl of 50mg/ml RNase A solution (QIAGEN) was added to the lysate, followed by 
mixing by inversion and incubation at 37 °C for 30 min. Samples were cooled on ice 
for 20 min before addition of 300 µl Protein Precipitation Solution. The resulting 
solution was mixed by vortexing for 20 seconds, and protein and cell debris was 
pelleted by centrifugation at 16,000 xg for 3 min. The supernatant was transferred to 
a new 2ml eppendorf, taking care not to move the white pellet. 900 µl of 100% 
isopropanol was added to this supernatant before inverting 30 times to precipitate the 
DNA. Samples were centrifuged at 16,000 xg for 3 min to pellet the DNA, before 
removing the supernatant. The pellet was then washed by adding 600 µl of 70% 
ethanol, with inversion, before further centrifugation at 13,000 xg for 2 min. 
Supernatant was carefully removed by pipetting, and residual ethanol removed using 




2.14.3 Analysis of DNA Quantity and Quality 
DNA concentration was then quantified by spectrophotometry using the Qubit, 
following manufacturer’s High Sensitivity protocol. DNA quality and purity was 
then assessed using the Nanodrop, examining the 260/280 ratio for protein and RNA 
contamination, and 260/230 for chemical contamination (see Table 2.2). DNA was 
also analysed by gel electrophoresis, giving a visual indication of DNA integrity, and 
RNA contamination. Each sample was combined with 5 µl of Orange G loading 
buffer, before loading into a 2 % agarose gel, and electrophoresing as previously. 
DNA ladder (100bp) was run in parallel, as a marker for band size. Gels were imaged 
using a BXT-20.M Transilluminator (see Figure 2.14). Method number 2 was found 
to give the greatest DNA yield, and purity ratios closest to the optimal (2), therefore 




DNA Yield/ 2 
million cells 
(ng) 
260/280 Ratio 260/230 Ratio 
1 91.8 11.63 0.01 
2 585 1.96/1.79 1.32/1.58 
3 540 1.44 0.65 
4 8.3 1.18 2.77 
 
Table 2.2. Concentration and purity of sperm DNA. DNA quantity was analysed by 
Qubit and purity by 260/280 and 260/230 ratios obtained from the Nanodrop. 












Figure 2.14. Quality of sperm DNA examined by gel electrophoresis. DNA was 
extracted using trial methods 1-4 and electrophoresed on an agarose gel. Distinct 
bands of genomic DNA were seen for methods 2 and 3, with no visible DNA 
shearing or RNA contamination.  
 
 
2.14.4  Extraction of DNA from Germ Cells 
2.14.4.1  Extraction from Cell Culture Cells 
A protocol for extracting DNA from germ cells had to be optimised to allow for 
isolation from cell pellets, and very limited sample sizes. In order to preserve the 
limited quantities of FACS sorted germ cell samples it was decided to perform an 
initial optimisation of DNA extraction using an equivalent number of cell culture 
cells. Candidate methods 1-5 were tested on aliquots of 30,000 AS4.1 cells, as 
described below: 
 
2.14.4.2 Method 1 
Extraction was based on a method from Mortensen et al. (2008) which involved 
DNA isolation as part of a homologous recombinant screen. This was adapted to try 
and give greater purity. Cell pellets were incubated with 300 µl digestion buffer 
(20mM Tris-Chloride, pH 8.0, 10mM NaCl, 10mM EDTA, 0.5% SDS, 1mg/ml 




proteinase K) at 55°C overnight. Samples were then centrifuged at 15,500 xg for 10 
min to pellet protein, before transferring the supernatant to a new eppendorf. 150 µl 
5M NaCl was then added to the solution before vortexing for 15 seconds. 1 µl of 
glycogen was then added, before DNA precipitation using 2 volumes of 95% 
ethanol. DNA was then pelleted by centrifugation for 10 min at 15,500 xg, and 
washed with 500µl of 75% ethanol. Centrifugation was repeated before supernatant 
was removed and residual ethanol evaporated using the SpeedVac. DNA was then 
resuspended in TE.  
 
2.14.4.3 Method 2 
A second method was tried, adapted from the QIAGEN Gentra Puregene Handbook 
(2011). Thawed AS4.1 aliquots were vortexed to loosen cell pellets before adding 
300 µl of Cell Lysis Solution (QIAGEN). Samples were vortexed for 10 seconds to 
promote cell lysis, before incubation at 37°C for 45 min. Solutions were then cooled 
on ice for 5 min. 100µl of Protein Precipitation Solution (QIAGEN) was added to the 
sample before vortexing vigorously for 20 seconds. Precipitated protein was pelleted 
by centrifugation for 1 min at 16,000 xg, and supernatant placed in a new eppendorf.  
Glycogen was added as previously, and DNA precipitated by addition of 300 µl of 
isopropanol, and mixing by inverting 50 times. DNA was pelleted by centrifugation 
for 10 min at 16,000 xg, and supernatant removed. The pellet was then washed by 
adding 300µl of 70% ethanol. Following further centrifugation, all ethanol was 
removed from the pellet, first by pipette, then by using the SpeedVac.  DNA was 
then dissolved in TE overnight at 4°C.  
 
2.14.4.4 Methods 3-5 
Extraction was also carried out using the Promega Wizard SU Genomic DNA 
Purification System (Promega, USA), following manufacturer’s instructions for 
tissue culture cell lysates (Method 3). The DNeasy Blood and Tissue, and AllPrep 
DNA/RNA Micro kits (both QIAGEN, Methods 4 and 5 respectively), were also 
used. It was hoped that the latter would be particularly effective as it is specifically 
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designed for small samples, and as RNA is purified from the same sample, that this 
would avoid the use of RNase A, which might compromise DNA integrity.  
 
2.14.5 Analysis of DNA Quantity and Quality 
DNA quantity and quality was then analysed by Qubit, Nanodrop and gel 
electrophoresis as previously (see Table 2.3 and Figure 2.15). Protocol number 2 was 
found to give the greatest DNA yield, with a reasonable 260/280 ratio. DNA also 










1 AS4.1 79 1.74 0.51 
2 AS4.1 725 2.11 0.44 
3 AS4.1 89.7 2.09 0.77 
4 AS4.1 43.2 1.58 0.16 
5 AS4.1 36.45 6.31 0.01 
 
Table 2.3. Concentration and purity of DNA extracted from 30,000 AS4.1 cells. 
DNA quantity was analysed by Qubit and purity by 260/280 and 260/230 ratios 
obtained from the Nanodrop. Method number 2 gave the greatest DNA yield, and 











Figure 2.15. Quality of AS4.1 cell DNA examined by electrophoresis. DNA was 
extracted using trial Methods 1-5 and electrophoresed on an agarose gel. Distinct 
bands of genomic DNA were seen for all methods, with varying intensity. Some 
nucleotide contamination is seen for the sample extracted using Method 2.  
 
2.14.6 Optimising RNase A Treatment Conditions 
As gel electrophoresis indicated some RNA contamination, but there was concern 
that RNase treatment could decrease the DNA yield of precious samples, it was 
decided to explore the effect of RNase on DNA concentrations. Three pellets of 
AS4.1 (30,000 cells) were taken through extraction using Method 2 (Puregene 
Protocol). Following cell lysis, either 1.5 µl or 0.75 µl of RNase A (diluted to 
4mg/ml in dH2O, QIAGEN) was added to each of 2 samples, with a third given no 
treatment. All samples were then incubated at 37°C for 5 min before continuing the 
protocol as previously. DNA was analysed using the Qubit and Nanodrop as 
previously (see Table 2.4). Concentration was not found to differ between the sample 
treated with 0.75µl and that without RNase A (both 31 ng/µl). However with 1.5 µl 
RNase A, DNA concentration was found to decrease to 12.9 ng/µl. This was 
confirmed visually by electrophoresis (Figure 2.16). 




To assess the effectiveness of each RNase A concentration, resulting RNA yield was 
analysed by Qubit using the RNA Broad Range quantification kit, and following 
manufacturer’s instructions. RNA concentration was found to be greatest without 
RNase treatment, reduced to 8.7% of that value with 0.75 µl, and unquantifiable with 
1.5 µl RNase A (see Table 2.5). It was decided therefore that the optimum balance 






No RNase A 31 2.08 1.29 
0.75 µl RNase A 31 1.96 0.66 
1.5 µl RNase A 12.9 2.29 0.35 
 
Table 2.4. DNA quantity and quality following RNase A treatment. The highest 
volume of RNase A was found to decrease DNA concentration and move the 






No RNase A 22.9 2.00 1.38 
0.75 µl RNase A 2.64 1.96 0.7 
1.5 µl RNase A Unquantifiable 1.99 0.4 
 
Table 2.5. Contaminant RNA quantity and quality following RNase A treatment. 
Treatment with 0.75 µl of RNase A reduced RNA contamination to around 10% of 
that in untreated sample. 1.5 µl of RNase A reduced contaminant to an 








Figure 2.16. DNA quality following RNase A treatment. Quality was assessed 
visually by gel electrophoresis. A clear DNA band is seen without treatment, and 
with 0.75 µl RNase A. A smaller band is seen following 1.5 µl RNase A.  
 
2.14.7 Confirming DNA Extraction Procedure on Fetal Germ Cells 
It was necessary to ensure that the final extraction procedure, using Method 2 and 
0.75 µl RNase A would work well on the final samples. Therefore 2 test litters were 
bred without treatment, and germ cells FACS-sorted at e19.5 as previously. DNA 
was then isolated from 2 test FACS-sorted fetal germ cell pellets (see Table 2.6). The 
optimisation litter 1 sample was extracted without RNase A treatment, whilst that for 
litter 2 was exposed to 0.75 µl of the enzyme.  
DNA concentration was seen to be decreased (to around 10%) in both litters relative 
to those for AS4.1 cells. It is thought that the number of cells counted by the FACS 
machine is very inaccurate (Buckley et al., unpublished observation), and that this 
could account for the difference in concentration. There may also be some variation 
in DNA content between fetal germ cells and AS4.1 cells in culture. However, 
RNase A treatment was not found to decrease DNA content, whilst effectively 




removing RNA contamination, as confirmed by Qubit quantification (Table 2.6), and 




Qubit DNA Conc 
(ng/µl) 
260/280 260/230 Qubit RNA Conc 
(ng/µl) 
 Litter 1  
(No RNase A) 
45,657 2.19 2.56 0.45 4.39 
Litter 2 
(0.75 µl RNase A) 
44,835 2.42 1.94 0.15 Unquantifiable 
 
Table 2.6. DNA quantity and quality and RNA contamination in fetal germ cells. 
DNA was extracted from fetal germ cells of optimisation litters to ensure that the 
protocol optimised on cell culture cells was suitable for use in the fetal germ cell 
study. DNA quantity was reduced to approximately 10% of the equivalent number of 
fetal germ cells. RNase A treatment (0.75 µl) reduced RNA contamination to an 




















Figure 2.17. Quality of fetal germ cell DNA examined by electrophoresis. DNA was 
extracted using trial Method 2 with (0.75 (µl)) or without (0) RNase A treatment, 
before electrophoresis on an agarose gel. Bands of genomic DNA are seen for both 
samples, with no visible RNA contamination.   
 
2.14.8 Investigating Problems with Nanodrop Readings 
I noted that 260/280 and 260/230 ratios were quite low in my samples, and that when 
read multiple times on the Nanodrop, variation was found between the readings for 
the same sample. I therefore explored the variability of Nanodrop readings at 
different sample concentrations. A trial liver DNA sample was quantified, and an 
aliquot diluted 1:100 in QIAGEN AE buffer, giving a concentration of ~10 ng/µl, in 
a similar range to sperm and germ cell DNA extracts. Both the neat and the diluted 
versions of the sample were quantified three times, with the computer turned off, and 
Nanodrop blanked in between each reading. Samples were first quantified using a 
Nanodrop within the Centre for Cardiovascular Science (CVS) (Table 2.7), and then 




one from the Centre for Reproductive Health (CRH), The University of Edinburgh 
(Table 2.8). Great variation was seen in the DNA concentrations given in each 
replicate, particularly on the CVS Nanodrop, which varied from 676.7ng/µl – 
1241.4ng/µl.  
Variation was also found in the 260/280 ratios between quantification replicates. The 
range of values in the neat sample replicates was lower (0.03 for both Nanodrops), 
than for the diluted sample replicates (0.52 and 0.12 for CVS and CRH Nanodrops 
respectively). Indeed when using the CRH Nanodrop, the mean 260/280 ratio was 
1.68 in the diluted, compared to 1.89 in the undiluted versions of the sample. This 
takes the diluted version further from the optimum value of 2, and below the standard 
threshold for acceptable purity (1.8).  
Similarly, variation was also found in the 260/230 ratios. The range of values in the 
neat replicates was lower (0.18 for CVS and 0.03 for CRH Nanodrops) than for 
diluted sample replicates (1.41 and 0.38 respectively). Diluting was therefore seen to 
take the neat sample below the standard threshold. This indicates that very small or 
dilute DNA samples (as for sperm and germ cell extractions) may not be able to be 
accurately assessed on the Nanodrop, and if samples have ratios below the expected 















Neat x1 676.7 1.93 2.05 
Neat x2 1011.7 1.90 1.87 
Neat x2 1241.4 1.92 1.89 
Mean Neat 976.6 1.92 1.94 
Range Neat 564.7 0.03 0.18 
Diluted x1 -113.1 1.90 1.21 
Diluted x2 96.4 1.83 1.25 
Diluted x3 11.7 2.35 2.62 
Mean Diluted -1.67 2.03 1.69 








Neat x1 794.1 1.91 1.93 
Neat x2 886 1.88 1.92 
Neat x2 933.7 1.89 1.90 
Mean Neat 871.3 1.89 1.92 
Range Neat 139.6 0.03 0.03 
Diluted x1 12.9 1.68 1.62 
Diluted x2 14.2 1.62 1.4 
Diluted x3 15.2 1.74 1.24 
Mean Diluted 14.1 1.68 1.42 
Range Diluted 2.3 0.12 0.38 
 
 
Table 2.7. Assessing quantity and quality of trial DNA using CVS Nanodrop. A Trial liver 
DNA sample was read 3 times on the CVS Nanodrop, before and after dilution 1:100 in AE. 
260/280 and 260/230 ratios were less variable between replicates in the neat, compared to 
diluted sample. Quantity reading varied in both neat and diluted states.  
 
 
Table 2.8. Assessing quantity and quality of trial DNA using CRH Nanodrop. A Trial liver 
DNA sample was read 3 times on the CRH Nanodrop, before and after dilution 1:100 in 
AE. 260/280 and 260/230 ratios were higher and less variable between replicates in the 





2.14.9  Extraction of DNA for Genotyping 
DNA for Sry and EGFP genotyping was extracted using the DNeasy Blood and 
Tissue Kit (QIAGEN), following manufacturer’s instructions. DNA was quantified 
to confirm that the extraction process had been successful. This was done using the 
Nanodrop as large yields were expected, and the exact DNA concentration was not 
required.  
  
2.15  Enhanced Reduced Representation Bisulfite Sequencing 
Enhanced Reduced Representation Bisulfite Sequencing (ERRBS) was performed at 
Weill Cornell University Epigenetics Core, New York, USA. Bioinformatic analysis 
was then conducted by Dr Thomas Smith (Computational Genomics Analysis and 
Training Programme (CGAT)), University of Oxford, UK).  
 
2.16 FACS 
Single cell suspensions, prepared as outlined in Chapter 2.5.2.1 and 2.5.2.2 were 
FACS sorted using a FACSAria II Special Order System sorter (Becton Dickinson 
Falcon). Sorting was conducted by Fiona Rossi and William Ramsay in the Centre 
for Inflammation Research Flow Cytometry Facility, The University of Edinburgh. 
EGFP-positive cells were separated from EGFP-negative cells based on their 
emission wavelength (525±50nm for EGFP). This was compared to a negative wild-
type control, so that consistent gates for EGFP-positive fluorescence could be set. 
For fetal germ cell sorting, DAPI was added (1µl DAPI/250µl sample) to the 
suspension, to act as a marker for dead cells, the membranes of which would be 
sufficiently disrupted to allow DAPI to enter, and bind DNA. DAPI-positive cells 
were identified as having a fluorescent emission of 450±50nm. Only live, DAPI-
negative cells were gated into the sample. Furthermore, only cells in single-cell 
suspension were selected, to prevent for example, a EGFP-negative cell being pulled 
into the EGFP-positive sample whilst attached to a EGFP-positive cell. Therefore the 
fetal germ cell sample was gated to include only cells which were DAPI-negative 
(live cells), singlets, and EGFP-positive. Distinct populations were seen for the 
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EGFP fetal germ cell sort. Their identity was confirmed by extraction of RNA and 
RT PCR as outlined in sections 2.11.2 and 2.11.5 respectively, followed by qPCR for 
Dazl, a germ cell-specific and Sox9 a Sertoli cell-specific marker, using the primers 
detailed in section 2.13 (data shown in Chapter 5.3.1.1).  
Due to the non-spherical morphology of sperm cells, doublets were not gated out of 
these samples. Indeed cells with a traditional forward-scatter for singlets were 
deemed to represent somatic cell contamination. DAPI was not used as a live/dead 
marker, due to its observed adherence to sperm which were seen to be moving under 
the microscope. We hypothesize that the marker might adhere to the sperm tails, seen 
in immunofluorescence studies to be particularly susceptible to non-specific staining 
(Chambers et al., unpublished observation). Therefore sperm were sorted based on 
EGFP fluorescence, relative to a wild-type control.  
Positive and negative fractions were collected into eppendorfs coated with 2% 
FCS/PBS, to reduce the risk of cells adhering to the plastic. After FACS sorting, all 
samples were centrifuged at 1200 xg for 5 min to give a cell pellet. The supernatant 
was then removed before cells were snap frozen on dry ice and stored at -80°C. 
 
2.17 Statistical Analyses 
Numerical data were tested for normality of distribution using the Lilliefors test. 
Normally distributed data were then analysed by Student’s t-tests or Analysis of 
Variance (ANOVA), with subsequent post-hoc Fisher’s Least Significant Difference 
(LSD) analysis. Nonparametric data were analysed by Mann Whitney U test, or log 
transformed before performing an ANOVA. The influence of intra-litter association 
of pups on weight data was analysed using Multivariate Linear Regression. 
Statistical analyses were performed using Statistica (StatSoft, UK) or SPSS (IBM, 
USA). Figures were created in Excel (Microsoft, USA), and data expressed as mean 





Chapter 3 Characterising Epigenetic Reprogramming in the Rat 
 
3.1 Introduction 
As discussed in Chapter 1, disease risk might be transmitted across generations 
through influences on developing fetal germ cells. In the Dex model of 
programming, the phenotype of low birth weight and altered cardiometabolic 
parameters is transmitted through both the maternal and the paternal line [12]. 
Offspring exposed to an insult in utero might have alterations in their germ cells 
which could allow a transmission of phenotype to the second generation.  
I hypothesise that one effect of Dex exposure may be to influence the period of 
epigenetic reprogramming in the developing germ cell. This process has been 
previously characterised in the mouse, and shown to involve an erasure and 
subsequent re-establishment of DNA methylation across the majority of the genome 
[14]. Germline epigenetic reprogramming has not however, been previously reported 
in the rat, which is used in many models of intergenerational disease transmission.  
I therefore sought to investigate whether epigenetic reprogramming occurs in the rat, 
as for the mouse. I also aimed to characterise the time-frame of remethylation in this 
species, in order to identify key time-points for exploring the influence of Dex 
exposure. I also investigated the presence of 5hmC, 5fC and 5caC, as they have not 
been previously studied in germ cell epigenetic reprogramming in any species, and it 
has been suggested that they may have a role in early stage development [157]. A 
broader understanding of germ cell methylation was obtained by studying postnatal 
tissues, and the TDG enzyme, which has been implicated in the excision of 5fC and 
5caC during active demethylation [150,151].  
By gaining a global insight into the changes in DNA methylation across mid-late 
gestation and postnatal development, key time-points and forms of methylation were 
identified allowing more focused studies into the effects of Dex exposure on germ 




3.2 Materials and Methods 
Tissues for this study were a kind gift from Richard Sharpe’s group.  
Virgin female Wistar rats had been timed-mated with stock Wistar males before 
sacrifice at e14.5-e21.5 (n=3-4 at each time-point) and all pups removed. Testes had 
been extracted from male pups and fixed in Bouins, before embedding in paraffin 
wax. Tissue blocks were then microtomed to give 5 µm sections, which were then 
mounted on microscope slides.  
For postnatal studies, rats were mated as previously, and pregnant dams allowed to 
deliver their pups naturally. Males were then sacrificed at PND4, PND8, PND10, 
PND15, PND25 and adulthood (≥90 days) (n=2-3 at each time-point). Tissues were 
fixed, embedded and sectioned as previously.  
I then used immunofluorescence to explore the localisation of 5mC, 5hmC, 5fC, 
5caC and TDG in the developing testis, following the protocols in Chapter 2.7. 
DAZL was used to confirm the location of germ cells within the testis throughout 
development, and Propidium Iodide was used as a nuclear counterstain. Image J was 
used to explore whether methylation patterns observed visually could be confirmed 















3.3.1 Localisation of 5mC and 5hmC in Fetal Rat Testis 
Immunohistochemistry with DAB detection was used to identify the localisation of 
5mC (Figure 3.1) and 5hmC (Figure 3.2) in the developing fetal testis between e14.5 
and e21.5. 5mC was largely undetectable in germ cells between e14.5 and e18.5 
(Figure 3.1A-E). At e19.5, 5mC was detected in some germ cells (Figure 3.1F), with 
staining becoming augmented by e21.5 (Figure 3.1G).  Conversely, 5hmC was 
detectable in germ cells between e14.5 and e16.5 (Figure 3.2A-C), but not from 
e17.5-e21.5 (Figure 3.2D-G). Both forms of methylation were found in somatic cells 
throughout the time-course. 
In order to further explore the localisation, or potential co-localisation of 5mC and 
5hmC, protocols were optimised for double immunofluorescence. Consistent with 
the immunohistochemistry results, little 5mC was detectable in germ cells between 
e14.5-e16.5 relative to the somatic component (Figure 3.3A-C) and was undetectable 
between e17.5 and e18.5 (Figure 3.3D and Figure 3.4A respectively). At e19.5 some 
5mC was detectable in germ cells (Figure 3.4B), becoming augmented by e21.5 
(Figure 3.4D). Some 5hmC was detectable in germ cells between e14.5 and e16.5 
(Figure 3.3A-C), but was thereafter undetectable. Both 5mC and 5hmC co-localised 
in the somatic component between e14.5-e21.5 (Figures 3.3A-D and 3.4A-D).    
In order to explore whether all germ cells become re-methylated at e19.5, I sought a 
nuclear counterstain that would be compatible with the HCl antigen retrieval required 
for methylation immunofluorescence. Propidium Iodide retained nuclear specificity 
after acid treatment (see Chapter 2.7.4). Tissues were therefore stained for 5mC and 
Propidium Iodide during the observed period of remethylation (Figure 3.5). Although 
germ cells were clearly present at e18.5 (Figure 3.5A), as identified by the position 
and morphology of their nuclei, 5mC was undetectable in the germ cells at this time-
point. At e19.5 5mC was weakly detectable in some germ cells but stronger in others 
(Figure 3.5B). At e21.5 all germ cells identified by Propidium Iodide had a 




Figure 3.1. Localisation of 5mC during mid to late gestation. Images of 
immunostained testis show that 5mC (brown, arrows) is undetectable between e14.5 
and e18.5 (A-E), appears at e19.5 (F) and becomes marked in germ cells at e21.5 
(G). 5mC is found in somatic cells throughout the time course. Dotted line indicates 
a representative tubule within which germ cells (GC) exist, surrounding which are 






Figure 3.2. Localisation of 5hmC during mid to late gestation. Images of 
immunostained testis show some detection of 5hmC (brown, green arrows) in germ 
cells between e14.5 and e16.5 (A-C), not found from e17.5 to e21.5 (D-G). 
Haematoxylin nuclear counterstain is shown in blue. 5hmC (brown) is detected in 






Figure 3.3. Localisation of 5mC and 5hmC during mid gestation. Images of 
immunostained testis show 5hmC localisation in germ cells between e14.5-e16.5 (A-
C) (red, arrows). Some 5mC is also weakly detectable. Neither forms of methylation 
are detectable in germ cells at e17.5 (D). Both 5mC and 5hmC are detectable in 
somatic cells throughout the time course. Bar = 50µm. An enlarged version of this 




Figure 3.4. Localisation of 5mC and 5hmC during late gestation. Images of 
immunostained testis show that 5mC (green, arrows) is undetectable at e18.5 (A), 
appears at e19.5 (B) and becomes marked in germ cells between e20.5-e21.5 (C-D). 
5hmC (red) is not detectable in germ cells.  Both forms of methylation are found in 






Figure 3.5. Details of germ cell remethylation. As previously shown, 5mC is not 
detectable in germ cells at e18.5 (A), appears at e19.5 (B) and becomes marked at 
e21.5 (C, green, white arrows). At e19.5, some germ cells identified by Propidium 
Iodide (PI) nuclear counterstain (red) have very little corresponding methylation 
(yellow arrows). Others have strongly detectable 5mC (white arrow). At e21.5 all 








3.3.2 Exploring the Localisation of 5fC and 5caC in Fetal Rat Testis 
I also explored the localisation of the two additional forms of cytosine methylation, 
5fC and 5caC, particularly as it has been suggested that they form part of the putative 
DNA demethylation pathway, or potentially have a role in development 
[149,150,157]. Immunofluorescence indicates that 5fC and 5caC are present in germ 
cells from e14.5-16.5 (Figures 3.6A-C and 3.8A-C), but are undetectable from e17.5 
(Figures 3.6D and 3.8D), and that this is maintained through to e21.5 in the germ 
cells (Figures 3.7A-D and 3.9A-D). Both 5fC and 5caC were identified in somatic 




Figure 3.6. Localisation of 5fC during mid gestation. Images of immunostained testis 
show 5fC localisation in germ cells between e14.5-e16.5 (A-C) (green, arrows), 
which is undetectable at e17.5 (D). Propidium Iodide (PI) acts as a nuclear 







Figure 3.7. Localisation of 5fC during late gestation. Images of immunostained testis 
show that 5fC (green) is not detectable in germ cells between e18.5 and e21.5 (A-D). 
Propidium Iodide (PI) acts as a nuclear counterstain (red). 5fC is found in somatic 






Figure 3.8. Localisation of 5caC during mid gestation. Images of immunostained 
testis show 5caC localisation in germ cells between e14.5-e16.5 (A-C) (green, 
arrows). Propidium Iodide acts as a nuclear counterstain (red). 5caC is found in 




Figure 3.9. Localisation of 5caC during late gestation. Images of immunostained 
testis show that 5caC (green) is not detectable in germ cells between e18.5 and e21.5 
(A-D). Propidium iodide acts as a nuclear counterstain (red). 5caC is found in 





3.3.3 A Potential Peak of 5hmC, 5fC and 5caC 
During the studies of global fetal germ cell methylation I noted that there was 
variability in the intensity of detection of 5hmC, 5fC and 5caC at e16.5. Although 
immunofluorescence is only semi-quantitative, one particular sample had a strikingly 
intense antibody detection in germ cells. This was seen in multiple sections from 
different runs of staining. Immunofluorescence in this tissue is compared to that of a 
pup from another litter at the same time-point for 5hmC (Figure 3.10), 5fC (Figure 
3.11) and 5caC (Figure 3.12).   
 
 
Figure 3.10. Exploring the homogeneity of 5hmC at e16.5. An example of variation 
in germ cell 5hmC staining (red, arrows) between litters. 5hmC is present in both 
samples, but staining is more intense, relative to somatic cells, in Pup 1 (A) 





Figure 3.11. Exploring the homogeneity of 5fC at e16.5. An example of variation in 
germ cell 5fC staining (green, arrows) between litters. Propidium Iodide (PI) acts as 
a nuclear counterstain. 5fC is present in both samples, but staining is more intense, 






Figure 3.12. Exploring the homogeneity of 5caC at e16.5. An example of variation in 
germ cell 5caC staining (green, arrows) between litters. Propidium Iodide (PI) acts as 
a nuclear counterstain. 5caC is present in both samples, but staining is more intense, 















3.3.4 Further Definition of the Localisation of Cytosine Methylation in Fetal 
Testis 
As discussed previously, the HCl antigen retrieval required for the methylation 
immunodetection protocol meant that traditional counterstains, such as DAPI were 
no longer nuclei-specific. I had also tried to detect Vasa, a germ cell specific marker, 
but found that it was unable to bind after HCl treatment. This, however, did not 
inhibit the study of reprogramming as the germ cell nuclei have a well characterised 
morphology and location within the developing testis. Following reviewers 
comments on the manuscript which subsequently became Rose et al. (2014) [249], I 
sought to optimise a protocol for germ cell identification along with 5mC 
immunohistochemistry, to provide an extra confirmation of germ cell location.  
A protocol was optimised for 5mC and the germ cell marker DAZL (see Chapter 
2.7.6), altering the pH of antigen retrieval. Immunohistochemistry indicates the 
location of germ cells across the prenatal time-course (Figure 3.13), and confirms 










Figure 3.13. Localisation of 5mC with DAZL germ cell marker. Images of 
immunostained testis show the localisation of 5mC (brown) and DAZL (blue, yellow 
arrows) from e14.5-e21.5 (A-H). Somatic cells (representative green arrows) line the 
seminiferous cords (dotted line), within which the germ cells exist (yellow arrows). 
Images show that 5mC is undetectable between e14.5 and e18.5 (A-E) in germ cells. 
5mC is detectable in germ cells at e19.5 (F) (red arrows) becoming augmented at 




3.3.5 Semi-Quantitative Confirmation of Methylation Patterns Visualised by 
Immunofluorescence  
In order to explore whether methylation patterns observed visually could be 
confirmed by pixel intensity analysis of immunofluorescence, Image J software was 
used. An estimate of germ cell pixel intensity was obtained by setting the region of 
interest to be within the seminiferous tubule, just inside the ring of Sertoli cell nuclei. 
The mean pixel intensity within each tubule was then normalised to that for somatic 
cells within the same image. Across 4 pups from 4 separate litters, the normalised 
pixel intensity was significantly increased (p<0.01, Figure 3.14A) for 5mC and 














Figure 3.14. Semi quantification of 5mC and 5hmC immunofluorescence. Mean 
tubule pixel intensity is normalised to the mean for somatic cells within the same 
image. Mean normalised tubule intensity was significantly increased (p<0.01) for 
5mC (A) and decreased (p<0.05) for 5hmC (B) staining at e21.5, compared to e16.5. 
All data were analysed by t-test. Bars represent mean ± standard error. *p<0.05, 




















































































3.3.6 The Localisation of Cytosine Methylation in Postnatal Testis Development 
In order to gain a broader understanding of germ cell epigenetics in early 
development, immunofluorescence was performed on postnatal tissues. Testes were 
studied at PND4-25, covering early life and puberty, and in the adult rat (>90 days). 
5mC was detectable in germ cells and somatic cells from PND4-15 (Figure 3.15A-C 
and Figure 3.16A-B), and in spermatogonia from PND25 (Figures 3.16C-D). 5hmC 
was largely undetectable in germ cells from PND4-8 (Figure 3.15A-C), with some 
detection from PND10 (Figure 3.16A-B). Intriguingly, strong 5hmC staining was 
seen in the spermatogonia of some tubules at PND25 (Figure 3.16C), which was 
largely absent in adult testis (Figure 3.16D). 5hmC was detectable in Sertoli cells 
from PND4-PND15, and staining was particularly intense at PND10 and PND15 
(Figure 3.16A-B).  
I performed a subsequent study examining the localisation of 5caC at key points in 
the previous time-course. Intriguingly, there was little detectable 5caC staining in 
any cell type at PND4 (Figure 3.17A), but staining was strikingly intense at PND10 
(Figure 3.17B) in Sertoli cell nuclei, with some also detectable in germ cells. At 
PND15 (Figure 3.17C), some 5caC was detectable in germ and Sertoli cell nuclei. At 
PND25 (Figure 3.17D), 5caC was undetectable in the germ cells lying within many 
tubules, whilst it was very intense in others. In adult testis, 5caC was detectable in 





Figure 3.15. Localisation of 5mC and 5hmC during early postnatal period. Images of 
immunostained testis show 5mC localisation in germ cells between PND4 and 8 (A-
C) (green, arrows). 5hmC is not detectable within the germ cells. Both forms of 





Figure 3.16. Localisation of 5mC and 5hmC during late postnatal period. Images of 
immunostained testis show 5mC localisation in germ cells (green, arrows) and 
somatic cells (green, arrowheads) at PND10-PND15 (A-B). 5mC is detectable in 
spermatogonia in PND25 and adult testis. 5hmC was detectable in germ cells (red, 
arrows) from PND10-PND15, with an intense stain at PND25. 5hmC was strongly 






Figure 3.17. Localisation of 5caC during  postnatal period. Images of immunostained testis 
show some 5caC localisation in germ cells (green, arrows) at PND10-PND15, with strong 
staining in the germ cells within some tubules at PND25. 5caC was also detectable in the 
spermatogonia of some tubules in adult tissue (green, arrow). Strong staining for 5caC was 
seen in Sertoli cell nuclei at PND10, with some staining remaining at PND15 (green, 
arrowheads).  Little 5caC was detectable in any cell at PND4. Propidium Iodide (PI) acts as 




3.3.7 The Localisation of TDG 
I studied the localisation of TDG throughout the pre- and post-natal time-course as it 
has been suggested that this enzyme excises 5fC and 5caC, completing a chain of 
demethylation [150,151]. It has not, however, been previously characterised in the 
developing testis. TDG was identified in germ cells between e14.5 and e16.5 (Figure 
3.18A-C), but was not detectable from e17.5-e21.5 (Figure 3.18D and Figure 3.19A-
D). TDG was detectable in the somatic component at all time-points, and staining 
was particularly striking in Sertoli cells from e17.5-e21.5. 
Between PND4 and PND15, TDG was detectable in Sertoli cell nuclei, with the 
greatest intensity of staining from PND10-PND15 (Figure 3.20B-C).  There was little 
detectable TDG in germ cells. Intriguingly, although this enzyme was not detectable 
in adult germ or Sertoli cell nuclei, it did appear to localise to unknown punctate 





Figure 3.18. Localisation of TDG during mid gestation. Images of immunostained testis 
show TDG localisation in germ cells between e14.5-e16.5 (A-C) (red, arrows), which is 
largely undetectable by e17.5 (D). TDG is found in somatic cells throughout the time 







Figure 3.19. Localisation of TDG during late gestation. Images of immunostained testis 
show TDG is largely undetectable in germ cells between e18.5-e21.5 (A-D). TDG is 
detectable in somatic cells throughout the time course, with notable intensity in Sertoli cell 
nuclei (red, arrows). Vasa and Sytox Green act as germ cell and nuclear markers 







Figure 3.20. Localisation of TDG during the postnatal period. Images of immunostained 
testis show little detectable TDG in germ cells. Strong staining for TDG was seen in Sertoli 
cell nuclei at PND4-PND15 (A-C) (red, arrowheads), which was thereafter absent.  TDG 
also gave a punctate staining pattern in PND25 (D) and adult tissues (E) (red, arrows). Vasa 




These data indicate for the first time that epigenetic reprogramming occurs in the rat, 
and that global cytosine methylation is re-established between e18.5 and e20.5. 
Dynamic changes were also seen in the localisation of 5hmC, 5fC and 5caC in both 
prenatal and postnatal development (Figure 3.21). The localisation of TDG during rat 
fetal development was also characterised for the first time, and immunofluorescence 
suggests that its pattern of expression largely follows that of 5caC.  
  
 
Figure 3.21. Proposed epigenetic reprogramming time-line in the rat. Germ cells 
showed asynchronous 5mC remethylation between e18.5 and e21.5. 5hmC, 5fC and 
5caC were moderately detectable in germ cells from e14.5-16.5 but were thereafter 
undetectable. 
 
There was little detectable 5mC in the germ cells from e14.5-e16.5, suggesting that 
the phase of bulk global demethylation may have been completed by this time. This 
is in keeping with mouse studies which indicate that a phase of demethylation occurs 
across the majority of the genome between e11.5-e12.5 [14]. Although this appears 
to be completed slightly later in the rat, it should be considered that they have a 
longer gestation (22 days in Wistar rats, compared to approximately 19 days in the 
mouse [250]). 
At e17.5 and e18.5, 5mC was not detectable in germ cells. Studies in the mouse 
suggest that although demethylation occurs across most of the genome there are 
some exceptions, for example IAP retrotransposons. These remain highly methylated 
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[166,180,187] which may act to prevent IAP retrotransposition, potentially 
protecting against epimutations [172]. Furthermore, recent data indicates that a 
number of non-IAP associated CpG islands may also escape epigenetic 
reprogramming in the male germline and could represent candidates for 
transgenerational epigenetic inheritance [187]. I would therefore hypothesise that at 
e17.5 in our model, 5mC levels have decreased below the threshold of detection for 
the antibody, and therefore cannot be imaged in the germ cells.  
At e19.5 5mC was detectable in some germ cells, and this became augmented at 
e20.5-e21.5. Staining with Propidium Iodide further indicates that there are germ 
cells present within the tubule which have no detectable 5mC at e19.5, whilst 
staining in others is comparatively strong. This suggests that the phase of 
remethylation occurs asynchronously from e18.5-e21.5. The remethylation phase has 
been less extensively characterised in mouse germ cells, although gene-targeted 
studies suggest that in male germ cells, the onset of DNA remethylation occurs at 
some imprinted loci and at repetitive elements from e15.5, with global remethylation 
re-established by e18.5 which may be further augmented perinatally 
[178,184,196,251].   
Asynchronous remethylation between germ cells has not been reported in the 
literature and might only be detectable using immunofluorescence, or single-cell 
studies. There is however evidence that remethylation occurs at different genes at 
different time-points [178]. This is consistent with studies showing that different 
genes are demethylated at different time-points [177,206].  
Intriguingly, 5hmC, 5fC and 5caC were identified in germ cells at e14.5-e16.5, but 
not from e17.5-e21.5. The presence of 5fC and 5caC in germ cells has not previously 
been reported, although 5hmC has been identified in the developing mouse germ cell 
[252]. It has also been shown that 5hmC, 5fC and 5caC are produced from 5mC, and 
that they may form part of a putative demethylation pathway, concluding with 5fC or 
5caC removal via the action of TDG and the BER pathway [149-151]. Support for 
this comes from recent work suggesting that 5fC is detectably enriched over the 
bodies of actively transcribing genes as well as over CpG islands and promoters in 
ES cells and these levels increase in the absence of TDG activity [171]. It would 
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therefore fit that 5hmC, 5fC and 5caC would be formed during the demethylation 
phase of epigenetic reprogramming. 
It is interesting that 5fC and 5caC are present for at least a 3 day period, rather than 
being rapidly removed. An in vitro study indicated that within a 10 minute 
incubation, TET2 was capable of converting over 95% of total 5mC, giving 60% 
progression to 5hmC, 30% to 5fC and 5% to 5caC by the end of the time period 
[149]. Intriguingly, the reaction rate of TET2 was found to be 4.9-fold or 7.6-fold 
lower when the starting substrate was 5hmC or 5fC respectively [149]. Even if the 
conversion of these forms takes longer than for 5mC, this does suggest that the action 
of TET2 enzymes and conversion through methyl forms could potentially be 
complete within a matter of hours. The more stable presence of 5fC and 5caC 
exhibited in our model suggests a number of potential hypothesises. The continuing 
presence of 5fC and 5caC could result from a gradual and constant removal of 5mC 
during e14.5-e16.5 which results in a steady production of methylation in its various 
forms. In this case the 5fC or 5caC at any particular base may be rapidly removed, 
but the constant turnover might give the appearance of a more stable expression of 
5fC and 5caC when assessed globally. This is supported by the identification of TDG 
throughout e14.5-e16.5, which indicates there is the potential for continual removal 
of 5fC and 5caC throughout the time period. Indeed, in pigs the phase of 
demethylation was shown to be complete at e22 for DMR2 of the IGF2 receptor  
(Igf2r), but found to occur gradually between e22-e42 in the Igf2-H19 regulatory 
region, suggesting that it is not always a rapid process, and that there is variation 
between genes, and indeed species [206].  
A second hypothesis is that the presence of 5fC and 5caC in fetal germ cells reflects 
an accumulation of unconverted intermediates during global demethylation. Indeed, a 
study of mouse zygotes indicates that 5hmC, 5fC and 5caC levels gradually decrease 
with increasing numbers of cell division, rather than exhibiting rapid removal 
[157,167]. These hypotheses could be tested by conducting genome-wide single base 
resolution studies of 5fC and 5caC, as in Wang et al. (2014) [169]. A number of 
precise time-points could be studied, giving an indication as to whether these 
modifications are rapidly or gradually removed. For example, 5fC and 5caC levels at 
128 
 
several loci could be examined at e14.5, e15.0, e15.5, e16.0 and e16.5. This would 
determine how rapidly demethylation occurs at a loci-specific level.     
In both cases it could be hypothesised that these forms of methylation have some 
functionality during mid-gestation, necessitating either their constant production 
from 5mC, or their lack of conversion and removal. Much has still be discovered 
about 5fC and 5caC, but Inoue et al. (2011) conclude from their observations of 
replication dependent dilution of these modifications in mouse zygotes that 5fC and 
5caC could have functionality in early development [157]. Indeed, a recent paper 
identifies transcriptional and chromatin regulators which are able to interact with 
5fC, and have a strong preference for this modification, compared to others. The 
authors conclude that although 5fC is part of a demethylation pathway, it may also 
have signalling properties [253]. 
Although the presence of 5fC and 5caC at e14.5-e16.5 might be expected as part of 
demethylation, the unexpected dynamics of these forms in both prenatal and 
postnatal development gives an additional suggestion of functionality. For example, 
it is intriguing that variability was identified in the germ cell staining at e16.5, with 
one particular pup having a very intense detection of 5hmC, 5fC and 5caC, relative 
to the somatic component. This could reflect a peak in these forms of methylation 
around e16.5. The fact that this was not replicated in the other litters could indicate 
that the peak was very brief, and that the exact time of fertilisation was slightly 
different between matings. A study using In Vitro Fertilisation (IVF) and looking at 
additional time-points around this time period, for example e16.3 and e16.7 might 
give greater indication as to whether this is a true phenomenon, or an experimental 
artefact.  
It is also intriguing that there were dynamic changes in the localisation of 5hmC and 
5caC postnatally, long after the period of demethylation in epigenetic reprogramming 
appears complete. Both forms of cytosine methylation were identified in Sertoli cells 
at PND10 and PND15, and a very intense stain was seen in the germ cells of some 
tubules at PND25. This could indicate that further demethylation is occurring in 
postnatal development, or indeed that 5hmC and 5caC have functionality at these 
time-points. It is interesting to note that although 5hmC and 5caC are being formed, 
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global 5mC is evident. For example, although 5hmC and 5caC are seen at PND25, 
they are co-localised with 5mC. It could be suggested that this may be followed by a 
decrease in 5mC, for example at PND26, but this is not evident in the adult tissues, 
where the spermatogonia appear 5mC positive. It is also notable that although 5caC 
is present, TDG was not detectable in germ cells at the corresponding time-point. 
Interestingly, although an intense stain for 5hmC was seen in many tubules at 
PND25, fewer tubules were 5caC positive. It is possible that this time-point might 
represent the beginning of 5caC formation, and that if for example PND26-PND28 
was studied, 5caC might be found in the majority of tubules, subsequently followed 
by a positive stain for TDG. Conversely, it could be suggested that 5caC is not being 
removed by TDG, as this time-point does not reflect demethylation, but that 5caC is 
being regulated by other, as yet undetermined means.  
It is unknown why 5hmC, 5fC and 5caC should be formed at this stage, whether as 
part of some 5mC removal, or by other undefined processes. PND25 is a key time-
point in functional maturation just prior to the start of puberty, where plasma 
testosterone levels begin to increase, and Sertoli cell numbers are fixed  and are more 
similar to that of the adult rat, than in pre-natal development [254,255]. It is possible 
that during this time of change 5hmC, 5fC and 5caC have a role in germ cell 
development. It could also be suggested that there is some change in chromatin 
compaction as the chromatin remodelling of spermatogenesis begins [256], and 
therefore differences in the intensity of 5hmC and 5caC staining at PND25 could 
reflect a change in the accessibility of these antigens for antibody binding. 
Although little TDG was detectable in germ cells at PND25, its dynamics were 
largely seen to correspond to that of 5caC, one of its proposed substrates. The global 
dynamics of TDG localisation in the germ cell throughout development has not been 
characterised previously. However, data mining of RNA-seq data from Seisenberger 
et al. (2012) indicates that TDG expression is low in late-stage mouse germ cells 
(after e13.5). Data mining also indicates that TDG expression is relatively high in the 
early postnatal whole testis, with expression decreasing progressively from PND10 
(R Meehan, unpublished data). 
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Immunofluorescence studies are not predominantly quantitative, but can provide key 
information about the location of the antigen within tissue, at a cellular level. In this 
study immunofluorescence was used to provide a broad picture of the localisation of 
global methylation in the testis throughout mid to late gestation, so that gene-
specific, quantitative analysis could then be performed at key time-points. 
Furthermore, Image J studies gave a second, semi-quantitative analysis of 
immunofluorescence, and supported the conclusions drawn visually from the images.      
This study indicates that germ cell epigenetic reprogramming does occur in the rat, 
and that remethylation occurs between e18.5 and e20.5. As this time-period shows 
dynamic changes in 5mC, and is within the window of Dex exposure (e15.5-e22.5), 
it was decided that this is a critical timeframe for study in the Dex programming 
model.  The dynamics of all known forms of methylation, and the regulatory enzyme 
TDG were also explored in both pre and postnatal life, giving a more global 
understanding of the dynamics of germ cell methylation in the rat. The presence of 
5hmC, 5fC and 5caC and TDG from e14.5-e16.5 supports the theory that they may 
form a pathway for demethylation, but their continuing presence during this time-
period, and unexpected dynamics postnatally suggest that they could also have 
functionality.  This indicates that there is still much to be discovered about DNA 











Chapter 4 Effects of Glucocorticoid Exposure on Fetal Germ Cell Development 
 
4.1 Introduction 
As discussed in the Chapter 1, fetal programming of disease risk has been shown to 
be transmissible through both maternal and paternal lines. In the Dex model of 
programming, the phenotype of low birth weight and altered cardiometabolic 
parameters is also transmitted through the paternal line [12]. In this animal model, 
one of the few methods of influence of the father on his offspring is the contribution 
of his sperm, as he is absent shortly after the point of fertilisation.   
One hypothesis is that first generation male offspring exposed to an insult in utero 
might have alterations in their sperm which allow a transmission of the phenotype to 
the second generation. One mechanism by which such an alteration might occur is by 
the direct influence of Dex treatment on their spermatogonial progenitor cells whilst 
they themselves are in utero.  
An initial exploration of the effects of Dex exposure on the epigenetic 
reprogramming time-line established in Chapter 3 was therefore conducted. A 
number of time-points were studied to give a broad investigation of any influence of 
Dex exposure on global methylation, so that a key time-window could be identified 
for a more in-depth gene-specific study.   
The DNA methyl transferase enzymes DNMT3a and DNMT3b have been shown to 
be key in the remethylation phase of epigenetic reprogramming in the mouse 
[200,257]. Their action is dependent on the co-factor DNMT3L [201,258]. The 
presence of these enzymes in the rat, and any influence of Dex on their localisation 
during remethylation was also investigated, giving an additional analysis of the 
effects of treatment on epigenetic reprogramming. 
An indication of the effect of Dex treatment on general testis development was also 
given by examining the localisation of Doublesex and Mab-3 Related Transcription 
Factor 1 (DMRT1). Previous research has indicated that this transcription factor is 
switched off in germ cells at around e19.5, but is present in somatic cell nuclei 
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throughout late gestation [259]. Therefore DMRT1 was used to give a marker of 
general testis development, apart from effects on epigenetic reprogramming.    
 
4.2 Methods 
Virgin female Wistar rats were timed-mated with stock Wistar males, and injected 
daily with either Dex (100µg/kg body mass) suspended in 0.9% Saline, or an 
equivalent volume of Saline from e15.5 until termination. Pregnant dams were 
sacrificed at e18.5-e21.5 (n=3-4 at each time-point), and all pups and placentas 
removed. Pup and placental mass was recorded for all litters at each time-point. 
Normality of data distribution was confirmed using the Lilliefors test. Normally 
distributed data (p>0.05) was analysed by Student’s t-test, and nonparametric data by 
Mann Whitney U test.  
Testes were extracted from male pups with the instruction and assistance of Dr 
Sander van den Driesche (Centre for Reproductive Health, The University of 
Edinburgh) and fixed in Bouins, before testes were embedded in paraffin wax by 
SURF staff. Tissue blocks were then microtomed to give 5µm sections, which were 
then mounted on microscope slides. Immunofluorescence was used to explore the 
localisation of GR within the testis, and to indicate any global changes in the 
established epigenetic reprogramming time-line with glucocorticoid exposure. Slides 
were immunostained for GR, 5mC, 5hmC, 5fC and 5caC, following the protocols 
outlined in Chapter 2.  
In order to give semi-quantification of 5mC staining, 2 sections were taken from a 
testis in every e19.5 and e20.5 litter, spaced 50 µm apart, and immunostaining for 
5mC and Propidium Iodide was conducted. Tile scans were used to capture an image 
of the entire cross-section. Images were put into random order, and titles changed to 
show only the time-point, colour channel, and a letter. Images were then assessed 
blindly by Ashley Boyle, MSc student, Centre for Reproductive Health, The 
University of Edinburgh. Germ cells were counted using Propidium Iodide, and 
counted and graded using 5mC staining, with 1 corresponding to a weak, 2 a 
moderate, and 3 an intense 5mC stain. 5mC intensity scores were normalised to the 
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total number of germ cells identified by Propidium Iodide in each tubule and a mean 
calculated by combining the data from both sections in every testis. The resulting 
data was then analysed by 1-way Analysis of Variance (ANOVA), with Fisher’s 
Least Significant Difference (LSD) post-hoc analysis. Data are expressed as mean 
percentage of germ cells expressing 5mC ± the standard error of the mean. 
To investigate any corresponding changes in the machinery of remethylation, the 
DNMT3 family was studied. Immunofluorescence was conducted for DNMT3a and 
DNMT3b by Ashley Boyle, under my instruction and supervision. I also conducted 
immunofluorescence for their co-factor DNMT3L. As an indicator of the general 
developmental stage of the Dex and Saline testes, I also investigated DMRT1 





















4.3.1 Confirming the Effectiveness of Dex Treatment 
Pup and placental weights were analysed in order to confirm that Dex exposure had 
given the expected phenotype. Pup weight was significantly decreased at e21.5 in 
litters exposed to Dex in utero, relative to Saline controls (Figure 4.1). However no 
significant difference was found at e18.5-e20.5.  
Placental weight was decreased at e19.5-e21.5, but not at e18.5, in litters exposed to 
Dex relative to controls (Figure 4.2). 
 
    
 
Figure 4.1. Pup weight at experimental time-points. All pups of both sexes were 
weighed prior to dissection. Pups exposed to Dex in utero were found to have a 
significantly decreased (p<0.001) weight at e21.5 relative to Saline controls. Weight 
at e18.5-e20.5 did not differ between groups. Data were analysed by Student’s t-test 
for all time-points, except for e18.5 and e21.5, which were not normally distributed 
(Lilliefors p<0.05), and for which a Mann-Whitney U test was therefore performed. 



























Figure 4.2. Placental weight at experimental time-points. All placentas were weighed 
during dissection. Placentas of litters exposed to Dex in utero were found to have a 
significantly decreased weight at e19.5 (p<0.05), e20.5 (p<0.001) and e21.5 
(p<0.001), relative to Saline controls. Weight at e18.5 did not differ significantly 
between groups. Data were analysed by Student’s t-test for all time-points, except for 
e18.5 and e21.5, which were not normally distributed (Lilliefors p<0.05), and for 
which a Mann-Whitney U test was therefore performed. Bars represent mean ± 





































4.3.2  Exploring the Localisation of GR 
The localisation of GR was investigated, in order to explore whether any influence of 
Dex on the testis was likely to be direct, through GR in germ cells, or indirect, 
through somatic cells. GR was detected in somatic cells from e18.5-e21.5 in both 
Saline and Dex groups (Figure 4.3 and Figure 4.4 respectively). Notably weaker 
staining was seen for GR in germ cells in both groups. Arguably slightly weaker 
detection was found in Dex germ cells, compared to controls. However, all germ 
cells indicated by Sytox Green staining had some corresponding detection for GR.    
 
Figure 4.3. Location of GR within the testis – Saline pups. Images of immunostained 
testes from Saline pups show detection of GR in somatic and germ cells (red, arrows) 
at e18.5-e21.5 (A-C). All germ cells indicated by Sytox Green have a corresponding 




Figure 4.4. Location of GR within the testis – Dex Pups. Images of immunostained 
testes from Dex pups show marked detection of GR in somatic cells (red, arrows) at 
e18.5-e21.5 (A-C). Weak staining is seen within germ cells at all time-points. Sytox 










4.3.3  Exploring Effects of Glucocorticoid Exposure on Global Germ Cell 
Methylation 
In order to explore any global effects of glucocorticoid exposure on the epigenetic 
reprogramming time-line, Dex and Saline slides were immunostained. In Saline 
tissues, 5mC was not detected in germ cells at e18.5 or e19.5 (Figure 4.5A-B), but 
staining became marked by e21.5 (Figure 4.5D). Conversely, whilst 5mC was not 
detected at e18.5 in Dex tissues (Figure 4.6A), some germ cells had a positive stain 
for 5mC at e19.5 (Figure 4.6B), intensifying by e21.5 (Figure 4.6D). Germ cell 
5hmC was not detected in either treatment group across the time-course (Figure 4.5 
and Figure 4.6).   
To gain a greater insight into methylation within these tissues, testes were also 
stained for 5fC (Figure 4.7 and Figure 4.8) and 5caC (Figure 4.9 and Figure 4.10). In 
keeping with previous results, 5fC and 5caC were localised to somatic cells 
throughout the time course for both treatment groups, but largely undetected in germ 
cells. However, a weak detection for 5fC was found in the germ cells of some tubules 




Figure 4.5. Localisation of 5mC and 5hmC in Saline testis. Images of immunostained 
testis show that 5mC (green, arrows) is not detected at e18.5 and e19.5 (A, B), and 
has some detection in germ cells at e20.5 (C), becoming marked by e21.5 (D). 5hmC 
(red) is not visualised in germ cells. Both forms of methylation are found in somatic 




Figure 4.6. Localisation of 5mC and 5hmC in Dex testis. Images of immunostained 
testis show that 5mC (green, arrows) is undetected at e18.5 (A), and is detected in 
some germ cells by e19.5 (B). At e21.5 there is a marked 5mC detection in germ 
cells (D) 5hmC (red) is not visualised in germ cells. Both forms of methylation are 
found in somatic cells throughout the time course. Bar = 50μm. 
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Figure 4.7. Localisation of 5fC in Saline testis. Images of immunostained testis show 
that 5fC (green, arrows) is largely undetectable at e18.5 and e19.5 (A, B), and has 
some detection in germ cells at e20.5 (C) and e21.5 (D). 5fC was found in somatic 
cells throughout the time course. Propidium Iodide (PI) acts as a nuclear 
counterstain. Bar = 50μm. 
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Figure 4.8. Localisation of 5fC in Dex testis. Images of immunostained testis show 
that 5fC (green, arrows) is largely undetectable at e18.5 (A), e20.5 (C) and e21.5 (D), 
but there is some positive staining in germ cells at e19.5 (B). 5fC was found in 
somatic cells throughout the time-course. Propidium Iodide (PI) acts as a nuclear 




Figure 4.9. Localisation of 5caC in Saline testis. Images of immunostained testis 
show that 5caC (green) is undetectable in germ cells from e18.5-e21.5 (A-D), but 
found in somatic cells throughout the time course. Propidium Iodide (PI) acts as a 





Figure 4.10. Localisation of 5caC in Dex testis. Images of immunostained testis show 
that 5caC (green) is undetectable in germ cells from e18.5-e21.5 (A-D), but is found 
in somatic cells throughout the time course. Propidium Iodide (PI) acts as a nuclear 




4.3.4 Semi-Quantification of 5mC Immunofluorescence 
The potential difference in 5mC germ cell staining between Dex and Saline groups at 
e19.5 was further explored. 5mC staining in germ cells was scored as outlined in 
Chapter 2 and expressed as a percentage of the total number of germ cells, counted 
using Propidium Iodide.  The total percentage of germ cells with a positive stain was 
greater in Dex tissues at e19.5, relative to Saline controls (Figure 4.11). These 
positive counts were predominantly split over intensity scores 1 and 2, indicating 
weak to moderate detection (Figure 4.12). 
In order to explore whether this difference was persistent, e20.5 tissues were 
examined in the same way. No difference was identified in the percentage of germ 
cells positive for 5mC between Dex and Saline groups. This was found when 
analysing both the total number of germ cells positive for 5mC (Figure 4.13) and 
each intensity scoring individually (Figure 4.14).  
 
Figure 4.11. Percentage of germ cells 5mC positive at e19.5. Number of germ cells 
detected with 5mC antibody is expressed as a percentage of the total number of germ 
cells identified by Propidium Iodide stain. This percentage was greater (p<0.05) in 












































Figure 4.12. Intensity scoring of 5mC positive germ cells at e19.5. Number of germ 
cells graded to be at each intensity score is expressed as a percentage of the total 
number of germ cells identified by Propidium Iodide stain. This percentage was 
greater (p<0.05) in Dex samples relative to Saline controls, split over intensity scores 








































Figure 4.13. Percentage of germ cells 5mC positive at e20.5.  Number of germ cells 
detected with 5mC antibody is expressed as a percentage of the total number of germ 
cells identified by Propidium Iodide stain. This percentage was not significantly 
different between Dex and Saline samples. Bars represent mean ± standard error.   
 
 
Figure 4.14. Intensity scoring of 5mC positive germ cells at e20.5.  Number of germ 
cells graded to be at each intensity score is expressed as a percentage of the total 
number of germ cells identified by Propidium Iodide stain. This percentage was not 
significantly different between Dex and Saline groups at any intensity score. Bars 

































































4.3.5 Exploring Mechanisms of Potential Time-line Shift 
 
4.3.5.1  DNMT3a and 3b 
The potential mechanisms of a change in the epigenetic timeframe with Dex 
treatment were explored. The DNMT3 family were investigated as an indication of 
impact upon other epigenetic mechanisms, and because of their known role in mouse 
remethylation [200,201,260]. DNMT3a and DNMT3b were detected in germ and 
somatic cells in both Dex and Saline groups (Figures 4.15-4.18). No notable 
difference in DNMT3a/3b localisation was seen between treatment groups. 
Comparison with Vasa suggests that all germ cells present have a corresponding 
DNMT3a or 3b stain.  
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  Figure 4.15. DNMT3a immunofluorescence in Saline tissues. Images of immunostained testis 
show that DNMT3a was detected in germ cells (blue, arrows) at e18.5-e21.5. Staining was 
detected in the somatic component throughout the time-course. Vasa staining (red), 
compatible with this protocol, was used to identify germ cells. Sytox Green acted as a nuclear 






Figure 4.16. DNMT3a immunofluorescence in Dex tissues. Images of immunostained 
testis show that DNMT3a was detected in germ cells (blue, arrows) at e18.5-e21.5. 
Staining was detected in the somatic component throughout the time-course. Vasa staining 
(red), compatible with this protocol, was used to identify germ cells. Sytox Green acted as 





Figure 4.17. DNMT3b immunofluorescence in Saline tissues. Images of immunostained 
testis show that DNMT3b was detected in germ cells (blue, arrows) at e18.5-e21.5. Staining 
was detected in the somatic component throughout the time-course. Vasa staining, 
compatible with this protocol, was used to identify germ cells. Sytox Green acted as a 









Figure 4.18. DNMT3b immunofluorescence in Dex tissues. Images of immunostained testis 
show that DNMT3b was detected in germ cells (blue, arrows) at e18.5-e21.5. Staining was 
detected in the somatic component throughout the time-course. Vasa staining (red), 
compatible with this protocol, was used to identify germ cells. Sytox Green acted as a nuclear 




4.3.5.2  DNMT3L 
As no visible change in DNMT3a or 3b staining was seen to account for an alteration 
in the timeframe of remethylation, expression of DNMT3L was explored. Since this 
methyl transferase acts as a co-factor for DNMT3a and 3b action [201], my 
hypothesis was that the expression or localisation of DNMT3L could be altered by 
Dex treatment, thus changing the remethylation activity of the other methyl 
transferases. Surprisingly, the DNMT3L antibody gave a diffuse cytoplasmic stain at 
e18.5-e21.5 in both Dex and Saline tissues (Figures 4.19 and 4.20). A previous study 
indicated germ cell staining was seen at PND25, but not at PND4 (Sharpe et al., 
unpublished data). I therefore studied these postnatal time-points to give an 
indication as to whether the current immunofluorescence protocol was working as 
previously. Whilst a weak diffuse cytoplasmic stain was seen for DNMT3L at PND4 
(Figure 4.21A), an intense detection was found in germ cell nuclei at PND25 (Figure 
4.21B). Interestingly, whilst this staining pattern was seen in some tubules, it was 
largely absent from others within the same testis section.   
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Figure 4.19. DNMT3L immunofluorescence in Saline tissues. Images of 
immunostained testis show a diffuse cytoplasmic detection of DNMT3L (red) at 
e18.5-e21.5, which is absent from germ cell nuclei. Sytox Green acted as a nuclear 





Figure 4.20. DNMT3L immunofluorescence in Dex tissues. Images of 
immunostained testis show a diffuse cytoplasmic detection of DNMT3L (red) at 
e18.5-e21.5, which is absent from germ cell nuclei. Sytox Green acted as a nuclear 





Figure 4.21. DNMT3L immunofluorescence in Dex tissues. Images of 
immunostained testis show a diffuse cytoplasmic detection of DNMT3L (red) at 
PND4 (A). However at PND25 (B), an intense nuclear stain is found in the germ 
cells of some tubules (arrow), but not others. Sytox Green acted as a nuclear 
counterstain. Bar = 50μm. 
 
4.3.5.3 DMRT1 
In an attempt to gauge the development of the testis as a whole, beyond changes in 
DNA methylation, DMRT1 was studied. This transcription factor was chosen as it is 
not directly linked to epigenetic mechanisms, it is present within the germ cells 
during mid-late gestation, when many traditional markers are absent, and 
immunodetectable protein expression is lost at e19.5-e20.5, a key time-point for 
change in our studies [259]. DMRT1 was detected in germ cells at e18.5 and e19.5, 




Figure 4.22.  Localisation of DMRT1 in Saline testis. Images of immunostained 
testis show that DMRT1 (red, arrows) is present in germ cells at e18.5 and e19.5, and 
is undetected by e20.5. DMRT1 is seen in Sertoli cell nuclei throughout the time 





Figure 4.23.  Localisation of DMRT1 in Dex testis. Images of immunostained testis 
show that DMRT1 (red, arrows) is present in germ cells at e18.5 and e19.5, and is 
undetected by e20.5. DMRT1 is seen in Sertoli cell nuclei throughout the time 




4.4  Discussion 
These data indicate that Dex exposure in utero may alter the epigenetic 
reprogramming time-line of developing fetal germ cells. I explored the localisation 
of GR within the testis, and therefore its susceptibility to glucocorticoid exposure, 
and then demonstrated for the first time that Dex treatment may correspond to a 
premature re-establishment of global germ cell 5mC. This however does not 
correspond to changes in localisation of DNMTs, as assessed by 
immunofluorescence.  
As in previous studies, in utero Dex exposure decreased placental and fetal weight. 
The former was demonstrated between e19.5-e21.5, which is in keeping with studies 
reporting this decrease at e20.5 [12]. A reduction in fetal weight was only 
demonstrated at e21.5, although previous work indicates that this would be expected 
to occur by e20.5 [12]. This discrepancy could reflect the smaller replicate number 
used in this study. The effect of Dex exposure on placental weight, however, gives an 
assurance that our treatment had some effect on the e18.5-e20.5 litters, even before 
this was evident in pup weight.  
The detection of GR in the somatic component of the fetal testis confirms that Dex 
may be able to act upon this tissue. As these cells promote the development of the 
germ cell, glucocorticoid exposure could have an indirect effect upon the germline in 
this way. Low levels of GR detection were also seen within the germ cells 
themselves suggesting that Dex could also have a direct action upon these cells. The 
location of GR within the fetal testis has not previously been reported, however my 
results are in keeping with studies examining expression within the testis of adult 
rats. GR has been shown to be located within Sertoli cells and interstitial 
components, such as Leydig cells and blood vessel endothelium during postnatal 
development [261,262]. Indeed, the Sertoli cell-specific GR knockout mouse has 
decreased Sertoli cell numbers, and intriguingly, a reduction in the circulating levels 
of Luteinizing Hormone (LH) and Follicle-stimulating Hormone (FSH) [263]. The 
authors propose that decreased Sertoli-cell GR may therefore inhibit the pituitary 
secretion of these gonadotrophins. In this study, the numbers of meiotic 
spermatocytes and postmeiotic spermatids were also reduced, and atypical germ cell 
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morphology was reported in the adult testis [263]. GR is also expressed within the 
nuclei of postnatal rat germ cells, with an increase in immunoreactivity reported from 
PND14 [261].  In the current study, Dex exposure did not visibly alter the 
localisation of GR. However, slightly weaker staining was observed in Dex-exposed 
germ cells, relative to Saline controls. Although immunofluorescence is only semi-
quantitative, this may indicate a decrease in germ cell GR expression with Dex 
treatment, which would need further validation. Previous studies have shown that 
Dex, acting through GR, can alter the expression of the androgen binding protein and 
the glycoprotein hormone stanniocalcin-1 in cultured Sertoli cells [264,265] and 
reduces the proliferation of cultured peritubular cells [261]. Thus, even if Dex 
exposure does not confer changes in germ cell GR expression, it may alter gene 
regulation within somatic cells, which could ultimately impact upon germ cells.  
My data indicate that Dex exposure may influence remethylation during germ cell 
reprogramming. Visually, more germ cells appeared to be 5mC-positive at e19.5 
following Dex exposure, relative to Saline controls. This was supported by semi-
quantification, indicating this was a statistically significant difference. As 5mC 
staining between groups was not significantly different by e20.5, I hypothesise that 
Dex is promoting a pre-mature remethylation phase during germ cell epigenetic 
reprogramming (Figure 4.24).  
 
Figure 4.24. Hypothesised effect of Dex treatment upon reprogramming time-line. 




An effect of Dex exposure on epigenetic reprogramming has not previously been 
reported. It is, however, in keeping with the hypothesis that an altered intra-uterine 
environment can influence DNA methylation in the offspring [266]. Dex exposure in 
cultured rat hepatocytes has also been shown to promote a stable state of 
demethylation of the promoter region of the tyrosine aminotransferase gene in liver, 
which in vivo may prepare the genome to respond to postnatal hypoglycaemia [267]. 
Maternal Dex treatment has been shown to reduce levels of 5mC at Igf2 [12] and 
Tex.19 (Drake, unpublished) in fetal liver. As the latter is predominantly expressed in 
germ and pluripotent cells, and is involved in the regulation of spermatogenesis [268] 
this indicates that an influence on methylation within the fetal germline itself might 
be anticipated.  
The mechanisms by which a Dex-induced change in epigenetic reprogramming could 
be mediated are yet to be deduced. DNMT3a and DNMT3b are implicated in germ 
cell remethylation in mice [269]. It was therefore hypothesised that their localisation 
might be altered following Dex exposure, influencing the timing of remethylation. 
The localisation of DNMT3a and DNMT3b in the rat has not previously been 
reported in the literature, although laboratory data suggests that it is present in the 
fetal testis. Immunofluorescence indicated that both DNMT3a and DNMT3b were 
present in germ and somatic cells from e18.5-e21.5 in the rat. No noticeable variation 
in staining was recorded between testes of Dex and Saline-exposed fetuses. The 
localisation of DNMT3L, known to act as a co-factor for DNMT3a and DNMT3b 
[200,201] was therefore studied however an unexpected staining pattern was seen for 
DNMT3L in fetal tissues. A very intense nuclear stain within some seminiferous 
tubules at PND25 suggested that the antibody staining conditions were correct, at 
least for some time-points. It is therefore unclear if this represents a true cytoplasmic 
localisation in the fetal rat seminiferous tubule, or an experimental artefact. 
Certainly, no observable difference in localisation between Dex and Saline groups 
was noted. Thus, if Dex mediates its actions on fetal programming through an 




It has recently been suggested that Dex may influence gene expression through 
DNMT3b. Data indicates that Dex may promote the formation of a repressor 
complex, comprising of GR, HDAC1 and MeCP2, which recruits DNMT3b to gene 
promoter regions, and subsequently increases methylation [270]. GR has been shown 
to be capable of interacting with DNMT3b, but intriguingly, not DNMT3a [270].  
This study, however, was conducted in rat hypothalamic cells. The response may be 
different depending on tissue type and stage in development. Thus the mechanism by 
which a shift in the epigenetic timeframe could be mediated has yet to be elucidated. 
Further research is also required to determine if any shift in epigenetic 
reprogramming is a specific action upon the germ cell, or simply an extension of the 
accelerated maturation promoted by Dex administration, shown in other organs. An 
increase in fetal glucocorticoids in late gestation is key for the development of lungs, 
kidney, liver and the gastrointestinal tract in preparation for birth (reviewed in 
[271]).  As such, premature babies can have problems with organ development, and 
therefore Dex is administered to pregnant mothers at risk of a premature delivery. 
For example, in a large epidemiological study, prenatal Dex exposure was found to 
reduce the incidence of respiratory distress syndrome in neonates, due to accelerated 
lung maturation [272].  In the Dex-programmed rat, liver maturation has also been 
shown to be accelerated [273]. It could therefore be hypothesised that Dex exposure 
accelerates maturation of the testis as a whole, rather than having a specific effect on 
epigenetic reprogramming.   
In order to give an initial indication of the maturation state of the testis as a whole, 
tissues were stained for DMRT1. This transcription factor was found to be present in 
germ cells at e18.5 and to a lesser extent e19.5, becoming undetectable in the 
majority of germ cells by e20.5. The same progression was seen for both Dex and 
Saline groups, giving an initial indication that testis maturation was occurring 
normally. This is in keeping with the work of Jobling et al. (2011) who noted that 
DMRT1 was expressed in the majority of germ cells at e17.5, decreasing to 7% by 
e19.5, and to 0% by e21.5. Intriguingly, this group identified significantly more 
DMRT1-positive germ cells at e19.5 following fetal DBP exposure, relative to 
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controls, and hypothesised that this represents a delay in germ cell differentiation 
[259].   
In conclusion, it appears that Dex exposure may alter epigenetic reprogramming, 
with more germ cells remethylated at e19.5 relative to controls. Genome-wide 
studies, capable of highlighting methylation changes at specific genes, are required to 
give a more quantitative analysis of this effect. This should give a greater 
understanding as to whether a shift in epigenetic reprogramming would be 




















Chapter 5 Profiling DNA Methylation in Germ Cells 
 
5.1 Introduction 
I hypothesised that Dex exposure might affect DNA methylation in developing fetal 
germ cells which would then go on to form the next generation. Based on Chapters 3 
and 4, which explored global changes in methylation, I conducted studies with base-
pair resolution in the developing germ cell. Chapter 3 indicated that global 
remethylation during epigenetic reprogramming occurs between e18.5-e21.5, and in 
Chapter 4, global methylation appeared to be increased at e19.5 following Dex 
exposure, suggesting that the epigenetic reprogramming time-line might be shifted 
with treatment. The e19.5 time-point was therefore chosen for detailed gene-specific 
studies as 5mC appeared to be present, and the data from immunofluorescence 
studies suggested it was a key point of change as a consequence of Dex exposure.   
In order to isolate pure populations of fetal germ cells and sperm, a transgenic rat 
strain was used. GCS-EGFP Sprague Dawley rats were reported to express EGFP 
specifically within germ cells and sperm [92]. Founder rats were a kind gift of Bob 
Hammer (University of Texas Southwestern Medical Centre, USA). As they were 
new to The University of Edinburgh, a homozygous colony had to be established, 
and use of their tissues optimised. I also sought to confirm that EGFP expression was 
germ cell-specific, and that the epigenetic reprogramming timeframe and Dex 
programming phenotype was similar to the Wistar rats used in previous Chapters and 
in published literature.   
After establishing that the GCS-EGFP rats were suitable for our programming 
studies, I collected fetal germ cells at e19.5. DNA extraction methodology was 
optimised and Enhanced Reduced Representation Bisulfite Sequencing (ERRBS) 
used to give a genome-wide view of specific cytosines that are differentially 
methylated following Dex exposure. This is based on the technique RRBS, first 
developed in 2005, which allows genome-wide methylation to be detected at single-
base resolution whilst focussing on regions that are most likely to be methylated, 
thus reducing the number of nucleotides to be sequenced to around 1% of the 
genome [274]. DNA is first cleaved by a restriction endonuclease such as 
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Microsomal Serine Proteinase 1 (MSP1), which cuts the DNA following a CpG. 
Other enzymes may be used to fragment the genome, but some have alternative 
cleavage sites, meaning that there is no bias towards CpG dinucleotides [275]. The 
majority of methylation occurs at CpGs, and therefore favouring the presence of CpG 
sites is advantageous for methylation sequencing studies [276].  Employing an 
enzyme such as MSP1 ensures that there will be at least 2 terminal CpG sites in 
every fragment. Crucially, MSP1 digestion is not sensitive to DNA methylation, thus 
there is no bias towards methylated or non-methylated CpGs [275]. The 3’-terminal 
ends are then repaired, and an extra adenosine base added to the ends of both strands 
in a process called A-tailing. This allows ligation of methylated adaptors on to the 
ends of the fragment. The methylation of these adapters ensures the integrity of their 
sequence during the bisulfite conversion step. Gel electrophoresis is used to isolate 
fragments of the desired length, which are then bisulfite converted [275]. This 
process converts unmodified cytosine to uracil, whilst methylated cytosines are 
protected from this conversion [277]. Bisulfite-converted DNA is then amplified by 
PCR, using primers specific to the adapter sequences previously added to the 
fragment. The amplified DNA is then sequenced, with uracil bases indicating sites of 
unmethylated (converted) cytosine and cytosine bases indicating those of methylated 
(unconverted) cytosine, in the original DNA sample [275].    
ERRBS follows the same protocol, but with some modifications to facilitate the 
analysis of small samples, and to enhance coverage of CpGs that exist out with CpG 
islands [278]. The two rounds of bisulfite conversion found in RRBS are substituted 
for one extended conversion period, eliminating an intermediate DNA clean-up step 
previously conducted, and thus reducing sample loss [278]. This also yields 
improved bisulfite conversion rates. A wider range of fragment sizes are also 
selected, encompassing longer lengths, and ensuring more of the regions beyond 
CpG islands are captured [278]. A recent study suggests that 25% of DNA 
methylation may occur out with CpGs, and therefore increasing the fragment length 
and the capture of these regions may be of relevance [276].   
The resulting ERRBS analysis gives a predicted methylation status for each CpG 
studied across all the given reads for that base. The percentage ratio of methylated to 
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unmethylated cytosines aligning to each CpG is therefore used to give a ‘methylation 
score’. Thus theoretically, if all reads from all samples in a group indicated CpG 
methylation, the predicted status would be 1 or 100% [278]. A preliminary 
descriptive analysis of differentially methylated cytosines (DMCs) was performed by 
Thomas Smith, CGAT, University of Oxford. This included all DMCs which 
exhibited altered methylation consistently across the samples. The numbers of DMCs 
exhibiting hypermethylation with Dex exposure were compared to those found to be 
hypomethylated. DMCs were then grouped based on their corresponding methylation 
status in control liver samples, as determined by ERRBS in Chapter 6. The liver 
methylation status was used to give an imperfect indication of the baseline 
methylation state for that DMC, and whether Dex exposure might cause cytosines to 
be reprogrammed to their ‘normal’ methylation state more quickly.  Biseq analysis 
was then performed. This analysis indicates which of the observed differences in 
cytosine methylation in a data set are statistically significant, and identifies clusters 
of significant DMCs, which we hypothesise could indicate particular relevance for 
gene expression [279]. It was hoped that this technique would give further insight 
into the relationship between Dex exposure and germ cell methylation. 
A second cohort of rats was taken to maturity (90 days) following in utero Dex or 
Saline exposure. Pure sperm populations were isolated by FACS sorting of the 
epididymis and DNA extraction protocols optimised. These samples were also 
prepared for ERRBS, so that any changes in methylation seen in germ cells with Dex 
exposure might be compared to those carried in the sperm. Two main aims therefore 
directed the experiments in this chapter; to characterise the GCS-EGFP rat as a 
potential programming model, and to use it to isolate pure populations of germ cells 






5.2 Materials and Methods 
We were provided with homozygous male GCS-EGFP rats from the University of 
Texas. In order to establish a homozygous colony of GCS-EGFP rats for our studies, 
one founder homozygous male was mated with a Sprague Dawley wild-type female. 
The resulting hemizygous offspring were mated. Genotyping was optimised to 
determine whether EGFP was present in the genome, as outlined in Chapter 2.6.2. 
EGFP-positive rats were continually mated, and if they consistently produced litters 
in which all pups had the EGFP insert, they were determined to be a homozygous 
pair.  
 
5.2.1 Confirming Germline-Specific Expression of EGFP in GCS-EGFP Rats 
In parallel, the founder males were sacrificed, and testis, heart, liver, kidney and 
spleen tissues were isolated. These tissues were fixed in formalin, embedded in 
paraffin wax, and sectioned by staff at SURF. They also used the Bond-Max 
immunostaining machine to give immunostaining for EGFP and the vimentin Sertoli 
cell marker. I then imaged slides to confirm both the tissue- and the cell-specific 
localisation of EGFP in the GCS-EGFP rats.  
Further confirmation of the expression of EGFP in the testis was obtained by 
extracting fetal testes from offspring of the established homozygous colony. Before 
any processing, testes were imaged under the fluorescent microscope, to ensure the 
expression of active EGFP. A single-cell suspension was then created from these 
tissues, as outlined in Chapter 2.5.2.1. The sample was then FACS sorted to confirm 
that a distinct EGFP-positive population was present. All FACS sorting was 
conducted by Fiona Rossi and William Ramsay of the Centre for Inflammation 
Research Flow Cytometry Unit, The University of Edinburgh, following the 
procedures outlined in Chapter 2.16. Additional confirmation of the identity of 
EGFP-positive cells was obtained by exploring the expression of a germ cell-specific 
marker. Homozygous females (n=3) were time-mated with homozygous males, and 
the morning a plug was found was denoted as e0.5. Pregnant dams were culled at 
e19.5, and fetal testes were extracted. A single-cell suspension was created as 
previously, pooling testes from every pup within a litter. The sample from each litter 
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was then FACS sorted separately, and EGFP-positive and EGFP-negative fractions 
collected. Cells were pelleted by centrifugation, supernatant was removed and cells 
were snap frozen on dry ice, before storing at -80°C. RNA was extracted as outlined 
in Chapter 2.11.2 and reverse transcribed to cDNA as outlined in Chapter 2.11.5. 
qPCR was then performed for the germ cell-specific marker Dazl, the Sertoli cell 
marker Sox9, and the housekeeping gene Tbp. qPCR was performed in parallel using 
liver cDNA, as a negative control.  
 
5.2.2 Isolation and DNA Extraction of F1 Germ Cells and Sperm  
In order to confirm that the global remethylation of epigenetic reprogramming occurs 
at similar time-points in wild-type Wistar and GCS-EGFP Sprague Dawley rats a 
litter was produced for each genotype at both e19.5 and e20.5, and tissues collected 
and processed as in Chapters 3 and 4. Immunofluorescence was then used to explore 
the localisation of 5mC at each time-point, as previously. 
Homozygous virgin female GCS-EGFP rats were then time-mated with homozygous 
males. Pregnant dams were injected with Dex or Saline solutions from e15.5 as 
previously, and culled by cervical dislocation at e19.5 (n=10 Saline and 9 Dex 
litters). All pups and placentas were then weighed, and pups sexed by identification 
of either testes or ovaries. Testes were collected and incubated with collagenase to 
create a single cell suspension, as previously. EGFP-positive and negative cells were 
then separated using FACS, as above. A wild-type control litter was also processed 
in the same way to give a negative control so that the appropriate EGFP-positive 
gates could be established. 
Isolated EGFP-positive and negative cells were then pelleted, the supernatant 
removed and cells were snap-frozen on dry ice. Samples were then stored at -80°C. 
DNA extraction was optimised because of the very low cell numbers (around 30,000 
germ cells per litter). Initial optimisation was performed on pellets of an equivalent 
number of AS4.1 cell culture cells, kindly supplied by Charlotte Buckley, as outlined 
in Chapter 2.14.4.1. This allowed initial trials to be performed without the excessive 
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use of animals. The optimised conditions were then used to extract DNA from the 
germ cells.  
A second animal study was conducted to explore methylation in sperm of rats 
exposed to Dex in utero. Homozygous virgin female GCS-EGFP rats were time-
mated with homozygous males, and Dex or Saline solutions given to pregnant dams 
as previously. Dams were allowed to deliver naturally, and pups weighed, and culled 
to 8 per litter. Pups were also weighed at weaning (PND22 ± 1 day) and at maturity 
(90 days). 
At 90 days, one male per litter was sacrificed and the epididymes were removed (n=8 
Saline and 9 Dex). Four incisions were made along the length of each epididymis 
before incubating in sperm swim buffer for 45 min on a rocking platform, allowing 
the motile sperm to swim out of the tissue. The epididymis was then removed and 
sperm pelleted by centrifugation. Sperm was re-suspended in TBS before being 
passed through a 70 µm cell strainer. EGFP-positive cells were removed from debris 
by FACS sorting, as outlined in Chapter 2.16. Sperm of a wild-type Sprague Dawley 
was also processed, giving a negative control, and allowing accurate EGFP FACS 
gates to be set. The resulting EGFP-positive sperm was pelleted by centrifugation, 
snap frozen, and stored at -80°C. DNA extraction from sperm was optimised, due to 
the ineffectiveness of standard extraction procedures on this cell type (see chapter 
2.14.2). Extraction was then conducted on each experimental sample.  
 
5.2.3 Exploring Programming Phenotype in GCS-EGFP Rats 
Glucose tolerance tests were performed at 90 days to explore the metabolic 
phenotype of Dex programming in the GCS-EGFP rat. All rats were fasted for 16 
hours and 1 male from each litter was randomly selected for experimentation. A tail 
bleed was conducted at 9am (time 0), and blood collected in heparin coated tubes.  
Glucose solution (0.5g/ml giving 2g glucose/kg rat) was administered immediately 
after by an oral gavage, performed by William Mungall (BRF, Little France). 
Subsequent tail bleeds were conducted after 30 and 120 min. Samples were 
centrifuged at 6000 rpm for 10 min and the plasma supernatant removed and stored 
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at -20°C. Glucose levels were then analysed by the glucose hexokinase assay, and 
insulin using an insulin ELISA kit as outlined in Chapter 2.9 and 2.10.    
A second generation was also bred from these rats, to confirm that a birth weight 
phenotype was being transmitted across generations. In order to minimise animal 
numbers and cost, only 2 of the 4 potential crosses were bred. Control females were 
crossed with control males (Saline x Saline, SS) and also with Dex-exposed males 
(Saline x Dex, SD). The SD experimental cross was chosen as it explores 
transmission through the male line, which is most relevant to these studies. This 
cross had also shown the greatest effect of treatment on birth weight in Drake et al. 
(2011) [12]. 
Normality of weight data distribution was confirmed using the Lilliefors test. 
Normally distributed data (p>0.05) was analysed by Student’s t-test, and 
nonparametric data by Mann Whitney U test, in keeping with previous studies 
[10,12].  As a second confirmation, data was analysed by multivariate linear 
regression, accounting for the intra-litter association of pups. 
ERRBS was performed on germ cell and sperm samples at Weill Cornell University 
Epigenetics Core, New York, USA.  Bioinformatic analysis was then conducted by 
Dr Thomas Smith (CGAT, University of Oxford, UK).     














5.3.1 Exploring GCS-EGFP rats as Programming Models 
5.3.1.1   Confirming the Germ Cell-Specific Localisation of EGFP 
Immunofluorescence showed no positive detection for EGFP in heart, liver, kidney 
and spleen tissues, as for negative controls, where no primary antibody was used 
(Figure 5.1 B-E). However in testis tissue, the majority of cells have a strongly 
positive EGFP detection (Figure 5.1A).  
Within the testis, little detection of EGFP was found in the nuclei of Sertoli cells, the 
cytoplasm of which was identified by vimentin staining (Figure 5.2B). A strong 
detection of EGFP was found in nuclei of other cells within the seminiferous tubule, 
counterstained with DAPI (Figure 5.2 A).  
EGFP was visualised in the testes of pups culled at e18.5, shown to be bright green 
under the fluorescent microscope, without any manipulation (Figure 5.3A). Testes 
were then FACS sorted, and a distinct EGFP-positive cell population visualised 
(Figure 5.3B). Further confirmation of the germ cell-specific expression of EGFP 
was obtained by reverse transcription and qPCR of RNA extracted from FACS 
sorted EGFP-positive and negative cells, and a liver tissue negative control. 
Significantly higher expression of the germ cell-specific marker Dazl was found in 
the EGFP-positive, compared to EGFP-negative samples (p<0.001). Higher 
expression of the Sertoli cell-specific marker Sox9 was found in the EGFP-negative 
(p<0.001) compared to EGFP-positive samples. Expression of Dazl and Sox9 in liver 




Figure 5.1. Confirming the testis-specific localisation of EGFP. Testis, heart, kidney, liver and 
spleen from GCS-EGFP founder males were stained for EGFP. Fluorescent secondary 
antibody immunostaining, without prior EGFP primary antibody incubation, was used as a 
negative control. Positive EGFP detection (green, arrow) was found in the testis, whilst images 






Figure 5.2. Exploring the localisation of testicular EGFP expression. Testes from 
GCS-EGFP rats were immunostained for EGFP and either DAPI (blue, A) or 
vimentin (red, B). Weak EGFP staining is identified in some extra-testicular cells 
identified by DAPI (blue), and cytoplasm of Sertoli somatic cells, stained by 















Figure 5.3. EGFP-positive cells in founder offspring at e18.5. Testes of GCS-EGFP 
offspring have green fluorescence (A). FACS analysis confirms that testes contain a 
EGFP-positive cell population (B, arrow). X-axis shows the relative fluorescence in 
logarithmic scale. Y-axis indicates the number of cells counted. Emission 










Figure 5.4. Confirming the expression of Dazl germ cell marker in EGFP-positive 
cells. Expression of Dazl, and Sox9 Sertoli cell marker is expressed relative to Tbp. 
Dazl was significantly increased in the EGFP-positive FACS sorted fraction relative 
to EGFP-negative cells (p<0.001) and liver (p<0.01). Conversely Sox9 expression 
was significantly reduced in the EGFP-positive, relative to negative fractions 












































5.3.1.2     Exploring Global Remethylation Patterns 
At e19.5, 5mC was detected in few germ cells (Figure 5.5) whilst at e20.5 (Figure 
5.6) all germ cells identified with Propidium Iodide had a corresponding 5mC stain, 
for both Wistar and GCS-EGFP rats.  
 
 
Figure 5.5. Comparing 5mC localisation in GCS-EGFP Sprague Dawley and wild-
type Wistar rat testis at e19.5. 5mC was identified in the somatic cells of both strains, 
and some of the germ cells of GCS-EGFP rats at e19.5 (green, arrows). Propidium 





Figure 5.6. Comparing 5mC localisation in GCS-EGFP Sprague Dawley and wild-
type Wistar rat testis at e20.5. 5mC (green, arrows) was identified in the somatic 
cells of both strains, and the germ cells of both GCS-EGFP (A) and Wistar (B) rats at 
e20.5. Propidium Iodide (PI) acts as a nuclear counterstain.  Bar = 50µm. An 













5.3.1.3     Confirming that GCS-EGFP Rats Show a Programmed 
Phenotype 
Dex-exposure corresponded to a decreased pup (p<0.01, Figure 5.7A) and placental 
weight (p<0.001, Figure 5.7B). As a second confirmation, data was analysed by 
multivariate linear regression, taking into account the intra-litter association of pups. 
Administration of Dex was found to predict a mean decrease in pup weight (mean 
decrease of 0.26g, p<0.001) and placental weight (mean decrease of 0.09g, p<0.001), 
independently of litter and litter size. Birth weight was also significantly reduced 
following Dex exposure (p<0.001). Linear regression predicted a mean decrease of 
0.73g (p<0.001, Figure 5.8A).  
F1 offspring weight was reduced in both females (p<0.001) and males (p<0.001) at 
weaning (Figure 5.8B) and in males at 90 days (p<0.001, Figure 5.8C). However, 
when accounting for inter-litter association by linear regression these differences 
were not significant. In the second generation, offspring of Dex-exposed males and 
control females (SD) were significantly lighter (p<0.001, Figure 5.9) than controls 











Figure 5.7. Mean pup and placental weight of F1 generation at e19.5. Pup weight (A) 
is decreased following Dex exposure, relative to controls (n=129 Saline, n=119 Dex, 
p<0.01). Placenta weight (B) is also decreased (p<0.001). Data was not normally 
distributed (Lilliefors p<0.01), and so analysed by Mann Whitney U test. Bars 













































































































Figure 5.8. Mean weight of F1 GCS-EGFP offspring at birth, weaning and maturity. Birth 
weight (A) is decreased following Dex exposure, relative to controls (n=113 Saline, 
n=101 Dex, p<0.001). Weight was also decreased at weaning (B) in females (n=29 Saline, 
n=28 Dex, p<0.001) and males (n=33 Saline, n=32 Dex p<0.001) and in adult males (C) 
(n=16 Saline, n=24 Dex, p<0.001). Birth weight and male weaning weights were not 
normally distributed and so analysed by Mann Whitney U test. All other data were 





Figure 5.9. Mean weight of F2 GCS-EGFP offspring at birth. SS represents Saline 
mother crossed with Saline father (n=134), and SD denotes Saline mother with Dex 
father (n=135). The birth weight of SD pups was significantly reduced (p<0.001) 
compared to SS controls. Data was not normally distributed (Lilliefors p<0.01) and 
so analysed by Mann Whitney U test. Bars represent mean ± standard error. 
***p<0.001 
 
Glucose tolerance test data were not normally distributed (Lilliefors p<0.01 for 
insulin and p<0.05 for glucose at 30 min time-point), and so were log transformed, 
before performing a repeated measures ANOVA. Plasma glucose (Figure 5.10A) and 
insulin (Figure 5.10B) increased 30 min after glucose administration and returned to 
baseline after 120 min. There was no significant difference at any time-point 



























Figure 5.10. Plasma glucose and insulin levels following glucose tolerance tests. F1 
Males at 90 days were taken through a glucose tolerance test, and blood taken before 
(Time 0) and 30 or 120 min after glucose administration. Data were not normally 
distributed (Lilliefors p<0.01 for insulin and p<0.05 for glucose at 30 min), and so 
were log transformed, before performing a repeated measures ANOVA. Plasma 
glucose (A) and insulin (B) had risen by 30 min and returned to baseline by 120 min. 
Glucose and insulin levels were not different between groups over the time-course 





























































5.3.2 Exploring the Effects of Dex on the Developing Germline 
5.3.2.1 Descriptive Analyses of e19.5 Germ Cell ERRBS Data 
Descriptive analyses of germ cell ERRBS data indicated that there was no global 
change in methylation between Dex and Saline samples. This was consistent both 
within and out with CpG islands (Pearsons R
2
 values of 0.833 and 0.937 
respectively) (Figure 5.11). The cytosines which were consistently differentially 
methylated across replicates between Dex and Saline samples were then analysed 
separately. Absolute difference in methylation score was calculated by subtracting 
the methylation score across Dex samples from that of the Saline samples, for the 
same DMC. The resulting value is presented as a degree of magnitude, without 
directionality. The vast majority (97%) of DMCs had absolute difference in 
methylation between Dex and Saline samples of 0.225 or less (Figure 5.12 A and B). 
The null hypothesis was that differentially methylated cytosines (DMCs) would 
show an even distribution between hyper- and hypomethylation. In DMCs with a 
difference of 0.225 or less between Dex and Saline groups there was a deviation 
from the null hypothesis. Thus there were consistently more hyper- rather than hypo-
methylated DMCs with Dex exposure (Figure 5.12 A and B).  
Germ cell DMCs were then grouped based on whether the corresponding e19.5 
Saline liver cytosines showed high (>0.6), medium (0.5-0.6) or low (<0.5) 
methylation scores, with regards to ERRBS data from Chapter 6. When considering 
the DMCs with a difference in methylation between Dex and Saline samples of 0.225 
or less; in DMCs with high corresponding liver methylation, there was a deviation 
from the null hypothesis, with a trend towards a predominance of hypermethylation 
(Figure 5.13); those with mid-range corresponding liver methylation showed little 
deviation from the null hypothesis (Figure 5.14); DMCs with low corresponding 
liver methylation deviated from the null hypothesis in the direction of 
hypomethylation (Figure 5.15). DMCs with a difference in methylation score of 
more than 0.225 showed little deviation from the null hypothesis across any of the 
liver methylation categories.   The vast majority of germ cell DMCs were located out 
with CpG islands. DMCs within and out with CpG islands were consistently more 





Figure 5.11. Methylation status of cytosines in Dex and Saline germ cell DNA. Each 
data point represents a single cytosine. The median methylation status across all 
reads from all samples (n=3 Dex and n=3 Saline) is given, based on 1 representing a 
methylated read, and 0 an unmethylated read aligning to that cytosine. Cytosines are 
separated into those within, and those out with CpG islands. Those with fewer than 

































Absolute Difference in Methylation 
Hypo
Hyper
Figure 5.12. Hyper- and hypomethylation of cytosines differentially methylated between Dex and 
Saline germ cell DNA. DMCs consistent across all samples are plotted. Absolute difference in 
methylation is calculated by subtracting the methylation score across Dex samples from that for 
Saline samples. 97% of DMCs have an absolute difference of 0.225 or less. (A) DMCs are ranked 
by absolute difference between Dex and Saline samples, with yellow denoting the lowest (<0.10), 
and purple the highest (0.35) mean difference. The black line represents the null hypothesis, 
where there is no difference between hyper- and hypomethylation between DMCs. The 
distribution in these data therefore deviates from the null hypothesis, for DMCs with an absolute 
difference of 0.225 or less. (B) The number of hyper- and hypomethylated DMCs are plotted 
against ranges of absolute difference in methylation between Dex and Saline samples. 
Consistently more DMCs are hyper-methylated than hypo-methylated in Dex samples, across the 
































Figure 5.13. Count and absolute difference of cytosines differentially methylated in 
germ cell DNA and hypermethylated in control liver. Cytosines differentially 
methylated between Dex and Saline germ cell DNA and which exhibit high 
methylation (>0.6) in liver samples are plotted. Absolute difference in methylation is 
calculated by subtracting the germ cell DNA methylation score across Dex samples 
from that for Saline samples.  Yellow denotes the lowest (<0.10), and purple the 
highest (0.35) mean difference. The black line represents the null hypothesis, where 
there is no difference between hyper- and hypo-methylation amongst DMCs. The 
distribution in these data therefore deviates from the null hypothesis, showing a shift 
towards hypermethylation, for DMCs with an absolute difference of 0.225 or less. 
 




























Figure 5.14. Count and absolute difference of cytosines differentially methylated in 
germ cell DNA exhibiting mid-level methylation in control liver. Cytosines 
differentially methylated between Dex and Saline germ cell DNA and which exhibit 
mid-level methylation (0.5-0.6) in liver samples are plotted. Absolute difference in 
methylation is calculated by subtracting the germ cell DNA methylation score across 
Dex samples from that for Saline samples. Yellow denotes the lowest (<0.10), and 
purple the highest (0.35) mean difference. The black line represents the null 
hypothesis, where there is no difference between hyper- and hypo-methylation 
between DMCs. The distribution in these data therefore is largely consistent with the 
null hypothesis. 




























Figure 5.15. Count and absolute difference of cytosines differentially methylated in 
germ cell DNA exhibiting hypomethylation in control liver. Cytosines differentially 
methylated between Dex and Saline germ cell DNA and which exhibit low 
methylation (<0.5) in liver samples are plotted. Absolute difference in methylation is 
calculated by subtracting the germ cell DNA methylation score across Dex samples 
from that for Saline samples. Yellow denotes the lowest (<0.10), and purple the 
highest (0.35) mean difference. The black line represents the null hypothesis, where 
there is no difference between hyper- and hypo-methylation between DMCs. The 
distribution in these data therefore deviates from the null hypothesis, showing a shift 




































Figure 5.16. Distribution of germ cell DMCs across the genome. All cytosines which 
are consistently hyper- or hypo-methylated in Dex samples, relative to Saline 
controls are plotted. The number of hyper- and hypo-methylated cytosines are plotted 
against ranges of absolute difference in methylation between Dex and Saline 
samples. Consistently more DMCs are hypermethylated with Dex exposure both out 
with (A) and within (B) CpG islands. The total number of DMCs is greater out with 





















































5.3.2.2 Biseq Analysis of e19.5 Germ Cell ERRBS Data  
Biseq analysis indicated that there were 5 clusters with at least a 5% alteration in 
DNA methylation between Dex and Saline e19.5 germ cell samples, which were 
statistically significant (Table 5.1).  Only one DMC (Chr6_540) was identified as 
having a statistically significant change in methylation of more than 10%. 
Methylation values represent the combined number of methylation positive (1, or 
100%) and methylation negative (0, or 0%) reads across the 3 samples per treatment 
group. The difference in methylation between samples represents the combined 
methylation value for Saline samples minus that for Dex. All of the clusters 
corresponded to gene bodies, except Chr5_2393, which was located out with any 
annotated gene.  
The greatest change in methylation was seen at Chr6_540, where there was a 12.2% 
increase in methylation with Dex exposure. An increase in methylation was also 
found in Chr5_2589 (7.5%), Chr5_2324 (6.2-6.3%) and Chr5_2393 (5.0-5.6%). A 






















160647125 0.062 4.17E-11 
160647126 0.063 1.48E-10 
160647135 0.051 5.73E-20 









165852606 -0.054 9.61E-28 
165852611 -0.056 3.98E-18 
171668663 Chr5_2589 -0.075 1.72E-73 
6 52306628 Chr6_540 -0.122 4.89E-34 
 
Table 5.1. Biseq analysis of DMCs in F1 e19.5 germ cell DNA following Dex 
exposure. The position of cytosines differentially methylated between treatment 
groups is given in terms of chromosome (Chr), base position and cluster. The median 
methylation status across all reads from all samples (n=3 Dex and n=3 Saline) is 
given, based on 1 representing a methylated cytosine, and 0 an unmethylated 
cytosine. The difference in methylation represents the methylation status of the 
Saline group minus that of the Dex group. Positive values therefore indicate 
decreased methylation in Dex samples. Negative values indicate increased 














These data suggest that the GCS-EGFP rat is suitable for studying the effects of Dex 
programming on the male germline. EGFP expression was specific to the testis, and 
more specifically, the germline in males. Furthermore, immunofluorescence 
suggested that GCS-EGFP rats follow the same epigenetic reprogramming time-line 
as the Wistar rats used in previous studies.  They also exhibited the characteristic 
programming phenotype of lower birth weight following in utero Dex exposure, and 
this was found to be transmitted through the male germline to the F2 generation. 
Using these rats for Dex programming studies suggested that there were no global 
changes in e19.5 germ cell DNA methylation as analysed by ERRBS. However 
DMCs identified consistently across all replicates were predominantly 
hypermethylated, indicating that premature remethylation may occur at a subset of 
cytosines with Dex exposure. 
Immunofluorescence studies showed that whilst EGFP staining in adult heart, 
kidney, liver and spleen resembled that of the negative controls, the testis had a 
strongly positive detection. Furthermore, when the fetal testes of the subsequently 
established colony were examined under the microscope, immediately after 
dissection, they had a strong fluorescence. This indicated that that active EGFP was 
found specifically within the testes of these rats. The precise localisation of EGFP 
within the testis was initially explored using the Sertoli cell marker vimentin. As 
Sertoli cells are found within the seminiferous tubule, as for germ cells, I sought to 
confirm that they were not EGFP-positive, and would not therefore contaminate 
FACS sorted germ cell samples. Immunofluorescence with the vimentin antibody 
highlighted Sertoli cytoplasm, framing the nuclei. Little corresponding staining was 
found for EGFP, relative to the strongly positive germline cell nuclei. Upon FACS 
sorting of fetal testes, a very distinct population of EGFP-positive cells were 
visualised, not only confirming that EGFP expression was cell-specific within the 
testis, but indicating that a pure population of EGFP-positive cells could be isolated, 
with little contamination from EGFP-negative cells. A final confirmation that the 
cells expressing EGFP were germ cells was obtained by conducting qPCR on FACS 
sorted cells. The EGFP-positive cells had a significantly higher expression of the 
germ cell specific marker Dazl, than the EGFP-negative population, confirming that 
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this fraction consists of germ cells. Conversely the EGFP-negative population had a 
significantly higher expression of Sox9, confirming that the Sertoli cells were found 
within the EGFP-negative population.  
This is in keeping with the results of Cronkhite et al. (2005), who produced the GCS-
EGFP transgenic rat and supplied the founder males for the current project [92]. 
They show EGFP in sperm, testes and ovaries under the fluorescent microscope. This 
fluorescence was not visualised in the spleen, heart, liver, kidney or brain. qPCR also 
confirmed expression of EGFP in whole testis, epididymis and ovary, but expression 
in specific cells within each organ was not explored. They do, however, present 
images of EGFP co-staining with alkaline phosphatase, a marker of pluripotency, 
which can therefore identify fetal germ cells. This is, however, only shown for the 
epiblast and genital ridge stages during germ cell development, rather than the fetal 
or adult testis. Fluorescent in situ Hybridisation analysis (FISH), imaging the 
location of EGFP-specific antibody binding to isolated chromosomes, was performed 
on embryonic fibroblast DNA to try to identify the location of EGFP insertion in the 
rat genome [92]. This indicated that EGFP was inserted into chromosome 11 
however the precise location or copy number of insertion was not identified [92].  
The current study therefore confirms that the reported characteristics for fetal and 
adult testes are found within our colony. It also builds upon the work of Cronkhite et 
al. (2005) by confirming the germ cell-specific localisation of EGFP within the 
testis, both by immunofluorescence, and by qPCR.  
Suitability of the GCS-EGFP rat for this study was further assessed in an initial 
comparison of their global epigenetic reprogramming time-line compared to Wistar 
rats. Immunofluorescence indicated that few germ cells were 5mC positive at e19.5 
in both strains, however slightly more were visible in the Sprague Dawley compared 
to Wistar rat. As there was only 1 litter per time-point in this initial study, this could 
reflect a variation in exact time of implantation between the pups. However, as each 
germ cell identified by Propidium Iodide at e20.5 had a corresponding 5mC positive 
detection, it could be concluded that bulk global remethylation was occurring 
between e19.5-e20.5 in both strains, and therefore that they were following the same 
pattern of remethylation.   
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Further confirmation of the suitability of GCS-EGFP rats was obtained when 
exploring their response to in utero Dex exposure. A significant reduction in pup and 
placental weight at e19.5 and in birth weight was found following Dex treatment. 
This is in keeping with data from Wistar studies, both in Chapter 6 of this thesis, and 
in previous reports of both fetal [12] and birth weights [8,10]. Interestingly, this 
decrease remains at weaning in both sexes and at 90 days in males. This difference 
however is no longer significant if intra-litter differences are accounted for. Indeed 
Drake et al. (2005) and Nyirenda et al. (1998) report that Wistar pups from the Dex 
treatment groups exhibited ‘catch up growth’, with no difference in weight to 
controls at weaning or in adulthood. The GCS-EGFP cohort may therefore show the 
characteristic pattern of reduced F1 fetal and birth weight, with catch up growth. 
I also sought to confirm that this phenotype would be transmitted to an F2 generation 
in GCS-EGFP rats. F2 pups bred from mothers exposed to Saline and fathers 
exposed to Dex in utero were significantly lighter than controls at birth, in keeping 
with previous studies in Wistar rats [10]. This indicates that the birth weight 
phenotype can be transmitted to a second generation through the male line, and 
therefore that it is relevant to study F1 germ cells and sperm in GCS-EGFP rats.   
The phenotype of the GCS-EGFP programmed rat was further assessed by 
performing glucose tolerance tests in F1 males at 90 days. Plasma glucose and 
insulin levels were seen to rise at 30 min and return to baseline at 120 min after a 
glucose bolus. However there was no significant difference in response between Dex 
and Saline groups.  This is in keeping with Drake et al. (2005) who found no 
difference in glucose or insulin response in F1 males at 6 months [10]. It is in 
contrast, however, with Nyirenda et al. (1998) who demonstrate an increase in both 
plasma glucose and insulin levels at 30 min following glucose load [8].  
As the GCS-EGFP rats had germ cell-specific expression of EGFP, showed an 
intergenerational programming phenotype in response to Dex exposure, and 
preliminary analysis suggested that they had the same timescale for male fetal germ 
cell reprogramming, this strain was used for base-specific study of the germline. 
ERRBS of DNA from e19.5 male germ cells identified DMCs following Dex 
exposure, relative to Saline controls. A preliminary descriptive analysis of DMCs 
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was used to compare prevalence of hyper to hypo-methylation. Intriguingly, the 
majority of these DMCs were in the direction of hypermethylation with Dex 
exposure, found across a range of absolute differences in methylation between 
groups. This suggests there may be accelerated reprogramming of a subset of genes. 
To explore this possibility further, germ cell DMCs were split into three categories, 
dependant on the corresponding level of methylation in e19.5 control livers for that 
gene (based on the study conducted in Chapter 6). Intriguingly, when considering 
DMCs with an absolute difference of 0.225 or less, germ cell DMCs with highest 
liver methylation tended towards hypermethylation in Dex treatment and those with 
lowest liver methylation towards hypomethylation in germ cell DMCs. Thus, if we 
assume that methylation patterns are grossly consistent between fetal liver and germ 
cells, this suggests that Dex exposure may reprogram genes to their ‘normal’ state 
first. Clearly this is an imperfect comparison due to tissue specific differences in 
methylation profiles, however it allows preliminary conclusions can be drawn [280].  
Further clarity would be achieved if the study was also conducted in germ cells from 
a later time-point (e20.5 or e21.5) to see if Dex exposure corresponds to a more 
‘mature’ methylation profile at e19.5.  
This prevalence of hypermethylation amongst DMCs was found both within and out 
with CpG islands. As CpG islands are predominantly unmethylated, it is not 
surprising that the majority of DMCs exist out with CpG islands [112]. However, in 
a previous study, CpG islands out with known transcription start sites were found to 
be more highly methylated, and it has been suggested that these might regulate as yet 
undetermined genes with particular relevance for development [112]. Thus DMCs 
within CpG islands, although infrequent, might be of particular relevance for further 
exploration.  
Biseq analysis was then performed to identify which DMCs had a statistically 
significant difference in methylation between Dex and Saline groups, and whether 
these existed in clusters of DMCs within the same region. Significantly decreased 
methylation was identified at 5 DMCs in Chr3_2256, located within the Ral 
Guanosine Triphosphatase Activating Protein, Beta Subunit gene (Ralgapb). The 
corresponding protein represents the non-catalytic subunit of the RALGAP1 and 
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RALGAP2 complexes, which activate the RalA and RalB guanosine triphosphatases 
(GTPases) [281]. These GTPases exist in 2 states – their active guanosine 
triphosphate (GTP)-bound and inactive guanosine diphosphate (GDP)-bound forms. 
This alters their interaction with effector proteins and allows them to regulate cellular 
processes such as transcription, translation and cell survival [281]. Intriguingly Ral A 
has been shown to have a role in regulating glucose uptake in adipocytes in response 
to insulin [282,283]. Therefore, if decreased methylation of Ralgapb corresponded to 
increased gene expression, it is possible that this could have some, as yet 
undetermined, effect on insulin signalling.  
Conversely, increased methylation was identified at Chr5_2324, corresponding to the 
Split Ends Family Transcriptional Repressor (Spen) gene. This hormone-inducible 
transcriptional repressor has been shown to have a role in developmental cell fate 
specification [284]. There are a range of proteins in the SPEN family, but all share a 
conserved SPEN paralog and ortholog C-terminal domain, which has been suggested 
to be responsible for transcriptional repression [285]. Knockout of the Msx2-
Interacting Nuclear Target (MINT) protein, encoded by Spen in mice, was found to 
be embryonic lethal at e12.5-e14.5, with fetuses displaying liver, pancreas and heart 
abnormalities [286]. Therefore the correct regulation of the Spen gene may be 
important to development. 
An increase in methylation (7.5%) was also found at Chr5_2589 in Dex-exposed 
germ cells. This DMC is located within the Period Circadian Clock 3 (Per3) gene, 
which is expressed in accordance with circadian rhythms. Published research 
predominantly focuses on the effects of polymorphisms in Per3 in relation to 
disrupted sleep patterns. Intriguingly, however, these polymorphisms have been 
shown to have wider physiological effects, with for example, polymorphisms in Per3 
shown to associate with prognosis in patients with hepatocellular carcinoma [287].  
Altered expression of Per3, irrespective of polymorphisms, has also been suggested 
to have physiological relevance, with decreased total mRNA expression of Per3 
found in hepatocellular carcinoma cells [288].  Further studies would be required to 
determine whether the change in methylation observed in our studies has an effect on 
expression of the Per3 gene. Interestingly, a previous study suggests that Dex 
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exposure could influence the expression of circadian genes, with Dex found to 
increase the expression Per3 in rat fibroblasts [289]. The related Per1 gene was 
found to be upregulated in the livers of mice exposed to Dex postnatally [289].  
The biggest increase in methylation was found at one cytosine in Chr6_540 (12.2%), 
corresponding to the Protein Disulphide Isomerase Family A Member 6 (Pdia6) 
gene. The PDIA6 protein exists in the endoplasmic reticulum and catalyses the 
formation and modification of disulfide bonds in proteins, and may have a role in 
protein folding [290]. PDIA6 has also been shown to have a role in maintaining 
calcium homeostasis within the endoplasmic reticulum [291].  
Increased methylation was also seen across 3 DMCs at Chr5_2393, which does not 
correspond to an annotated gene. However, the closest known gene, found 
approximately 2880bp from the region, is Preferentially Expressed Antigen in 
Melanoma-like 1 (Pramel1). The Preferentially Expressed Antigen in Melanoma 
(Prame) gene family encodes leucine-rich repeat (LRR) proteins, which facilitate 
protein-protein interactions required in a range of cellular processes, such as cell 
adhesion, transcriptional regulation and signal transduction [292,293]. In the mouse, 
PRAMEL1 was identified solely in the testis, with mRNA and protein expression 
seen to increase postnatally. PRAMEL1 was subsequently identified in the acrosome 
of developing spermatids, suggesting that it might have a role in spermatogenesis and 
fertilisation [293].  As Chr5_2393 is located in relatively close proximity to Pramel1, 
it is possible that this represents a regulatory region for this gene, and altered 
methylation could ultimately influence the expression of the Pramel1 gene. 
For most of these targets it is unclear specifically what effects altered methylation, 
and thus potentially altered gene expression might have in the developing germline, 
and indeed in the next generation of pups, should these effects be carried in to the F2 
generation. These changes should be validated by pyrosequencing and any 
corresponding effects on gene expression explored by qPCR, using primers for 
mRNA corresponding to the regions of differential DNA methylation. The longer 
term effects of these changes may also be explored by comparing to data from the 
ERRBS sperm study, which is pending. It should be considered that some of these 
sites of altered methylation correspond to changes at only one cytosine, therefore 
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caution should be exercised when inferring significant biological relevance. It should 
also be noted that many of the alterations represent relatively small changes in 
methylation between treatment groups, of 5-6%. This is still in keeping, however, 
with the liver studies in Drake et al. (2011), where there was a 5-6% change in 
methylation following Dex exposure [12]. Furthermore, previous studies report 
similarly modest alterations in DNA methylation with intra-uterine growth restriction 
[294], and variations of only 20% at the Igf2 DMRs implicated in the growth 
restriction associated with Silver Russell Syndrome [295].  Thus subtle changes in 
DNA methylation may be expected in the Dex model, and in other examples of 
growth restriction, but these could potentially still have some relevance for 
development.  
However the majority of CpGs are not differentially methylated between treatment 
groups, suggesting that there is not a global change in methylation at e19.5, as 
determined by ERRBS. This is in contrast to the immunofluorescence data in 
Chapter 4, which indicated that there is an increase in the number of 5mC positive 
germ cells at e19.5 following Dex exposure. There are a number of possible 
explanations for this discrepancy. The first is that ERRBS only interrogates a small 
portion of the genome, whereas immunofluorescence looks at the whole genome 
[278]. The enzymatic cleavage in ERRBS selects for CpG dinucleotides and so will 
capture the majority of promoters and CpG islands, but will not cover all sites of 
methylation throughout the genome [275]. The selection of longer MSP1 fragments 
in ERRBS enables capture of more regions out with CpG islands, however some 
DMCs will still be missed by ERRBS [278]. 
Differences in 5mC between treatment groups might also be missed by ERRBS as 
this bisulfite sequencing method cannot distinguish between 5mC and 5hmC [296]. 
Time-line studies in Chapters 3 and 4 indicated that little global 5hmC is detected in 
germ cells at e19.5 by immunofluorescence. However, as ERRBS by nature is more 
sensitive at detecting methylation at a base-specific level than immunofluorescence, 
and because the changes in methylation in this study are relatively modest (10-30%) 
it is possible that changes in 5hmC are making global changes in 5mC harder to 
detect. A major benefit in choosing ERRBS for these studies is that it can be 
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performed on low quantities of DNA (approximately 100ng), compared with the 5µg 
required for some other studies. As small quantities of DNA are obtained from 
FACS-sorted fetal germ cells (around 80ng per litter), this was a major consideration. 
ERRBS also focusses on CpG rich regions which are most likely to be methylated, 
reducing the cost of sequencing, whilst still giving relevant data [278]. However, 
further studies should also include a genome-wide technique which can distinguish 
between different forms of methylation. For example, Methylated DNA 
Immunoprecipitation (MeDIP) uses an antibody to isolate methylated DNA for 
subsequent sequencing [297]. An antibody specific to 5mC or 5hmC can therefore be 
used, distinguishing between these two forms of methylation.  
It is also possible that the variation in global methylation results is due to the exact 
timing of fertilisation. Time-line data from Chapter 3 indicates that global 
remethylation is very time-specific, with the bulk occurring rapidly between e19.5 
and e20.5. Although it appears that mating occurs shortly after the rats are paired 
(Drake et al., unpublished observation), there will be variations in the exact time of 
fertilisation between mothers, and potentially, between different embryos in the same 
litter. This slight difference could impact upon the study, when global bulk global 
remethylation occurs rapidly. We tried to minimise this issue by performing ERRBS 
on 3 samples per group, each pools from 3 litters, giving 9 different litters per group. 
Indeed one pooled Dex sample was found to have greater global methylation than the 
others. Future studies could use in vitro fertilisation to ensure that the embryos have 
the same time of fertilisation, however, such intervention could potentially influence 
the results.     
However, the main aim of experiments in Chapter 4 was to identify an interesting 
time-point for further study, and indeed an effect on a subset of genes was observed. 
These gene-specific changes will be validated by pyrosequencing, and corresponding 
gene expression analysed by qPCR.  
It would also be informative to compare DMCs in fetal germ cells to that of mature 
sperm, which will be carried to the next generation. Although sperm samples were 
collected from F1 rats at 90 days, sequencing was unfortunately unsuccessful when 
DNA was first sent for RRBS (BaseClear, Belgium). The root of this issue was never 
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identified, however when trial sperm samples were sent to Weill Cornell for ERRBS, 
successful sequencing was achieved. This confirms that it is possible to perform 
ERRBS on these samples, but because of the delay caused by problems with the 
initial set of data, the full sperm study is still pending for ERRBS. Once conducted 
this should provide greater understanding of the relationship between alterations in 
germ cell methylation, and that of the resulting sperm in adulthood. 
In summary these studies indicate that the GCS-EGFP rat has EGFP expression 
specifically in the germline, and that the global remethylation time-line and Dex 
programming phenotype is conserved with Wistar rats. FACS sorting of pure 
populations of fetal germ cells and performing ERRBS on the corresponding DNA 
revealed no global change in methylation between treatment groups. However of the 
DMCs, hypermethylation was predominant. Highly methylated genes in liver also 
had greater hypermethylation in fetal germ cell DMCs, whilst those of lowest 
methylation in the liver had prevalent hypomethylation. Taken together, this suggests 
that a subset of DMCs in fetal germ cells may undergo premature remethylation in 
association with Dex exposure. Biseq analysis indicated that clusters of statistically 
significant DMCs were found at Ralgapb and Spen, with significant increases of 
7.5% and 12.2% found at single DMCs within the Per3 and Pdia6 genes 
respectively. Validation of these results by pyrosequencing, and an exploration of the 
corresponding effects on mRNA expression has yet to be performed. Pending 
ERRBS of sperm will also indicate whether this corresponds to DMCs in sperm, and 










Chapter 6 Effects of Dex on the Liver 
 
6.1 Introduction 
As my data indicate that Dex exposure may shift the period of DNA remethylation in 
epigenetic reprogramming, I decided to explore what other pathways and processes 
may be influenced. I also sought to further compare the influence of Dex in the 
traditional Wistar rat programming model to that in the GCS-EGFP rat. Liver was 
chosen as a key organ for these studies because it is a critical regulator of metabolism 
[298]. Furthermore, a microarray had been performed on liver tissue from a previous 
programming study in the Drake lab, but had yet to be validated, giving some 
direction to a candidate gene approach. 
Virgin Wistar females were mated with Wistar males and pregnant dams 
subsequently sacrificed at e20.5, and liver collected from the fetuses. I then explored 
gene expression in these samples, seeking firstly to examine the expression of 
metabolism and growth genes in the liver in response to Dex exposure, and secondly 
to compare gene expression in this cohort to that of previous studies. I then compared 
gene expression in GCS-EGFP rats to that of the Wistar cohort.  
 
6.1.1 Glucocorticoid Regulation and Imprinted Genes 
Expression of GR, the receptor through which Dex acts, was examined. Previous 
work indicated that the expression of Gr mRNA was increased at PND5 and in 
adulthood in the livers of F1 rats exposed to Dex in utero [8]. Conversely, there was 
no effect on Gr mRNA levels in liver of the Dex programmed marmoset at 24 
months [75]. This indicates that altered GR expression could have relevance for the 
Dex programming phenotype, in a species-specific manner. Furthermore, Gr mRNA 
expression was explored in a maternal protein restriction programming model, which 
confers reduced birth weight and increased blood pressure in offspring from 5 weeks 
[299].  Gr mRNA expression was reported to increase in a variety of tissues, 
including liver, kidney and hypothalamus. This not only supports the findings of 
Nyirenda et al. (1998), but indicates that the effects on Gr may not necessarily be 
restricted to the liver. Indeed, increased glucocorticoid levels have been shown to 
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alter Gr mRNA expression in rat brains in a region-specific manner, ultimately 
producing more anxiety-based behaviour [300]. An increase in Gr mRNA expression 
may mediate some of the effects of Dex through its action in regulating gene 
expression, such as increased Pepck mRNA expression, first exhibited at PND5, and 
persistent at 8 months [8]. Gr mRNA expression was therefore explored because of 
its potential relevance in programming and development, and to provide a 
comparison between the current and previous cohorts.  
11β-HSD1, which converts inactive glucocorticoids to their active forms (cortisone 
to cortisol in humans, and 11-dehydrocorticosterone to corticosterone in rodents) was 
then studied, as it is key in regulating the actions of glucocorticoids [41,42]. 
Nyirenda et al. (1998) show that the expression of this enzyme is not altered at 
PND5 or in adulthood in the liver of F1 in the Dex programming model, but fetal 
expression was not reported [8]. However, the authors subsequently identified an 
increase in the expression (at 4 and 12 months) and activity (at 12 months) of 11β-
HSD1 in the liver of Dex-programmed marmosets [75]. Hepatic 11β-Hsd1 
overexpression correlates with insulin resistance and hypertension in mice [301], 
whilst knockout mice have improved insulin sensitivity and glucose tolerance [302]. 
Indeed lower hepatic 11β-Hsd1 mRNA expression and enzyme activity is found in 
obesity, which may be a compensatory mechanism, protecting against insulin 
resistance [303,304]. This relevance for insulin sensitivity, regulating glucocorticoid 
levels and its previously identified upregulation in the Dex programming of non-
human primates made it an interesting candidate gene for study.  
I then explored expression of imprinted genes involved in growth and development. 
Imprinted genes have monoallelic expression in accordance with the parent of origin, 
are involved in the regulation of fetal and placental growth, and their DNA 
methylation is retained during zygote reprogramming [305,306]. They therefore 
represent suitable candidates for intergenerational inheritance of disease risk [12]. 
Igf2 is a paternally imprinted gene which promotes fetal growth [307,308]. 
Conversely, Cdkn1c and Grb10 are maternally expressed, and restrict fetal growth 
[305,306,309]. Drake et al. (2011) show an increase in the expression of these genes 
in F1 fetal liver at e20.0 following Dex exposure. The expression of H19, which is 
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adjacent to Igf2 and proposed as a regulator of Igf2 expression, was also increased 
[12,310,311]. The expression of these genes was therefore studied in the current 
cohort because they are suitable candidates for contributing to the programming 
phenotype, and to compare gene expression to previous work. 
 
6.1.2 Microarray Genes   
An Illumina Gene Expression Microarray was previously performed on e20.0 F1 
Wistar liver tissue in the Dex programming model by the Wellcome Trust Clinical 
Research Facility, Edinburgh, with additional analysis by Khulan Batbayar, The 
University of Edinburgh. This allowed the expression of a large array of genes to be 
examined in parallel in Dex and control samples. A number of genes were 
highlighted which might be differently expressed between treatment and control 
groups, but required validation by qPCR. I selected some of the novel genes 
highlighted in the microarray for study in my cohort. Those with particular relevance 
for growth, development and reproduction were chosen for validation. For example, 
Alcohol Dehydrogenase 1 (Adh1) is involved in the conversion of vitamin A into its 
active derivatives, which in turn have many key roles in development [312,313]. 
Vitamin A deficiency in pregnant rats correlates with abnormal development of 
hindbrain in e12.5 fetuses, and fetal reabsorption by e18.5 or neonatal death [314]. 
Vitamin A excess has also been found to be teratogenic, correlated in particular with 
abnormal brain development [315]. It is therefore important that Vitamin A 
metabolism is correctly regulated. The ADH1 enzyme is also expressed in both the 
fetal and adult testis [312,316], with castration of male rats corresponding to an 
increased activity of liver ADH1 [317] . Its role in both fetal development and 
testicular function made it an interesting candidate for study in my project.  
The microarray also indicated decreased expression of High Mobility Group Box 2 
mRNA (Hmgb2) with Dex treatment. This is thought to have roles in transcriptional 
regulation, DNA repair and cellular differentiation [318]. HMGB2 is capable of 
bending DNA, thus facilitating the formation of nucleoprotein complexes [319], and 
inhibition of its function by RNA competition leads to a disruption of the cell cycle 
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[320]. A Dex-mediated change in Hmgb2 could therefore affect chromatin 
compaction and repair in the developing fetus.   
Gelsolin is characteristically known as an actin binding protein which helps to 
regulate the assembly and organisation of actin filaments [321]. Increased Gelsolin 
expression is associated with increased pathological remodelling of the heart after 
acute injury from myocardial infarction and heart failure, potentially through the 
promotion of DNAse1-mediated apoptosis [322]. Intriguingly, protein levels of 
Gelsolin were found to be increased in the adipose tissue of obesity-prone rats 
exposed to high fat diet, and the authors proposed it as a novel marker of obesity 
[323]. Furthermore, Gelsolin knockdown in adipocyte cells was associated with 
increased expression of the pro-inflammatory genes Tumour Necrosis Factor Alpha 
(Tnfα) and Interleukin 6 (Il6) [324]. This may be linked to increased Tnfα and Il6 
mediated lipolysis, ultimately resulting in lower triglyceride content, and therefore 
lower risk of heart disease [324,325]. Furthermore, Gelsolin may also have a role 
within the epididymis, regulating the actin cytoskeleton of sperm, and their 
subsequent uptake of calcium [326]. Therefore a Dex-induced alteration in Gelsolin 
expression may impede sperm maturation.  
The Heat Shock 70kDa Protein 5 (Hspa5) gene encodes for the protein 5 of the 70kDa 
Heat Shock Protein (Hsp70) molecular chaperone family. This member facilitates the 
translocation of proteins into the endoplasmic reticulum, and their correct folding within 
[327]. As Hspa5 knockout mice die at e3.5 due to an inhibition of cellular proliferation 
and increased apoptosis, a Dex-mediated alteration in this protein may result in 
dysregulation of cellular development [328].  
Translationally-Controlled Tumour Protein (TPT1) acts as a key regulator of the p53 
tumour suppressor, and of cancer stem cells [329]. It has also been implicated in fetal 
growth and development, with Tpt1 knockout mice having increased apoptosis, reduced 
cell numbers and mortality at e9.5-e10.5 [330]. This indicates that Tpt1 is essential for 
normal fetal development. Some research in drosophila has indicated that TPT1 may 
also be involved in growth regulation through an indirect interaction with the 
Mammalian Target of Rapamycin (mTOR) signalling pathway [331]. This pathway can 
be regulated by growth factors, stress and nutrient intake, and therefore Tpt1 was an 
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interesting target for the programming model [332]. It has also been shown to be 
expressed in fetal germ cells and adult spermatogonia [333], and so could also be a target 
for germline studies.  
 
6.1.3 Insulin Signalling Pathway Genes 
 The microarray also indicated increased expression of Insulin-Like Growth Factor 
Binding Protein 1 (Igfbp1). The Insulin-Like Binding Protein (IGFBP) family bind 
Insulin-like Growth Factors (IGF) 1 and 2 and therefore regulate their activity [334]. 
IGFBP1 is predominantly expressed in the liver, and binds IGFI [334,335]. Insulin 
down-regulates production of hepatic IGFBP1 protein, and in longitudinal studies 
decreased circulating IGFBP1 protein concentrations were correlated with 
subsequent glucose intolerance and diabetes [336,337]. Furthermore low fasting 
plasma IGFBP1 levels were correlated with increased cardiovascular disease risk 
factors, such as high blood pressure and blood triglyceride concentration [338]. 
Increased IGFBP1 in amniotic fluid is also associated with lower birth weight in 
humans [339], and expression was increased in the placentas of fetuses with intra-
uterine growth restriction [340].  As these studies indicate that IGFBP1 regulates the 
action of the IGF1 growth factor, and is correlated with risk of diabetes and 
cardiovascular disease, this was an interesting target in the Dex programming model, 
characterised by low birth weight and subsequent cardiometabolic disease risk.  
As an increase in Igfbp1 expression with Dex exposure was indicated on the 
microarray, I went on to explore the expression of the serine 6 kinases, which form 
part of the insulin signalling pathway (see Figure 6.1). These kinases are activated by 
insulin-like growth factors and nutrients, and are involved in regulating transcription, 
through the formation of a protein synthesis pre-initiation complex [341,342]. As 
part of this process the RPS6 kinases phosphorylate serine 6 (RPS6) of small 
ribosomal subunits [342]. It also has other targets such as the Insulin Receptor 
Substrate 1 (IRS1) protein, which may be implicated in insulin resistance [343].  
Knockout of Rps6k1 in mice blunts responsiveness to IGF1 [342], and was shown to 
protect against a loss of insulin sensitivity in ageing, and to increase lifespan [344]. It 
also protects insulin sensitivity in mice fed a high-fat diet, potentially through 
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downregulation of the negative feedback loop through IRS1 [345]. Indeed 
therapeutic inhibition by antisense RNA in rats corresponded to decreased weight 
gain and food consumption, improved insulin sensitivity and a dose-dependent 
increase in hepatic Igfbp1 expression [346].  
A second isoform of the serine 6 kinase (RPS6K2) works with RPS6K1 to 
phosphorylate RPS6 [347]. Specific knockouts of Rps6k1 or Rps6k2 have a different 
phenotype, with the Rps6k1 knockouts being significantly lighter both prenatally and 
postnatally, than wild-type controls, whilst Rps6k2 weight was unaffected [347]. 
However, double knockouts exhibit perinatal lethality, and both isoforms appear to 
be required for full phosphorylation of RPS6, with potentially a more significant 








Figure 6.1. Summary of IGF1 signalling through RPS6K1. IGFBP1 competes with 
the IGF1 receptor (IGF1R) for interaction with IGFs [335]. Upon ligand binding, the 
IGF1R can interact with the Insulin Receptor Substrate 1 (IRS1) protein, which it 
phosphorylates [348]. This ultimately stimulates the Mammalian Target of 
Rapamycin C1 (mTORC1) signalling pathway [342,349]. This promotes the activity 
of Serine 6 Kinases 1 and 2 (RPS6K1/2) which both negatively regulate IRS1 [343], 
and phosphorylate the serine 6 (RPS6) ribosomal protein, ultimately promoting 










6.1.4 Exploring Gene Expression in GCS-EGFP Dex Programmed Rats 
In order to confirm whether the gene changes seen in Wistar rats were conserved in 
GCS-EGFP rats, liver tissues collected during the F1 e19.5 germ cell study in 
Chapter 5 were also examined. The time-point of collection was different between 
the 2 strains, as I collected the Wistar tissues at the start of my PhD, and the e20.0 
time-point had previously been shown to correspond to changes in pup weight and 
the expression of some key genes [12]. After the completion of the Wistar tissue 
collections, I identified the e19.5 time-point for interest in epigenetic 
reprogramming, and liver tissue was collected along with germ cells. Although the 
time-points therefore differ slightly between the 2 strains, a comparison of gene 
expression in fetal liver was nevertheless still likely to be informative. Therefore the 
expression of genes studied in the Wistar rat, as outlined above was also explored in 
GCS-EGFP fetal liver.  
 
6.1.5 Exploring DNA Methylation in Liver of Dex Programmed GCS-EGFP Rats 
Further understanding of the effects of Dex treatment on gene regulation in the liver 
was gained by studying DNA methylation. Some research has suggested that Dex 
programming may alter DNA methylation in the liver, with Drake et al. (2011) 
reporting a decrease in methylation at a DMR of Igf2 in F1 liver at e20.0. An 
interaction of maternal and paternal Dex exposure was also found to decrease 
methylation at the H19 Imprinting Control Region (ICR) in F2 e20.0 liver [12]. 
These were identified using a candidate rather than genome-wide approach. 
Glucocorticoid exposure also decreased DNA methylation of the tyrosine 
aminotransferase gene, involved in hepatic tyrosine metabolism, persistent in 
cultured rat liver cells even 3 months after exposure [267]. Maternal protein 
restriction was also reported to reduce methylation at the promoter of Gr in F1 and 
F2 adult rat liver [350,351]. However caution should be exercised when interpreting 
these studies as subsequent lab data has repeatedly indicated that the Gr promoter is 
unmethylated (Drake et al., unpublished data). Because DNA methylation may 
contribute to the regulation of gene expression directly or indirectly [352,353] these 
alterations could lead to changes in gene expression and ultimately have detrimental 
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consequences, or compensatory benefits for the programmed pup. To better 
understand the effects of Dex exposure on DNA methylation in the liver, I sought to 
identify additional sites of differential methylation, adopting a genome-wide, rather 
than candidate-gene approach. ERRBS was used to give a genome-wide view of 
specific cytosines that are differentially methylated following Dex exposure, as in 
Chapter 5.  GCS-EGFP rats were chosen for this study, so that data could be 
compared with that for germline ERRBS studies.  
  
6.2 Materials and Methods 
Virgin female Wistar rats were timed-mated with stock Wistar males, and injected 
daily with either Dex (100µg/kg body mass) suspended in 0.9% Saline, or an 
equivalent volume of Saline from e15.5 until termination.  Pregnant dams were 
sacrificed at e20.5, and all pups and placentas removed and weighed. Liver was 
collected from 6 pups per litter and snap frozen. Tissue was subsequently genotyped 
for the Sry gene, as outlined in Chapter 2.6.1, to identify the male pups. Livers from 
e19.5 GCS-EGFP rats were collected and snap frozen during the fetal germ cell 
study outlined in Chapter 5. They were not genotyped for Sry, as tissue was collected 
after testis isolation, and therefore the sex of the animal was known.  
RNA from all samples was extracted as outlined in Chapter 2.11.3. Reverse 
Transcription and qPCR was then performed using the protocols outlined in Chapter 
2.11.5 and 2.12 respectively.  
RNA extraction from F1 e20.5 Wistar livers was performed by a masters student, 
Marina Mitsikakou (Centre for Reproductive Health, The University of Edinburgh), 
under my training and supervision. She also conducted qPCR for H19, Cdkn1c and 
Igfbp1 in F1 Wistar tissues. I performed qPCR for all other genes, and extracted 
RNA from F1 e19.5 GCS-EGFP livers, collected in Chapter 5. I then conducted 
reverse transcription and qPCR on these samples, as previously. Normality of data 
distribution was confirmed using the Lilliefors test. Normally distributed data 
(p>0.05) was analysed by Student’s t-test, and nonparametric data by Mann Whitney 
U test.  Birth weight was analysed by both Student’s t-test, as in previous studies, 
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and by multivariate linear regression, accounting for the intra-litter association of 
pups.  
I also extracted DNA from F1 e19.5 GCS-EGFP livers, as outlined in Chapter 2.14.1. 
ERRBS was performed at Weill Cornell University Epigenetics Core, New York, 
USA. Bioinformatic analysis was then conducted by Dr Thomas Smith (CGAT, 




6.3.1 Effects of Dex on F1 Wistar Liver 
Pup and placental weight was normally distributed (Lilliefors test p>0.05) and data 
were therefore analysed by t-test, as in previous studies [10,12]. Dex-exposure 
corresponded to a decrease in pup (p<0.01, Figure 6.2A) and placental (p<0.001, 
Figure 6.2B) weight. As a second confirmation, data was analysed by multivariate 
linear regression, taking into account the intra-litter association of pups. The 
administration of Dex was found to predict a mean decrease in pup weight (mean 
decrease of 0.38g, p<0.001) and placental weight (mean decrease of 0.07g, p<0.01), 









Figure 6.2. Mean pup and placenta weight of F1 Wistar rats at e20.5. Pup weight (A) 
was decreased following Dex exposure, relative to controls (n=112 Saline, n=87 Dex 
from 7 litters per group, p<0.01). Placental weight (B) was also decreased (p<0.001). 
Data was normally distributed (p>0.05) and analysed by t-test. Bars represent mean ± 






















































6.3.1.1 Effects on Glucocorticoid Regulation and Imprinted Genes 
The effects of Dex exposure on fetal liver gene expression in the F1 offspring were 
then explored by qPCR. Gene expression is expressed relative to the mean of TATA-
Binding Protein (Tbp) and Hypoxanthine Guanine Phosphoribosyl Transferase 
(Hprt) for each sample. Gr expression was significantly increased (p<0.01) following 
Dex exposure in F1 liver at e20.5 (Figure 6.3). Conversely 11β-Hsd1 expression was 
not significantly altered between groups. The expression of Igf2, H19, Cdkn1C and 
Grb10 was not significantly altered with Dex exposure (p>0.05, Figure 6.3).  
 
       
 
Figure 6.3. Expression of glucocorticoid regulation and imprinted genes in F1 Wistar 
male rat liver at e20.5. Gene expression is expressed relative to the mean of Tbp and 
Hprt. Mean expression of Gr was increased (p<0.01) at e20.5 following Dex 
exposure, relative to Saline controls. Each sample was from a male in a different 
litter. N=7 (for Saline and Dex samples). Data were analysed by t-test for all genes, 
except for Grb10 which was not normally distributed (p<0.01). A Mann-Whitney U 






































6.3.1.2 Effects on Array Genes 
The expression of Adh1 (p<0.001) and Tpt1 (p<0.01) was significantly increased in 
e20.5 liver following Dex exposure (Figure 6.4). The expression of Hmgb2, Gelsolin 
and Hspa5 were not significantly different between groups. All data was normally 
distributed (p>0.05) and therefore analysed by t-test.    
  
 
Figure 6.4. Expression of microarray genes in F1 Wistar male rat liver at e20.5. Gene 
expression is expressed relative to the mean of Tbp and Hprt. Mean expression was 
increased for Adh1 (p<0.001) and Tpt1 (p<0.01) at e20.5 following Dex exposure, 
relative to Saline controls. Each sample was from a male in a different litter.  N=7 
(for Saline and Dex samples). Data were analysed by t-test for all genes. Bars 












































6.3.1.3 Insulin Signalling Pathway 
Igfbp1 was significantly increased (p<0.01) with Dex treatment (Figure 6.5). 
Conversely, expression of Rps6k1 was significantly decreased (p<0.001) in Dex 
liver, whilst expression of isoform 2 (Rps6k2) and mRNA corresponding to the 
protein which these kinases act upon (Rps6) was not altered with treatment.   
 
 
Figure 6.5. Expression of insulin signalling pathway genes in F1 Wistar male rat 
liver at e20.5. Gene expression is expressed relative to the mean of Tbp and Hprt. 
Mean expression was increased for Igfbp1 (p<0.01) and decreased for Rps6k1 
(p<0.001) at e20.5 following Dex exposure, relative to Saline controls. Each sample 
was from a male in a different litter. N=7 Saline and 7 Dex. Data were analysed by t-











































6.3.2 Effects of Dex on F1 GCS-EGFP Sprague Dawley Liver Gene Expression 
Gene expression in the F1 GCS-EGFP livers at e19.5 was investigated, to explore 
whether the liver phenotype was similar to that for the Wistar rat, used in previous 
studies. Pup and placental weights were found to be significantly reduced with Dex 
exposure (p<0.01 and p<0.001 respectively) in this cohort, as reported in Chapter 
5.3.1.2. 
 
6.3.2.1 Effects on Glucocorticoid Regulation and Imprinted Genes 
Expression of Gr and 11β-Hsd1 was not altered with Dex treatment. However the 
expression of imprinted genes H19 (p<0.01), Cdkn1c (p<0.01) and Grb10 (p<0.05) 
was significantly increased in Dex-exposed pups (Figure 6.6). The expression of Igf2 
was not altered between groups. 
    
 
Figure 6.6. Expression of growth and imprinted genes in F1 GCS-EGFP male rat 
liver at e19.5. Gene expression is expressed relative to the mean of Tbp and Hprt. 
Mean expression was increased for H19 (p<0.01), Cdkn1c (p<0.01) and Grb10 
(p<0.05) at e19.5 following Dex exposure, relative to Saline controls. N=9 (for 
Saline and Dex samples). Data were analysed by t-test for all genes, except for 
Cdkn1c, for which a Mann-Whitney U test was performed. Bars represent mean ± 





































6.3.2.2 Effects on Array Genes 
Expression of Adh1 was increased (p<0.05) and Hmgb2 and Gelsolin decreased 
(p<0.05 and p<0.001 respectively) with Dex exposure (Figure 6.7). Tpt1 and Hspa5 
gene expression was not significantly altered between treatment groups. All data 
were normally distributed and analysed by t-test, except for Adh1, for which a Mann-




Figure 6.7. Expression of microarray genes in F1 GCS-EGFP male rat liver at e19.5. 
Gene expression is expressed relative to the mean of Tbp and Hprt. Mean expression 
was increased for Adh1 (p<0.05), and decreased for Hmgb2 (p<0.05) and Gelsolin 
(p<0.001) at e19.5 following Dex exposure, relative to Saline controls. N=9 (for 
Saline and Dex samples). Data were analysed by t-test for all genes, except for Adh1, 
for which a Mann-Whitney U test was performed. Bars represent mean ± standard 









































6.3.2.3 Effects on Insulin Signalling Pathway Genes 
As for the Wistar cohort, Igfbp1, found by microarray to be increased in Dex-
exposed pups, was studied. An increase in Igfbp1 expression (p<0.001) with Dex 
treatment was also seen in the livers of F1 GCS-EGFP rats at e19.5 (Figure 6.8).  As 
in Wistar rats, the expression of Rps6k1, downstream of Igfbp1 in the insulin 
signalling pathway, was decreased (p<0.05) in the Dex group, relative to Saline 
controls. Decreased expression was also found for the second isoform, Rps6k2 
(p<0.05). mRNA corresponding to the protein which RPS6K1 and 2 act upon (RPS6) 




Figure 6.8. Expression of insulin signalling pathway genes in F1 GCS-EGFP male 
rat liver at e19.5. Gene expression is expressed relative to the mean of Tbp and Hprt. 
Mean expression was increased for Igfbp1 (p<0.001), and decreased for Rps6k1 
(p<0.05) and Rps6k2 (p<0.05) at e19.5 following Dex exposure, relative to Saline 
controls. N=9 (for Saline and Dex samples). Data were analysed by t-test for all 
genes, except for Igfbp1 which was not normally distributed (p<0.01). A Mann-
Whitney U test was therefore performed. Bars represent mean ± standard error.  

































6.3.3 Summary of Gene Expression Results 
Table 6.1 summarises the expression data for Wistar and GCS-EGFP rats, indicating 
whether expression was increased, decreased or unaltered with Dex treatment, 
relative to controls.  
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Table 6.1. Summary of gene expression data for F1 fetal liver in Dex programming model. 
Gene expression for Dex-exposed pups is shown relative to Saline controls. Expression in 
Wistar cohort (e20.5), GCS-EGFP cohort (e19.5) and previous studies is shown. Dex exposure 
corresponds to increased (upward arrow), decreased (downward dotted arrow) or unaltered 
(equals sign) gene expression relative to controls, based on a minimum of p<0.05 by t-test or 
Mann-Whitney U test. Blue font indicates a consistent pattern of expression between strains. 




6.3.4 Effects on GCS-EGFP DNA Methylation (ERRBS) 
DNA methylation was explored at a nucleotide level in liver DNA from F1 e19.5 
GCS-EGFP rats, and was highly correlated between Dex and Saline samples, both 
within and out with CpG islands (Pearsons R
2
 values of 0.976 and 0.960 
respectively) (Figure 6.9). Biseq analysis identified 9 gene clusters which had 
significantly different methylation scores following Dex exposure (Table 6.2), 
however only 2 clusters, on Chromosome 13 and 20 had a difference in methylation 
reads of greater than 10%. Methylation values represent the combined number of 
methylation positive (1) and methylation negative (0) reads across the 3 samples per 
treatment group.  
Two clusters were identified within gene bodies – cluster 787 on chromosome 5 
(denoted as Chr5_787) and cluster 284 on chromosome 7 (Chr7_284).  For 
Chr5_787, Dex exposure gave a decrease in methylation of 6-7% methylation at 5 
DMCs. At Chr7_284, 2 CpGs had a decrease in methylation of 6.2%. The greatest 
decreases were identified in the Dex-exposed group for Chr13_572 (12.8-13.2%) and 


















Figure 6.9. Median methylation status of cytosines in Dex and Saline liver DNA. 
Each data point represents a single cytosine. The median methylation status across all 
reads from all samples (n=3 Dex and n=3 Saline) is given, based on 100 representing 
a methylated read, and 0 an unmethylated read aligning to that cytosine. Cytosines 
with fewer than 10 repeats were excluded from the analysis. The red line indicates 




















113187590 0.128 6.71E-06 





41652434 0.051 2.12E-06 





615738 0.071 1.44E-06 





10270586 0.169 3.31E-08 





115122142 0.054 7.62E-06 
115122143 0.054 4.49E-06 
115122153 0.058 1.69E-08 








144350984 0.063 1.41E-07 
144350985 0.063 2.75E-07 
144350991 0.062 6.61E-06 





13047750 0.062 1.39E-24 





6514491 0.093 8.43E-06 
 
Table 6.2. DMCs in F1 e19.5 liver DNA following Dex exposure. The position of 
CpGs differentially methylated between treatment groups is given in terms of 
chromosome (Chr), base position and cluster. The median methylation status across 
all reads from all samples (n=3 Dex and n=3 Saline) is given, based on 1 
representing a methylated cytosine, and 0 an unmethylated cytosine. The difference 
in methylation represents the methylation status of the Saline group minus that of the 
Dex group. Positive values therefore indicate decreased methylation in Dex samples. 







These data indicate that Dex exposure in utero alters the expression of several genes 
across multiple pathways in fetal liver. Some of the genes had been previously 
researched, allowing comparison with previous cohorts. Other candidate genes were 
novel targets, explored to give a greater understanding of the effects of Dex on the 
developing fetus. Dex treatment affected gene expression in both wild-type Wistar 
and GCS-EGFP Sprague Dawley rats, with some changes exhibited in both strains, 
whilst others appeared to be strain-specific.  
Expression of Gr was increased in Wistar rat liver at e20.5 following Dex exposure 
(see Table 6.1). This is in keeping with previous studies which show that the 
expression of Gr in the liver is increased at PND5 and in adulthood following in 
utero Dex exposure in rats [8,354]. It is also in keeping with studies that found an 
increase in Gr expression at e20.0 liver following maternal protein restriction [299]. 
Such an increase in Gr expression may mediate the effects of Dex, for example the 
increased Pepck mRNA expression, first exhibited at PND5, and persistent at 8 
months, through its action in regulating gene transcription [8]. Indeed Gr expression 
has been shown to be increased in the skeletal muscle of type II diabetes patients, 
compared to controls, with Gr expression levels inversely correlated with insulin 
sensitivity [355]. Furthermore, administration of the insulin sensitising agent 
metformin abolished an increase in Gr with Dex programming [354].  
Conversely the expression of Gr was not altered with Dex in the GCS-EGFP cohort, 
bearing similarity to the studies in Dex programmed marmosets [75]. This may 
represent a strain-specific difference in response to Dex. For example, strain of 
mouse was shown to influence the phenotype of an 11β-Hsd1 knockout [356]. This 
variation could also be due to the difference in time-point between GCS-EGFP 
(e19.5) and Wistar (e20.5) tissues. As previous studies have explored the relationship 
between prenatal Dex exposure and Gr expression postnatally [8], it is possible that a 
change in Gr expression is not established until e20.5. Indeed, the expression of Gr 
normally increases in late gestation [38], so a Dex-induced change in Gr expression 
might not be visible until later time-points.    
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The expression of 11β-Hsd1, involved in the activation of corticosterone was 
unaltered between Dex and Saline groups in both Wistar and GCS-EGFP rats. This is 
in keeping with previous studies which found no change in the hepatic expression of 
this enzyme at PND5 or in adulthood [8]. It does however confirm a difference in 
response to Dex programming between rats and marmosets, where increased hepatic 
11β-HSD1 was observed postnatally [75].   
An increase in expression was also seen in the imprinted genes H19, Cdkn1c and 
Grb10 in the GCS-EGFP, but not Wistar cohort (see Table 6.1). This discrepancy is 
likely to result from the difference in time-point between cohorts, rather than strain 
differences, because Drake et al. (2011) report an increase in the expression of these 
genes in Wistar rats at e20.0 [12]. Indeed, previous data indicates that fetal liver gene 
expression can change rapidly, within a day of gestation (Drake et al., unpublished 
data). It is fitting that Cdkn1c and Grb10, which restrict fetal growth [305,309], 
should be increased in the Dex model, where birth weight is decreased. It is 
intriguing that the expression of H19 was also increased, whilst the expression of 
Igf2, of which it is proposed to be a negative regulator, was not altered in either 
Wistar or GCS-EGFP cohorts [310,311]. This may result from a complex regulation 
of the H19/Igf2 locus, involving various regulatory elements, such as antisense RNA 
[357].  Unaltered Igf2 expression is in contrast to the increased expression 
demonstrated previously [12], but may reflect a precise interaction of strain and time-
point. It does however fit with the programming phenotype that Igf2, which is 
paternally imprinted to promote fetal growth [307,308], would not be increased in a 
model of low birth weight.    
Altered expression was also seen in some of the candidate genes chosen based on a 
previous microarray (see Table 6.1). The significant increase in expression of Adh1 
following Dex exposure, identified on the microarray was validated in both strains. 
Because castration of male rats corresponds to an increase in activity of liver ADH1, 
I hypothesise that the Dex-induced increase in expression may be a consequence of 
the  decreased testosterone levels which have been reported in F1 offspring of Dex-
exposed dams between e19.5 and e21.5 [317,358]. As previously discussed, the 
importance of the correct expression of Adh1 is evidenced by studies indicating the 
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detrimental effects of Vitamin A deficiency or excess in fetal development 
[314,315]. As knockout of Adh1 decreases the production of active Vitamin A 
derivatives [359], I hypothesise that a Dex-mediated dysregulation of Adh1 would 
alter Vitamin A levels, potentially promoting abnormal fetal development. If this 
increase in Adh1 was also found in the testis, it might affect testicular development 
since research has indicated that increased Vitamin A can have a wide range of 
effects on the developing testis [360]. For example, retinoic acid can inhibit the pre- 
and early post-natal development of seminiferous tubules [361,362], and impact 
upon the development of cultured germ, Sertoli and Leydig cells [363]. If Dex was 
found to mediate changes in testicular Adh1, this could have longer lasting influences 
on spermatogenesis. 
In accordance with microarray data Hmgb2 and Gelsolin expression was reduced in 
GCS-EGFP rats. Hmgb2 is thought to have roles in transcriptional regulation, DNA 
repair, extracellular signalling, and cellular differentiation [318-320]. A Dex-
mediated decrease in the expression of Hmgb2 may therefore affect chromatin 
compaction and repair in the developing fetus.   
A decrease in Gelsolin mRNA expression could promote inflammation and 
susceptibility to insulin resistance. Gelsolin knockdown in adipocyte cells was 
associated with increased expression of the pro-inflammatory genes TNFα and Il6 
which may decrease triglyceride content, potentially lowering the risk of heart 
disease [324,325]. In this way decreased Gelsolin expression may be a protective, 
compensatory mechanism in programming. Furthermore, a Dex-induced alteration of 
Gelsolin, if also found in the epididymis, may also impede sperm maturation due to 
its role in regulating the actin cytoskeleton of sperm, and their subsequent uptake of 
calcium [326]. As a decrease in Hmgb2 and Gelsolin is found in the microarray from 
Wistar tissues and my GCS-EGFP rats, but not the Wistar cohort, I hypothesise that 
these changes are time-point-specific rather than strain-specific.  
The increase in expression of Igfbp1 identified by microarray was validated in both 
Wistar and GCS-EGFP cohorts.  As IGFBP1 binds IGF1 an increase in expression 
should decrease the amount of growth factor circulating.  Indeed, increased IGFBP1 
in amniotic fluid is also associated with lower birth weight in humans [339]. 
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Expression was also increased in the placentas of fetuses with intra-uterine growth 
restriction [340]. This could also represent a compensatory mechanism, acting to 
protect insulin sensitivity. In longitudinal studies decreased circulating IGFBP1 
levels were correlated with subsequent glucose intolerance and diabetes [336,337]. 
Furthermore low fasting plasma IGFBP1 levels were correlated with increased 
cardiovascular disease risk factors, such as high blood pressure and blood 
triglyceride concentration [338]. 
The expression of RPS6K isoforms 1 and 2 and the target of their phosphorylation 
RPS6 was studied. Expression of Rps6k1 mRNA was reduced in both Wistar and 
GCS-EGFP cohorts, whilst Rps6k2 was only reduced in GCS-EGFP rats. This 
relationship of an increase in Igfbp1 with decrease in Rps6k1 is consistent with 
antisense RNA Rps6k1 knockdown studies, where there was a dose-dependent 
increase in hepatic Igfbp1 expression [346]. This corresponded to improved insulin 
sensitivity. Furthermore, knockout of Rps6k1 in mice blunts responsiveness to IGF1 
[342], and was shown to protect against a loss of insulin sensitivity in ageing, and to 
increase lifespan [344].  It also protects insulin sensitivity in mice fed a high-fat diet, 
potentially through downregulation of the negative feedback loop through IRS1 
[345]. A decrease in Rps6k1 expression with Dex treatment may therefore act to 
counter insulin resistance.  
Expression of the second isoform, Rps6k2 was also reduced, but only in GCS-EGFP 
rats. This could represent either a strain-specific or a time-point-specific change. 
Whilst RPS6K1 and RPS6K2 work together to phosphorylate RPS6, the phenotype 
of specific knockouts is different. Rps6k1 knockout mice were significantly lighter 
both prenatally and postnatally, than wild-type controls, whilst Rps6k2 weight was 
unaffected [347]. It therefore fits that in a model of low birth weight, Rps6k1 
downregulation may be more important. Indeed if the main action of these kinases is 
to phosphorylate RPS6 rather than regulating its expression, it is not surprising that 
Rps6 levels are not altered with changes in Rps6k1 or Rps6k2. Any effect on Rps6 
might be further explored by comparing Western Blots for phosphorylated and 
unphosphorylated RPS6 protein.   
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Whilst many of the changes in gene expression proposed by the microarray were 
validated in either or both of my cohorts (Table 6.1), those for Tpt1 and Hspa5 did 
not. This could reflect a cohort- or specific time-point-dependent change, or indeed a 
false positive in the microarray.   
Taken together, these data suggest that in both Wistar and GCS-EGFP rats there are 
changes in fetal liver gene expression with Dex exposure. Some may be a reflection 
of decreased birth weight and fetal growth, but also potentially promote the 
associated negative cardiometabolic phenotypes. Conversely, some of these and 
others may also form part of a compensatory mechanism, protecting insulin 
sensitivity. Further studies, including Western Blots, would confirm whether changes 
in gene expression confer changes in protein levels. Given that many of the genes 
studied were also explored by a microarray in Wistar rats it is possible to make 
educated hypotheses regarding which differences between cohorts are due to strain, 
and which are due to the exact time-point. However further studies with Wistar and 
GCS-EGFP tissues collected at exactly the same time-point, or of one strain at 
multiple time-points, would also confirm the basis for differences in gene expression 
between cohorts. These studies do however give an indication of the effects of Dex 
treatment on fetal liver, informing further studies.  
Furthermore, ERRBS data indicated that at the sites investigated, there was no global 
difference in methylation between Dex and Saline groups in F1 e19.5 liver. When 
looking at specific cytosines however, a significant decrease in methylation status of 
around 13% was identified at Chr13_572, as identified by Biseq analysis. This 
cluster does not lie within a gene body or promoter, but exists 80kb upstream of the 
SET and MYND Domain Containing 2 (Smyd2) gene. Intriguingly, SMYD2 is an N-
lysine methyltransferase which methylates H3K4 and H3K36 [364]. It can also 
interact with RNA polymerase II, giving another potential role in regulating gene 
expression [365].  SMYD2 also methylates Lysine 370 in p53, repressing the 
expression of this tumour suppressor, and increasing the expression of p53-regulated 
genes [366,367]. Indeed, inhibiting Smyd2 expression by short interfering RNA 
promotes p53-induced apoptosis [366]. Combined with an ability to methylate the 
retinoblastoma tumour suppressor [368], this suggests that SMYD2 may therefore 
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have an oncogenic function [366]. Recently Sese et al. (2013) showed that Smyd2 is 
highly expressed during human ES cell differentiation, and that knockdown in 
zebrafish correlates with developmental delay [369]. Therefore Smyd2 could have an 
important role in cellular differentiation, and consequently early development.    
It is possible that Chr13_572 could encode, for example, an enhancer for this gene, 
influencing its expression. Clearly, with roles in regulating gene expression, 
dysregulation of Smyd2 could have a widespread impact on gene expression, 
although the literature does not indicate specifically what effect this might have in 
the liver.   
Nine clusters in total had significantly altered methylation scores. Of those, only 2 
were within gene bodies – cluster 787 on chromosome 5 and cluster 284 on 
chromosome 7. The former had 5 cytosines that were each differentially methylated 
by 6-7% and the latter had 2 cytosines both differentially methylated by 6.2%. 
Although this difference is smaller than for cluster Chr13_572, near Smyd2, where 
there was approximately 13% change in methylation score, it is still in keeping with 
Drake et al. (2011) where there was a 5-6% change in methylation in Dex-exposed 
liver. As previously discussed, a similarly moderate change in methylation was 
reported in studies of intra-uterine growth restriction [294], and 20% variations at 
Igf2 DMRs implicated in the growth restriction associated with Silver-Russell 
syndrome [295]. It therefore appears that subtle changes in methylation may have 
relevance for development.    
Little is known about the gene corresponding to Chr5_787, Adenylate Cyclase-
Associated Protein 1 (yeast) (Cap1), which is related to the CAP protein in 
Saccharomyces cerevisiae, involved in the cyclic AMP pathway [370]. In humans 
CAP1 has been shown to interact with another member of the family, CAP2, and be 
involved in the recycling of actin filaments in cultured human cells [371]. 
Interestingly, single nucleotide polymorphisms in the Cap1 gene have been found in 
association with type II diabetes [372]. It is therefore not clear exactly what effect 
differential methylation of Cap1 might have in the liver, before further study of the 
function of the Cap1 gene, but the literature hints that it could have some relevance 
for metabolic disease.  
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The second gene encoding cluster with differential methylation, Chr7_284 
corresponds to Basigin. This extracellular receptor is important in a number of 
pathways due to its role in intracellular recognition. For example, Basigin binds 
Cyclophilin A acting as a mediator in the inflammatory response [373]. Knockout of 
Basigin in mice is predominantly embryonic lethal at the point of implantation, 
potentially due to incorrect intracellular recognition. Those mice that survived were 
infertile, with primary spermatocytes present, but an absence of sperm production, 
potentially due to the interruption of meiosis during spermatogenesis [374]. Very 
recently it has also been indicated that Basigin may facilitate the interaction of germ 
and Sertoli cells during spermatogenesis [375]. For both Cap1 and Basigin it is not 
clear what effect a change in liver methylation might have on the developing fetus, 
although the literature does suggest that in other organs they do have important roles 
in development and metabolism.        
These genes differ from previous studies where, for example, Drake et al. (2011) 
indicate a decrease in methylation at Igf2 DMR2 in e20.0 liver with Dex exposure 
[12]. The fact that this was not found in the current study could reflect a difference in 
response to treatment between strains or cohorts. It is also possible that ERRBS is 
not sufficiently sensitive to detect a change in methylation reported to be 
approximately 4-5%. Because so many cytosines are studied in this technique, the 
threshold p value for statistical significance is much lower, in order to control the 
false discovery rate [376]. As approximately 1M cytosines are covered in our study, 
a standard significance threshold of p≤0.05, used in pyrosequencing would yield 
50,000 false positive DMCs. As such, a lower p value threshold is calculated, which 
could mask subtle differences. A greater ‘n’ was also used in Drake et al. (2011), 
which gives a greater likelihood of detecting subtle changes. It might be necessary to 
perform ERRBS on more replicates to be able to detect more subtle changes in gene 
expression [294].  
It is possible that Dex could induce larger changes in methylation, out with CpG 
islands, predominantly favoured by RRBS. The ERRBS technique has a greater 
coverage of these areas than RRBS as it characterises longer fragments from MSP1 
sites, with for example a 54% increase in CpG island shore data [278]. There is 
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however, still a bias towards areas of high CpG density, although research has 
suggested that regions out with CpG islands can also be biologically relevant 
[113,278].  
The current data could also indicate that other epigenetic mechanisms, such as 
histone modifications or ncRNA may be more influential than DNA methylation in 
mediating the observed changes in liver gene expression in Dex programming. 
However, caution needs to be exercised in the interpretation of this data before 
further validation is performed. Validation of changes in DNA methylation could be 
performed using pyrosequencing, with primers specific to DMRs identified by 
ERRBS. Any resulting effect on gene expression could then be studied using qPCR, 
and on protein levels, by Western Blot.  
A major benefit in choosing ERRBS for these studies is that it focusses on CpG rich 
regions which are most likely to be methylated, reducing the cost of sequencing, 
whilst still giving relevant data [278]. As this technique was also initially chosen for 
the germline studies in Chapter 5, where cell numbers, and therefore DNA quantity 
was very limited, it was particularly useful that ERRBS can be performed on low 
quantities of DNA (approximately 100ng), compared with the 5µg required for some 
other studies. However, bisulfite sequencing cannot distinguish between 5hmC and 
5mC, which essentially limits our interpretation and curtails our conclusions [296]. 
Further studies should also include a genome-wide technique which can distinguish 
between different forms of methylation. For example, methylated DNA 
immunoprecipitation (MeDIP) uses an antibody to isolate methylated DNA for 
subsequent sequencing [297]. An antibody specific to 5mC or 5hmC can therefore be 
used, distinguishing between these two forms of methylation. Our current analysis 
does not take into consideration the possible contribution of 5hmC and the TET 
family of protein dioxygenases in contributing to DNA modification profiles [377]. 
This may be particularly relevant as recent work demonstrates that 5hmC profiling 




Taken together, these data suggest that there are alterations in gene expression in 
response to Dex treatment in both Wistar and GCS-EGFP fetuses, with some 
common and some species-specific alterations. This adds to the knowledge of the 
effects of Dex programming and provides direction for further study. Limited effects 
of treatment were seen on DNA methylation, as studied by ERRBS, although some 




















Chapter 7 Discussion 
 
The main aim of this thesis was to explore whether the transmission of the Dex 
programming phenotype through the male germline occurs through epigenetic 
mechanisms. Within this I aimed to confirm that epigenetic reprogramming occurs in 
the rat and give a timeframe for the phase of remethylation. I also explored the 
presence of all known forms of DNA methylation during germ cell development, 
both pre- and postnatally. I then sought to identify a key time-point of change in 
global germ cell DNA methylation during reprogramming with Dex exposure. 
Furthermore, I investigated the suitability of GCS-EGFP rats for Dex programming 
studies, and used them to explore changes in germ cell DNA methylation. I also 
aimed to further investigate the relationship of Dex exposure with gene expression 
and DNA methylation in fetal liver.  
 
7.1 Exploring Epigenetic Reprogramming in the Rat Germline 
In this thesis, I gave the first demonstration of the occurrence of epigenetic 
reprogramming of DNA methylation in rat fetal germ cells. Little 5mC was detected 
by immunofluorescence in male germ cells until e19.5 where some germ cells had a 
positive detection for 5mC, becoming augmented by e20.5. This indicated that an 
asynchronous bulk 5mC DNA remethylation phase was occurring in the rat between 
e19.5-e21.5. This is in keeping with mouse data, which indicates that bulk 
remethylation occurs prenatally in male germ cells [178,184,196]. The exact timing 
of demethylation was of less relevance for our studies, as bulk 5mC appeared to have 
been lost prior to the period of Dex exposure in the Dex-programming model. 
However 5mC and 5hmC were explored at e12.5 and e13.5, and whilst little 5mC 
was detected at either time-point, 5hmC was present. This suggested that the period 
of bulk demethylation occurs before e12.5 in the rat, which is again in keeping with 
mouse studies, reporting bulk demethylation from e11.5-e12.5 [14,177]. 
It was intriguing that 5hmC, 5fC and 5caC were detected in germ cells from e14.5-
e16.5. This is the first report of 5fC and 5caC detection in germ cells, although 5hmC 
has previously been reported in mouse fetal germ cells [252]. As 5hmC, 5fC and 
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5caC can be produced by progressive oxidation from 5mC, and have been proposed 
to form part of a putative DNA demethylation pathway [149,150], it is not surprising 
that they are present during epigenetic reprogramming. It is however intriguing that 
5fC and 5caC should be detected over a 3 day period, since previous research 
indicates that TET2 is capable of rapidly converting 5mC through its different 
methyl forms [149]. Therefore the continuing presence of 5fC and 5caC could reflect 
a gradual and constant removal of 5mC during e14.5-e16.5. In this case the 5fC or 
5caC at any particular base may be rapidly removed, but the constant turnover might 
give the appearance of a more stable expression of 5fC and 5caC when assessed 
globally. This is supported by the identification of TDG throughout e14.5-e16.5, 
indicating that there is the potential for continual removal of 5fC and 5caC 
throughout this time period. Conversely, it could be hypothesised that there is an 
accumulation of these methyl forms during the period of demethylation, with bulk 
removal between e16.5 and e17.5. In both cases, it is possible that the continued 
presence of 5fC and 5caC has some functionality in germ cell development. 
Furthermore, the dynamic changes in detection of 5hmC, 5fC and 5caC postnatally 
were particularly intriguing, as bulk demethylation was not expected or detected at 
these time-points. Taken together, these studies suggest that 5hmC, 5fC and 5caC 
could have a functional role in germ cell development, in addition to forming part of 
a demethylation pathway. This is supported by previous work indicating that these 
forms may have some, as yet undetermined, role in development [157].  
Clearly, there is still much to be discovered about the dynamics and potential roles of 
these additional forms of methylation. Performing base-pair resolution analysis of the 
localisation of 5fC and 5caC, such as the modified bisulfite sequencing protocol from 
Wang et al. (2014) might give greater clarity [169]. This could identify whether these 
modifications have a stable presence across the whole genome from e14.5-e16.5, or 
if they exist at different loci at different time-points, reflecting their continual 
removal. Identifying their localisation would also give greater insight into their 
potential functionality. Furthermore, studies in mice indicate that the timeframe for 
remethylation in epigenetic reprogramming is later in females [184,197]. It would be 
interesting to study this process in female rats, comparing the time-course to that 
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found in males and exploring whether 5hmC, 5fC and 5caC are also present in mid-
gestation germ cells.   
     
7.2 Exploring the Suitability of GCS-EGFP Rats for Dex Programming 
Studies 
As GCS-EGFP rats were reported to have germline specific expression of EGFP, a 
colony was established so that pure populations of fetal germ cells and adult sperm 
could be isolated by FACS-sorting, and used for base-specific methylation studies. 
Because these rats were new to The University of Edinburgh, their use had to be 
optimised, and their phenotype explored. Immunofluorescence indicated that EGFP 
expression was tissue-specific, and germ cell-specific within the testis. A further 
confirmation of EGFP localisation was given by gene expression analysis of FACS-
sorted cells from the fetal testis. Therefore, in keeping with Cronkhite et al. (2005), 
EGFP expression was confirmed to be germline-specific in this strain of rats, at least 
in the male [92]. However, whilst performing FISH identifies the genomic region of 
the EGFP insert, Cronkhite et al. (2005) did not report the exact location, or indeed 
copy number of EGFP. Whole genome sequencing would allow this to be identified, 
adding to the characterisation of this strain. If the insert is likely to affect the function 
of genes crucial, for example in regulating PGC development, this could influence 
the observed phenotype in response to Dex exposure, and should be considered when 
interpreting the results.   
As Wistar rats had been used for the immunofluorescence studies in Chapters 3 and 
4, as the GCS-EGFP colony had not yet been established, I confirmed that the time-
course for epigenetic reprogramming of DNA methylation, and the Dex 
programming phenotype were similar in both strains of rat. Prenatal Dex exposure 
corresponded to reduced birth weight and e19.5 fetal and placental weight in the F1 
generation.  To ensure that this phenotype would be transgenerational, F1 Dex males 
and Saline females were bred, and had offspring with a significantly reduced birth 
weight compared to those whose parents had both been exposed to Saline in utero. 
Thus a low birth weight phenotype was seen to be transmitted to an F2 generation, 
through the male line, as previously found in Wistar rats [10].  
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7.3 Exploring Effects of Dex Exposure on Epigenetic Reprogramming 
The effects of Dex programming on epigenetic reprogramming were explored in two 
different studies. In Chapter 4, the effects of Dex exposure on global 5mC 
remethylation were explored by immunofluorescence. At e19.5 more 5mC positive 
germ cells were identified with Dex exposure, relative to controls, although this 
difference had resolved by e20.5. I therefore hypothesised that the epigenetic 
reprogramming time-line might be shifted forward slightly with Dex exposure, and 
that e19.5 was an interesting time-point for further study.  This change however did 
not correspond to alterations in the localisation of DNMT3a or 3b, or indeed the 
global time-course of DMRT1, used as a marker of testis development.  
Fetal germ cells were then isolated at e19.5 by FACS sorting, DNA extracted and 
ERRBS performed to explore the localisation of methylation at a base-specific level. 
Of the DMCs, hypermethylation was more prevalent than hypomethylation, 
indicating that there might be accelerated remethylation in a subset of genes. To 
further explore this hypothesis, germ cell DMCs were grouped by whether the 
corresponding gene in control fetal liver had high, medium or low levels of 
methylation.  Intriguingly, there was prevalence of hypermethylation in DMCs which 
had highly methylated corresponding genes in the liver, and of hypomethylation in 
DMCs with low liver methylation. This comparison is clearly imperfect, due to 
differences in the methylation profile between cell types, but gives some weight to 
the hypothesis that Dex may accelerate the acquisition of the completed state of 
remethylation in germ cells.  
Biseq analysis then indicated which of these DMCs were statistically significant, and 
where clustering of significant DMCs occurred. 5 regions were identified as having 
significant DMCs with at least 5% change in methylation between Dex and Saline 
e19.5 germ cell samples. Chr3_2256, corresponding to the Ralgapb gene, had a 
consistent decrease in methylation across 5 DMCs.  This gene is involved in 
regulating the action of RalA and RalB GTPases, which in turn regulate a range of 
cellular processes, such as transcription, translation and cell survival [281]. 
Intriguingly, RalA has also been shown to have a role in regulating glucose uptake in 
adipocytes in response to insulin [282,283]. 
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Conversely, increased methylation was seen at Chr5_2324, Chr5_2589, and 
Chr6_540. The biggest increase (12.2%) was found at Chr6_540, corresponding to 
the Pdia6 gene. The PDIA6 protein has a role in protein folding and the regulation of 
calcium homeostasis within the endoplasmic reticulum [290,291]. Chr5_2589 
corresponds to the circadian clock gene Per3, which has been found to be 
upregulated in hepatocellular carcinoma, with Per3 polymorphisms altering disease 
prognosis [287,288]. Any effect of decreased methylation on gene expression in our 
study has not yet been characterised. However, previous research indicates that Dex 
exposure increases the expression of Per3 in cultured rat fibroblasts, and that it 
increases liver expression of the associated Per1 gene in vivo [289].   
Increased methylation was also seen at Chr5_2324 in Dex-exposed germ cells. This 
corresponds to the Spen gene, encoding transcriptional repressors [285]. Knockout of 
MINT, encoded by the Spen gene in mice corresponded to embryonic lethality, with 
liver, heart and pancreatic abnormalities in the fetus [286]. Therefore Spen appears to 
be of relevance for transcriptional regulation in development. An increase in DNA 
methylation was also seen at Chr5_2393. The closest annotated gene to this cluster 
was Pramel1, a member of an LRR family involved in a range of pathways through a 
role in facilitating protein-protein interactions [292,293]. In the mouse, expression of 
this gene was identified solely in the testis, and specifically in the acrosome of sperm 
during spermatogenesis [293].  
Although there are associations with the regulation of glucose uptake, development, 
and transcription, the precise effect of altered methylation of these genes in the fetal 
germ cell is unknown. Due to a substantial delay in receipt of data following initial 
sequencing issues, and subsequent time constraints, validation of ERRBS data was 
not performed. Pyrosequencing should be conducted to confirm the base-specific 
changes reported for ERRBS, and qPCR should be used to compare changes in DNA 
methylation with gene expression. It should also be considered that in some cases, 
altered methylation corresponds to a single DMC, as identified by ERRBS, therefore 
caution should be exercised with inferring significant biological relevance. 
Furthermore, some of the clusters represent relatively small changes of only 5-6% 
with Dex exposure. This, however is in keeping with previous studies in the Dex 
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model, showing 5-6% changes in liver DNA methylation [12]. Indeed, subtle 
changes in DNA methylation have also been reported in studies of growth restriction 
[294,295], suggesting that small changes could still be of physiological relevance.  
The effect of Dex exposure on fetal germ cell methylation has not previously been 
studied in any species. However this data is in keeping with Radford et al. (2014) 
who report that in utero undernutrition in mice corresponds to hypomethylation at 
some loci in adult sperm, in the absence of a global change in methylation [93]. 
These DMCs were also identified to be hypomethylated at e16.5, suggesting aberrant 
remethylation. Indeed, of the regions seen to be hypomethylated in sperm, 43% are 
known to be resistant to whole embryo reprogramming, suggesting that these 
changes could influence the phenotype of the next generation [93]. Hammoud et al. 
(2014) also demonstrated that DNA methylation profiles are strikingly conserved 
throughout the process of spermatogenesis [211]. This supports the theory that 
changes in DNA methylation in the fetal germ cells, which form the progenitors of 
the spermatogenic pathway, could be maintained in mature sperm and therefore 
transmitted to the next generation.    
The predominance of hypermethylation amongst DMCs was identified both within 
and out with CpG islands. As CpG islands are predominantly unmethylated it was 
fitting that the majority of DMCs should be located out with CpG islands [112]. 
However, it has been suggested that orphan CpGs islands are frequently methylated 
during development [112], indicating that DMCs at CpG islands, although few in 
number, may be of particular relevance in the programming phenotype.  
However, germ cell DMCs formed a small proportion of the total number of 
cytosines studied by ERRBS and the majority of cytosines did not show differential 
methylation between Dex and Saline groups. This could result from the fact that 
ERRBS only interrogates a small proportion of the genome. The process of 
enzymatic cleavage favours CpG dinucleotides, and so will capture the majority of 
promoters and CpG islands, but will not cover all sites of methylation [275]. ERRBS 
selects longer MSP1 fragments, enabling the capture of more regions out with CpG 
islands than in standard RRBS, however some DMCs will still be missed [278]. 
Furthermore, ERRBS cannot discriminate between different forms of methylation. 
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Whilst timeline immunofluorescence studies indicate that there is not a global 
prevalence of 5hmC, 5fC or 5caC at e19.5, as in mid-gestation, these forms may still 
have some influence on the observed methylation differences between groups, 
particularly as the percentage change in DMCs is relatively modest (10-30%). Data 
should therefore be supplemented with DNA immunoprecipitation studies, allowing 
the identification of individual methyl forms, particularly as they have recently been 
shown to be effective with 5fC and 5caC antibodies [152].  It is also possible that the 
differences between immunofluorescence and ERRBS data result from variation in 
the exact time of fertilisation. Although rats were time mated, and were previously 
found to mate quickly after pairing (Drake et al., Unpublished data), the exact time 
of fertilisation could vary slightly between, and even within litters. As bulk 
remethylation was found to occur over a short time period, between e19.5 and e20.5, 
it is possible that slight differences in age of the pups could have an effect on the 
result.  The impact of this issue was reduced by performing ERRBS on three samples 
each pooled from three litters, giving nine different litters per group. Indeed one 
pooled Dex sample was found to have greater global methylation than the others. 
Future studies using in vitro fertilisation would remove this variable. 
Fetal liver was used as an indicator of baseline DNA methylation and allows some 
reference point for DMCs in Dex-exposed germ cells at e19.5. However, a more 
relevant comparison could be made if a second ERRBS study were to be performed 
on fetal germ cells at e20.5. This would give greater clarity as to whether DMCs at 
e19.5 represent accelerated remethylation, and if these changes are persistent in the 
germline. A better understanding of the involvement of DNMTs in changes in 
methylation might be achieved by performing a DNMT enzyme activity assay, as in 
Luo et al. (2013) [380]. This would give a quantitative analysis of the activity of 
these enzymes following Dex exposure, indicating whether this might underpin a 
change in remethylation. A wider understanding of the effects of Dex on the 
developing germ cell would also be obtained by studying effects on other epigenetic 
mechanisms, such as ncRNA and histone modifications. Previous studies indicate 
that histones may be altered in the germline as a result of diet [213,214,238], and that 
early life stress may alter sncRNA in sperm [241]. It is therefore possible that Dex 
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exposure also alters these epigenetic marks, which in combination with DNA 
methylation allow transmission of the programming phenotype.    
The studies in this thesis predominantly explore the direct effects of Dex exposure on 
the F1 developing pup, both in the germline and in the liver. The characteristic 
decrease in birth weight was found in the experiments presented in this thesis, and 
indeed, this was transmitted to a second generation when studied in GCS-EGFP rats. 
Therefore, this suggests that the previously characterised Dex programming 
phenotype had been replicated. Previous studies have shown that effects of Dex 
exposure are found in the F2, in terms of pup weight, gene expression, PEPCK 
expression and glucose tolerance [10,12]. We therefore hypothesise that observed 
effects on the F1 germline DNA methylation, if validated, may have influence on the 
development of the F2 offspring. Such effects on the F2, however, may not be truly 
inherited, in the sense that there has been some exposure, in the form of F1 germ 
cells, to the initial insult. Thus, whilst the experiments in this thesis, with the 
exception of GCS-EGFP F2 birth weight studies, look at the direct effects of Dex 
exposure on the liver and germ cells of the developing pup, they also explore the 
potential for indirect effects on the F2 generation, through alteration of the germline.    
Insight into the long-term impacts of Dex exposure on germline epigenetics would 
also be achieved by performing ERRBS on adult sperm samples. The DNA from 
such samples has been prepared, and is pending sequencing. This will allow a 
comparison of the DMCs established in fetal germ cells, during the period of Dex 







7.4 Investigating the Effects of Dex Programming on Liver Gene Expression 
and DNA Methylation 
Further insight into the effects of Dex programming in both Wistar and GCS-EGFP 
rats was achieved through gene expression analysis of fetal liver tissue. The 
expression of Gr, 11β-Hsd1 and imprinted genes implicated in growth and 
development was explored, to compare our cohorts to those of previous studies. Gr 
expression was increased in Wistar rats at e20.5, which is in keeping with studies by 
Nyirenda et al. (1998), showing increased expression shortly after birth [8]. No 
significant alteration in Gr expression was found in GCS-EGFP rats, or in 11β-Hsd1 
expression in either strain. Nyirenda et al. (1998) similarly found no change in the 
expression of 11β-Hsd1 in the rat, but did report an increase in hepatic expression 
postnatally in the Dex programmed marmoset [8,75]. Imprinted genes H19, Cdkn1c 
and Grb10 all had increased expression with Dex in GCS-EGFP, but not Wistar rats. 
Drake et al. (2011) had previously demonstrated an upregulation of these genes in 
Wistar rats, and so this discrepancy might result from a slight difference in time-
point between the two cohorts [12].  
A gene expression microarray had previously been performed in Wistar fetal liver, 
and I sought to validate some of the expression changes in the current study. Some 
validated in both cohorts, whilst others were only found in either Wistar or GCS-
EGFP rats. These variances could result from strain-specific or time-point-specific 
effects on gene expression. The difference in time-point between Wistar and GCS-
EGFP was a result of the Wistar cohort being collected prior to the identification of 
the e19.5 time-point for interest in germ cell studies.  To make best use of time, 
resources, and animal life, these tissues were used for a comparison between strains. 
Although the exact cause of variation in gene expression between cohorts may not 
always be determined, these studies do demonstrate that Dex exposure affects gene 
expression in the livers of Wistar and GCS-EGFP rats, with some similarities and 
some differences between cohorts. However, further clarity would be achieved by 
studying the same time-point in both strains. 
These data identified some interesting candidates for further study, such as the 
growth factor binding protein IGFBP1, found to have increased expression in fetal 
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liver of both strains following Dex exposure. This is supported by studies in humans 
which show an association between increased IGFBP1 protein in amniotic fluid and 
decreased birth weight [339]. Increased human placental Igfbp1 mRNA expression 
was similarly associated with intrauterine growth restriction [340]. As low 
circulating IGFBP1 protein has been correlated with increased cardiovascular risk 
factors such as glucose intolerance, diabetes and high blood pressure [336-338], a 
Dex-induced increase in Igfbp1 could represent a protective mechanism. I also 
explored the expression of RPS6K1, which exists downstream of IGFBP1 in the 
insulin signalling pathway [343]. Rps6k1 mRNA expression was significantly 
decreased with Dex-exposure in the fetal livers of both wild-type Wistar and GCS-
EGFP Sprague Dawley rats.  This is consistent with antisense RNA Rps6k1 
knockdown studies in adult Sprague Dawley rats, which demonstrated a dose-
dependent increase in hepatic Igfbp1 mRNA expression, and improved insulin 
sensitivity [346]. As previous studies also suggest that Rps6k1 knockout in mice is 
associated with a protection of insulin sensitivity in ageing or high-fat diet 
consumption [344,345], a decrease in Rps6k1 expression with Dex-exposure may 
also be protective, and act to counter insulin resistance. 
It would also be interesting to see if there were concurrent effects on other members 
of the insulin signalling pathway, such as IRS1 and members of the mTORC1 
cascade. Importantly, as the actions of RPS6K1/2 involve substrate phosphorylation, 
this should be studied by Western Blot for phosphorylated RPS6 protein, or IRS1 
[342,343]. Western Blot should also be performed for IGFBP1 and RPS6K1, and 
together this would confirm whether a reduction in mRNA expression reduces levels 
of the corresponding protein, and whether this confers a reduction in total substrate 
phosphorylation. The ultimate effects of Dex on this pathway could also be explored 
by measuring the blood pressure of the F1 adults, and insulin levels in ageing or 
response to high-fat diet, comparing results to Rps6k1 knockout studies [344-346].   
Some changes in DNA methylation were also identified in e19.5 GCS-EGFP liver by 
ERRBS. No global change in DNA methylation was exhibited, but Biseq analysis 
indicated that there were 9 clusters which were significantly differentially 
methylated. Of these, 2 aligned to annotated genes, Cap1 and Basigin. The observed 
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changes were relatively subtle (6-7%), yet this is in keeping with a previous 
candidate gene study by Drake et al. (2011) where a 5-6% change in methylation was 
identified in fetal liver following Dex exposure [12]. Intriguingly, single nucleotide 
polymorphisms in the Cap1 gene have been found in association with type II 
diabetes in human studies, suggesting it may have some, as yet undetermined, role in 
metabolic disease [372]. As for CAP1, the hepatic functions of Basigin have not been 
characterised, but it is thought to be involved in intercellular signalling, and 
potentially facilitates the interaction of Sertoli and germ cells during spermatogenesis 
[373,375]. The cluster with the most substantial difference in methylation between 
Dex and Saline groups did not correspond to a gene body, but was found 80kb 
upstream of Smyd2. This methyltransferase methylates H3K4 and H3K36, and can 
also interact with RNA polymerase II, giving another potential role in regulating 
gene expression [364,365]. SMYD2 has recently been suggested to have a role in 
development, being highly expressed during ES cell differentiation, with knockdown 
in zebrafish corresponding to a developmental delay [369].  I hypothesised that the 
cluster upstream of the Smyd2 gene could, for example, correspond to an enhancer 
region, and thus Dex-mediated differential methylation might ultimately influence 
the regulation of the Smyd2 gene. Clearly, with roles in regulating gene expression, 
dysregulation of Smyd2 could have a widespread impact on gene expression, 
although the literature does not indicate specifically what effect this might have in 
the liver. Taken together, this study indicates that Dex exposure corresponds to 
DMCs at a few locations of potential relevance for development and metabolism, 
providing candidates for further investigation.   
   
7.5 Relevance 
This study therefore contributes to our understanding of how environmental factors 
can influence the developing fetus, and its offspring. Dex programming may alter 
remethylation at a subset of genes in the developing germ cell, and as initial research 
in other models indicates that this could impact upon sperm, these changes could 
affect the development of the next generation. 
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Less is known about epigenetic reprogramming in humans, due to the limited 
availability of fetal tissue. However infertility has been shown to correlate with 
alterations in sperm methylation at loci key for growth and development, therefore it 
appears that DNA methylation can be changed in the human germline [224,225]. I 
hypothesise that in utero exposure to environmental factors may also alter DNA 
methylation in the developing human fetal germ cells and subsequent sperm. 
Improved understanding of the potential to transmit intra-uterine exposures to the 
next generation emphasises the importance of a healthy in utero environment for the 
development of the fetus and the subsequent generation. A greater understanding of 
these mechanisms also provides the foundation for future development of therapy-
based approaches. Indeed it has recently been shown that RNA targeting of DNMT1 
may enable gene-specific alteration of DNA methylation [381].  Although in its 
infancy, this suggests that carefully targeted therapeutic approaches may be possible 
in the future.  
 
7.6 Conclusion 
I have demonstrated that epigenetic reprogramming of DNA methylation occurs in 
the rat, given a time-frame for the phase of remethylation, and explored the presence 
of all known forms of methylation in the developing germ cell. I also explored the 
effects of Dex exposure on this global remethylation timeline, and identified more 
5mC positive germ cells at e19.5 following Dex exposure, relative to controls, 
indicating that remethylation may be accelerated. I then used GCS-EGFP rats to 
allow the isolation of pure populations of fetal germ cells for base-specific 
methylation analysis. ERRBS indicated that premature DNA remethylation may 
occur at a subset of loci, and future studies will explore whether these represent 
stable changes in germ cell methylation, and if they are transmitted to sperm. Novel 
changes in gene expression and methylation were also identified in the fetal liver. 
This study provides further insight into the transmission of the Dex programming 
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An enlarged version of two figures is provided, to make the localisation of 
immunofluorescence more visible.  Images originally displayed in Figure 3.3, 
presenting the localisation of 5mC and 5hmC in the fetal testis during mid gestation, 
are given in Figures A1 (e14.5-e15.5) and A2 (e16.5-e17.5). An enlarged version of 
Figure 5.6, comparing 5mC localisation in GCS-EGFP Sprague Dawley and wild-




  Figure A1 – Enlargement of Figure 3.3 Part 1 - Localisation of 5mC and 5hmC during mid 
gestation. Images of immunostained testis show 5hmC localisation in germ cells between e14.5-
e15.5 (A-B) (red, arrows). Some 5mC is also weakly detectable. Both 5mC and 5hmC are 




 Figure A2 – Enlargement of Figure 3.3 Part 2 - Localisation of 5mC and 5hmC during mid 
gestation. Images of immunostained testis show 5hmC localisation in germ cells at e16.5 (A) 
(red, arrows). Some 5mC is also weakly detectable. Neither forms of methylation are detectable 
in germ cells at e17.5 (B). Both 5mC and 5hmC are detectable in somatic cells throughout the 





Figure A3 – Enlargement of Figure 5.6 - Comparing 5mC localisation in GCS-EGFP Sprague 
Dawley and wild-type Wistar rat testis at e20.5. 5mC (green, arrows) was identified in the 
somatic cells of both strains, and the germ cells of both GCS-EGFP (A) and Wistar (B) rats at 
e20.5. Propidium Iodide (PI) acts as a nuclear counterstain.  Bar = 50µm. 
 
